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Abstract 
 
 
Testing can be a substantial driver of health care costs. Increase in test use over recent 
decades has occurred despite disappointing results from test accuracy evaluations. Poor 
quality and reporting of primary test accuracy studies and difficulties with understanding and 
application of test accuracy information are purported to be important contributors to this 
observed evidence ‘gap’.  
 
The objectives of this thesis were to: 
 Systematically review evidence concerning the understanding and application of test 
accuracy metrics. 
 Undertake primary research building on the review of understanding and application. 
 Assess whether the contribution of test accuracy reviews to the test accuracy 
evidence base is compromised by deficiencies in their contextual fit, or of included 
primary studies. 
 
Existing research concerned with understanding and application of test accuracy information 
is not driven by the needs of decision makers. Contrary to the prevailing view in the literature, 
findings of original research from this thesis demonstrate that probability revision is not a 
feature of diagnostic decision making. Choice of test accuracy metric however was shown to 
have a profound influence on diagnostic decision making. Deficiencies in question 
formulation and contextualisation of test accuracy reviews are undermining their contribution 
to the test accuracy evidence base. 
  
 
 
Executive Summary 
 
Background 
In recent decades the total number of tests ordered by doctors has increased substantially, 
despite observations that primary studies of test accuracy are characterised by poor 
reporting, poor quality and lack of contextual fit.  A particular feature of this gap between 
evidence and practice in diagnostic decision making, is that application of test accuracy 
evidence is purported to be far more problematic than application of evidence about 
interventions. Improving the accessibility (contextual fit and informed use of outcome 
measures) of test accuracy evidence has the potential to positively impact on test use. 
Systematic reviews and meta-analyses of test accuracy are increasing in number and 
prominence as a resource for diagnostic decision making and offer the opportunity to 
mitigate some of the current limitations of primary studies. In particular, by considered 
framing of research questions and by enabling a comparative approach to test evaluation. 
The potential of systematic reviews to improve evidence based testing has been supported 
by the relatively recent and rapid development of statistical techniques for undertaking meta-
analyses. However the potential for new summary test accuracy measures generated by 
these statistical developments to exacerbate problems with application of test accuracy 
evidence has not been investigated.  
Aims  
The aims of this thesis were to assess the accessibility of existing secondary test accuracy 
research with respect to the extent to which their conduct and reporting reflects testing 
context and the extent to which decision makers can interpret and apply test accuracy 
outcome metrics. 
 
 
 
 
 
Objectives 
Contextual fit of existing test accuracy research: 
• An epidemiological mapping exercise of systematic review databases in order to 
document the volume and characteristics (disease category, review purpose and test 
application) of existing secondary test accuracy research. 
• A methodological review of a representative (in terms of quality) sample of systematic 
reviews of test accuracy, identified from the mapping exercise, in order to assess the 
extent to which review authors considered clinical context at each stage of the review 
process (question formulation; reporting primary study findings; synthesis; making 
recommendations).  
Interpretation and application of test accuracy outcome metrics by decision 
makers: 
 
• Systematic reviews of qualitative and quantitative research concerned with the 
understanding and application of test accuracy and risk measures. 
• A survey of general practitioners to assess: sources of test accuracy information 
used for diagnostic decision making; familiarity with a range of test accuracy 
metrics; ability to apply a range of test accuracy metrics to a hypothetical 
scenario. 
Results 
Contextual fit of existing test accuracy research: 
Reviews of test accuracy dominate the test evaluation landscape. Within this body of 
research, tests more commonly applied in secondary care and certain disease topic areas 
predominate and there is a lack of comparative test accuracy evaluation. Based on the 
epidemiological characteristics of test evaluations it is unlikely that the existing evidence 
base reflects the clinical need for evidence. 
 
 
Assessment of the contextual fit of test accuracy reviews reveals ill-defined objectives which 
are reflected in question formulation, review synthesis (including investigation of 
heterogeneity) and reporting of findings. The place of index tests within a testing pathway is 
mostly not articulated by consideration of test role, (add, replace, triage), healthcare setting, 
patient presentation, prior tests or current testing practice: Seventy six percent of reviews did 
not state the setting in which index tests were to be used and only 24% of reviews detailed 
all of index test application, role and prior tests as part of question formulation. Reporting of 
study characteristics was poor: setting, participant presentation and age were documented 
by just over 50% of reviews whilst chronicity and severity of the target disorder were 
documented by less than one third of reviews. A minority of reviews (between 1% and 8% of 
reviews depending on characteristic) cited limitations in primary studies as a reason for this 
poor reporting. 
Interpretation and application of test accuracy outcome metrics by decision makers: 
The literature reviewed was characterised by well educated and self-selected samples and 
the UK, policy making and generalist perspectives were under-represented. Evaluation of 
metrics more common to meta analyses of test accuracy is have received very limited 
attention in the literature to date. The features of test accuracy measures that are perceived 
to impact on the extent to which they facilitate formal probability revision include:  
-Having the test result (rather than disease status) as the reference class when interpreting 
conditional probabilities. 
-Discrimination between the 2 dimensions of test accuracy and quantification of test errors 
(ability to rule in or rule out a diagnosis or the value of a positive test result separate to a 
negative test result). 
-Portability of test accuracy metrics across populations. 
With the exception of predictive values (self reported use 80%), all other metrics are reported 
to be used by <4% of clinicians. The utility of different metrics for diagnostic decision making 
has only been evaluated from the perspective that formal probability revision is a necessary 
 
 
pre-requisite for informed diagnostic decision making. This is despite evidence that 
application of Bayes’ theorem is not commonplace in practice, estimation of pre-test 
probability and the accuracy of named tests is inaccurate and highly variable and provision of 
quantitative test accuracy information does not appear to improve probability revision.  
There is no empirical evidence supporting the superiority of a single test accuracy metric for 
diagnostic decision making. Natural frequency and multiple presentation formats appear to 
facilitate understanding. No consideration has been given to how metrics may be used in a 
complimentary way to assist with diagnostic decision making. Although comprehension of 
test accuracy information by academic clinicians has been shown to be superior to practising 
physicians, no consistent difference is observed between practising health professionals and 
non-health professional samples, suggesting that medical education per se may offer no 
advantage in this respect. 
A general practice survey revealed the majority of respondents were familiar with predictive 
values, sensitivity and specificity and the diagnostic 2x2 table, in contrast to likelihood ratios 
and metrics more commonly associated with systematic reviews (DOR, AUC, ROC curves). 
Clinical experience, colleagues and guidelines were reported as sources most commonly 
used to assist with diagnostic decision making whilst use of quantitative estimates of test 
accuracy was generally low (55% for sensitivity and specificity; 20% for predictive values; 
13% for the diagnostic 2x2 table and less than 2% for likelihood ratios, the DOR, AUC and 
ROC curve). 
Application of test accuracy metrics to a hypothetical scenario resulted in marked variation in 
responses to both positive and negative test results. Summary measures that separate the 
two dimensions of test accuracy in the absence of prevalence information (for example 
sensitivity and specificity) appeared to result in a misplaced emphasis in one or other of false 
positive or false negative test errors. Presenting test accuracy data using the 2x2 diagnostic 
table or a pictograph attenuated this effect. 
 
 
 
Conclusions 
At the current time, inadequacies in question formulation and the subsequent impact on 
contextualisation of test accuracy review findings may be undermining the potential for 
statistical and methodological advances in meta-analysis of test accuracy to positively impact 
on diagnostic decision making. 
Choice of test accuracy metric appears to have a profound effect on diagnostic decision 
making. Understanding, contextual factors and motivational biases are likely to be 
contributing factors to the observed variability. It is unclear to what extent any advantage of 
test accuracy metric for informed decision making is based on familiarity as opposed to their 
intuitive nature. Simultaneous illustration of both dimensions of test accuracy in order to 
facilitate informed diagnostic decision making requires further exploration. 
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Systematic reviews and meta-analyses of test accuracy: developing 
methods that meet practitioners’ needs. 
Evolution of the Plan of Research 
 
Research rationale 
 
Diagnosis is self-evidently a key clinical activity. Further, from a health policy perspective it 
can be a substantial driver of health care costs1. In recent decades the total number of tests 
ordered by doctors has increased substantially. This is despite observations that primary 
studies of test accuracy are characterised by poor reporting, poor quality and lack of 
contextual fit 2,3 suggesting a gap between diagnostic evidence and clinical diagnostic 
activity. A particular feature of the test accuracy evidence ‘gap’ is that application of test 
accuracy evidence is purported to be far more problematic than application of evidence 
about interventions 4. In addition the considerable impact of contextual variables on 
estimates of test accuracy and on the value placed on testing outcomes has implications for 
the interpretation and application of test accuracy measures.  
Improving the quality and accessibility of test accuracy evaluations has the potential to 
positively impact on test use. Parallel developments in both primary and secondary research 
will be required as the value of systematic reviews of test accuracy as a resource for decision 
making is dependent on the nature of the primary test accuracy evidence base. However 
systematic reviews of test accuracy offer the opportunity to mitigate some of the current 
limitations of primary studies, in particular framing of review questions to optimally use 
primary evidence pertinent to a particular testing context, investigation of reasons for 
observed variation in test accuracy estimates and consideration of the downstream 
consequences of test results reflecting the context in which a test is to be used.  Systematic 
reviews and meta-analyses of test accuracy are increasing in number and prominence as a 
resource for diagnostic decision making. Systematic reviews offer the potential for an 
ii 
 
immediate improvement in the contextual fit of evidence and by way of research 
recommendations, to improvements in the primary test accuracy evidence base.  
Considerable challenges to the conduct of systematic reviews of test accuracy including 
identification of primary studies and statistical challenges associated with meta-analysis of 
test accuracy have fuelled research in this area and in particular statistical techniques have 
developed rapidly over the last 15 years 5. However the potential for new summary test 
accuracy measures generated by these important statistical developments to exacerbate any 
existing problems with understanding and application of test accuracy evidence has not been 
investigated.  
Research aims 
 
The aim of this thesis is to focus on systematic reviews of test accuracy, as an increasingly 
prominent resource for decision makers and to redress the current imbalance in 
methodological developments taking place in systematic reviews of test accuracy by focusing 
on the accessibility of review findings to decision makers. The accessibility of test accuracy 
reviews will be assessed with respect to the extent to which their conduct and reporting 
reflects testing context and the extent to which decision makers can interpret and apply test 
accuracy outcome metrics. 
 
Original research plan 
Assessing the contextual fit of systematic reviews of test accuracy 
In order to assess the contextual fit of secondary test accuracy research, a review of existing 
test accuracy reviews was planned, in order to capture how testing context was being 
incorporated into systematic review methods and represented in the reporting of review 
findings. 
iii 
 
Accessibility of test accuracy metrics to decision makers 
In order to assess the extent to which decision makers are able to interpret and apply test 
accuracy outcome measures, a review of research concerned with diagnostic decision 
making was planned. In addition, focus groups were to be used to access the perspectives of 
decision makers from a range of healthcare settings with respect to barriers and facilitators to 
the interpretation and application of existing meta-analytic summary measures. 
 
Development of novel test accuracy metrics 
Drawing on the findings from the literature reviews and focus groups novel summary 
measures that better met the needs of decision makers were to be developed.  
The original focus of the research was on meta-analytic summary measures of test accuracy 
on the basis that their derivation would be relatively unfamiliar to decision makers and pose 
challenges to their interpretation and application. 
 
Emerging findings from the literature reviews of diagnostic decision 
making 
 
Empirical literature concerning the application and understanding of more established 
summary test accuracy measures shared by primary and secondary test accuracy research 
(including sensitivity and specificity, predictive values and likelihood ratios),  was considered 
pertinent because of the popularity of these measures for reporting the findings from 
narrative and meta-analytic syntheses of systematic reviews of test accuracy 6,7. At the 
outset it was anticipated that the volume of existing empirical research concerning the 
understanding and application of less familiar meta-analytic summary measures (including 
the Diagnostic Odds Ratio (DOR), the Receiver Operator Characteristic (ROC) space and 
curves, the Area Under the Curve (AUC), relative measures of test accuracy and forest plots) 
would be limited compared to more established metrics.  
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However emerging findings from the empirical literature revealed the volume, quality and 
applicability of empirical research was limited even for the more established test accuracy 
measures. Research was characterised by highly selected academic clinical samples and 
almost exclusively confined to evaluation of sensitivity, specificity and likelihood ratios (LRs). 
Evaluation of understanding and application of test accuracy measures was largely based on 
the premise that formal probabilistic reasoning was commonplace in clinical practice and 
there was no empirical investigation of the extent to which testing context might influence 
application. Primary care professionals were under-represented and the perspective of policy 
makers was entirely absent. Understanding of more established test accuracy metrics, even 
in these highly selected decision makers was poor and self-reported use of test accuracy 
information raised questions about the extent to which clinicians seek and use quantitative 
estimates of test accuracy. Additionally an unexpected finding from the literature reviews was 
a rich qualitative data set of the perspectives of clinical academics concerning facilitators and 
barriers to understanding of the more established test accuracy metrics.  
 
Modification of the original plan of research concerning the 
understanding and application of test accuracy metrics 
 
Broadening the scope of the literature review in place of the planned focus 
group  
 
On the basis of initial findings from the literature review revealing the considerable difficulty 
decision makers have interpreting and applying even the more established test accuracy 
metrics and the limitations of the evidence base concerning newer meta-analytic summary 
measures, the plan of investigation concerning the understanding and application of test 
accuracy metrics was modified. The original aim to develop novel meta-analytic summary 
metrics seemed unrealistic and premature. In addition the existence of a relatively rich 
qualitative dataset in combination with empirical evidence that self-reported familiarity with 
test accuracy metrics was not necessarily associated with understanding and application, 
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raised questions concerning the added value of a focus group at this stage of the 
investigation. 
In place of the focus group originally planned, the scope of the literature review concerned 
with diagnostic decision making was broadened. The perspectives and experience of other 
disciplines (psychology and education) with respect to the communication of probability and 
risk was sought. In addition to a synthesis of quantitative empirical literature concerned with 
test accuracy interpretation, a synthesis of published perspectives, comments and analyses 
about diagnostic decision making was undertaken. 
 
Primary research to address the limitations of the existing empirical literature 
concerning the understanding and application of test accuracy measures 
 
Addressing the considerable limitations of the existing empirical evidence base was now 
considered a priority as part of this programme of research. In particular: 
 capturing the perspectives and experience of a representative sample of decision 
makers  
 assessment of the extent to which quantitative estimates of test accuracy are sought 
and used to assist with diagnostic decision making in practice 
 assessment of barriers and facilitators to the use of test accuracy information for 
diagnostic decision making in practice 
 assessment of the impact of quantitative test accuracy estimates on diagnostic 
decision making 
The scope of the primary research possible in the time available was limited and test 
accuracy metrics, testing context and the decision maker sample were selected to best 
address limitations of the existing published literature whilst supporting the evolution of the 
evidence base.  
Improving understanding about the accessibility to decision makers of the more established 
test accuracy metrics was considered a natural first step in this investigation. In addition 
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established test accuracy metrics (sensitivity and specificity, predictive values (PVs) and 
LRs) are relevant to the application of results of both primary and secondary test accuracy 
research. The results of the literature review suggested that global test accuracy metrics 
were unfamiliar to decision makers and their inclusion in the primary research was not to be 
at the expense of a more detailed consideration of the more established metrics. Reflecting 
findings from the review of risk communication, alternative formats to percentage and 
normalised frequency representations of probabilistic information were also included. 
Primary care clinicians were chosen over secondary care as the decision maker sample 
because the primary care perspective was under-represented in the published literature. In 
addition although the culture of testing would be expected to differ between specialists and 
generalists, a generalist perspective is likely to encompass a broader mix of testing contexts 
compared to any particular medical speciality alone. Clinicians were chosen over policy 
makers because the existing evidence base is concerned with decision making at the 
bedside and improving understanding of the clinician perspective was seen as a natural 
progression in this respect.  
 
Thesis outline 
 Chapter 1 outlines the potential role of test accuracy information in diagnostic 
decision making and provides a framework, drawing on behavioural decision theory, 
within which probabilistic information and professional, patient and contextually 
dependent utilities might combine to influence testing behaviour.   
 Chapter 2 presents a review of the existing empirical and non empirical literature 
concerning understanding and application of test accuracy measures, complimented 
by a review of the more established risk communication evidence base.  
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 Chapter 3 presents an epidemiological mapping exercise of existing test reviews with 
respect to coverage of disease topic areas, representation of healthcare setting and 
review purpose.  
 Chapter 4 presents a review of the degree to which clinical context shapes the 
conduct and reporting of existing test accuracy reviews.  
 Chapter 5 is a survey of use, understanding and application of test accuracy 
measures in a sample of primary care clinicians. 
  
viii 
 
  
ix 
 
List of Abbreviations 
Abbreviation Explanation 
AR Attributable Risk 
ARR Attributable Risk Reduction  
AUC Area Under the Receiver Operator Characteristic 
Curve 
DOR Diagnostic Odds Ratio 
EBM Evidence Based Medicine 
FN False Negative 
FP False Positive 
GP(s) General Practitioner(s) 
LR- Negative Likelihood Ratio 
LR(s) Likelihood ratio(s) 
LR+ Positive Likelihood Ratio 
NNT Number Needed to Treat 
NPV Negative Predictive Value 
PPV Positive Predictive Value  
PV(s) Predictive Value(s) 
Q Point on the ROC curve where sensitivity=specificity 
RCT Randomised Controlled Trial  
rDOR Relative Diagnostic Odds Ratio 
ROC Receiver Operator Characteristic Curve 
RR Relative Risk 
RRR Relative Risk Reduction 
SnNOUT Sensitivity high, Negative test result rules OUT 
SpPIN Specificity high, Positive test result rules IN 
sROC Summary Receiver Operator Characteristic Curve 
TN True Negative 
TNT Tablets Needed to Take 
TP True Positive 
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Medical 
Test 
Chapter 1: Background: The role of test accuracy information and 
interpretation in clinical decision making  
 
1.1 The impact of testing on patient outcomes 
Diagnosis is self-evidently a key clinical activity; making a correct diagnosis is a pre-requisite 
for appropriate management. Testing may result in the correct identification of a greater 
number of individuals who might benefit from effective treatments as well as the avoidance of 
unnecessary further interventions in those without disease. In addition acquiring knowledge 
about diagnosis and prognosis has a value to both clinicians and patients regardless of its 
impact on eventual health outcomes 8-10. For example Pauker (1998)11 observed that 20% of 
tests ordered in a primary care setting were described by general practitioners (GPs) as tests 
performed to re-assure patients. Due to the inevitability of test errors, testing will also 
generate false positives and false negatives with associated negative outcomes for patients. 
In addition to errors as inherent properties of a test itself, errors can occur as a result of 
misinterpretation of test results12. Tests can also have a direct effect on patients if the test 
itself causes anxiety or carries risk.  
 
Fig 1.1 The pathway from testing to patient outcomes 
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1.2 Trends and variations in testing behaviour 
In recent decades the total number of diagnostic tests ordered by doctors has increased 
substantially 13-17. This increase may in part be due to political and organisational factors. 
Organisational factors include the shift of patient care from secondary to primary care; 
technological advances that have vastly expanded the range of investigative technologies 
available to clinicians and simultaneously created a barrier to evaluating each new test 18 
patient preference and demand18,19, fear of litigation11,19 and a quest to reduce uncertainty 
which is argued to be a part of medical culture 18,19. As well as an increase in the number of 
tests being ordered, international 20,, regional 21,22 and between-doctor variation in test 
ordering 15,23 has been shown to be large to a degree that is unlikely to be explained by 
differences in patient demographics or need. 
Although it has been suggested that variations in testing are likely to be due to both under 
and over utilisation based on clinical need 23, the overall rise in test use is generally assumed 
to be largely due to over utilisation14,24.  
Uncritical adoption of new tests is encouraged by the lax regulatory system for the 
introduction of new tests. The Medicine and Healthcare products Regulatory Authority 
(MHRA) is the competent authority responsible for regulating devices in the United Kingdom 
(UK). There is currently no requirement for a particular standard of evidence or level of 
accuracy in order for in vitro diagnostic devices to meet the performance standards required 
for award of a certified (CE) mark that is primarily designed to assure safety rather than 
improvements in accuracy. In addition MHRA certification is not a well regulated process: 
devices considered low risk may be self-certified by manufacturers and although those 
considered to pose a greater risk are required to be assessed by commercial organisations, 
these organisations are chosen by manufacturers of the test who are at liberty to disregard a 
negative assessment in preference to a positive alternative (personal communication John 
Webster, Medical Devices Consultants International Ltd (MDCI) February 2009). A similar 
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situation exists in the USA equivalent, the Food and Drug Administration (FDA)25. Rink 
(1993)15 for example demonstrated that the rate of testing with 6 new near-patient tests 
increased by 16% following their introduction without a concomitant reduction in laboratory 
based testing.  
A survey in 2007 26 demonstrated that the independent body charged with producing 
guidance for the National Health Service (NHS) in England and Wales, the National Institute 
for Health and Clinical Excellence (NICE) health technology appraisal programme, appraised 
an estimated 9.5% of all pharmaceuticals between 1996 and 2004; the comparable figure for 
devices (diagnostic and interventions) was 0.1%. There remains an imbalance between 
national guidance issued concerning interventions and interventional procedures in 
comparison to diagnostic procedures. In 2009 less than 2% of NICE guidance published and 
in development involved detailed consideration of the diagnosis of a condition and only 1% 
was solely concerned with evaluation of a diagnostic procedure, (see figure 1.2) 
Fig 1.2: Details of NICE guidance published and in development as at 24-07-09  
 
* This includes 6 interventional procedures listed apparently incorrectly under diagnostic procedures. 
 
Further factors that may fuel inappropriate increases in testing are test errors. Inevitably 
increases in test use generate increased numbers of false positives and results of uncertain 
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clinical significance, of which one of the consequences is further testing 16,27. For example 
Wennberg (1996) 27 demonstrated significant, positive relationships between tests used early 
in the diagnostic pathway for coronary vascular disease (stress testing) and tests used later 
in the diagnostic pathway (coronary angiography) across 72 hospital service areas that were 
of a magnitude unlikely to be explained by variation in disease prevalence, variation in 
availability of technology or unmet need. There is a volume of evidence supporting an 
inappropriate excess of testing which will have direct and indirect adverse outcomes for 
patients as well as being a substantial driver of health care costs.  
 
1.3 Variables affecting testing behaviour 
Two recent systematic reviews 28,29 (see table 1.3) have attempted to summarise variables 
that affect test ordering by clinicians.  
A systematic review of interventions aimed at changing testing behaviour 24 found that 
enabling interventions aimed at changing testing behaviour directly, such as restrictions on 
ordering and feedback, were the most potent intervention, followed by reinforcing 
interventions (such as audit) with educational interventions having the most modest effect. 
Educational interventions included in the review were poorly described but included 
guidelines, conferences and lectures covering the clinical utility of testing and cost-
effectiveness. Interventions targeting more than one behavioural factor were more successful 
than those targeting single factors (62% versus 56%). Evidence was generally of poor quality 
and only 12% (6/49) of included studies were conducted in the primary care setting.  
This body of research demonstrates that reasons for test ordering and influences on test 
ordering are many. The relationship between individual variables is likely to be complicated 
and in the studies considered here, only a small percentage of the observed variation in test 
ordering behaviour could be explained by contextual, doctor, or patient variables studied. 
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Clearly, understanding the causes of variation in testing is important in order to encourage 
testing that is considered evidence based.  
Importantly the reviews above provide no direct evidence concerning the impact of test 
accuracy evidence on testing behaviour. Some of the variables investigated may be proxies 
for knowledge of test properties. Involvement in research or guideline development, provision 
of educational materials and provision of feedback were observed to decrease test use. 
Clinical experience did not demonstrate a consistent relationship with test use but this 
variable is likely to reflect the relationship between experience and the process of decision 
making in a broader sense rather than decisions about test use alone. 
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Table 1.3: Factors associated with test ordering derived from empirical research 
Category Example Effect on test ordering (↑ or ↓) 
Patient-related factors Patient preference Variable depending on test and condition being sought 
 Patient acceptability (side effects of test) Variable depending on test and condition being sought  
 Impact of diagnosis or lack of diagnosis Variable depending on test and condition being sought 
 Consequences of test errors Variable depending on test and condition being sought 
 Patient reassurance Variable depending on test and condition being sought 
 Patient demographics Variable (eg older patients ↑; female patients, ↑) 
Doctor-related factors Confidence in clinical judgement/ clinical experience ↓ with ↑ confidence and ↑experience 28 
Inconsistent effect of clinical experience 29 
 Knowledge of test properties No evidence found 28 
 Involvement in research / guideline development ↓ 
 Attitudes to risk litigation ↓with ↓ fear or risk taking /fear of litigation 
 Response to patient requests (appropriate & 
inappropriate) 
↑ or no effect according to individual doctor 
 Feedback on test ordering behaviour ↓ 
 Doctor speciality Variable depending on speciality 28 
Specialists ↑ tests from a narrower repertoire compared to 
generalists 29 
 Doctor demographics (age and sex) Variable and contradictory 28 
Female doctors ↑ tests 29 
Policy and organisational-
related factors 
Time constraints ↑ with time constraints 
 Primary care practice size ↓ with ↓ practice size 
 Availability of tests ↓ with ↓access 
 Method of doctor payment ↓ with payment by salary; ↑with fee for service 
 Existence of testing policies / clinical guidelines ↓ with introduction of clinical guidelines and policy 
recommendations 
 Structured test ordering forms  ↓ with introduction of structured test ordering forms 
 Geographical location Inconsistent 
 Knowledge of test costs Inconsistent 
Categorisation adapted from Whiting et al. Journal of Clinical Epidemiology 2007 28
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It has been observed that important barriers to the use of evidence include accessibility 
(accessing information in a timely manner and possession of skills necessary to interpret 
information) and the acceptability and applicability of the research evidence (provision of 
information relevant to the decision context) 30. In addition clinicians may not be aware of the 
extent to which their own practice diverges from the evidence base 31. This has implications 
for education; not least the motivation of practitioners to question their understanding. 
There is a widespread belief that decision makers are less familiar with evidence about test 
accuracy compared to evidence about effectiveness and have difficulty understanding and 
applying test accuracy evidence 32,33. In order to address any gap between the evidence 
base and testing behaviour, the relationship between understanding and application of test 
accuracy information and testing behaviour needs to be examined. However to date there 
has been systematic interrogation of the evidence base to allow quantification or 
characterisation of the extent of the problem and therefore the impact this might have on 
testing behaviour. 
Certainly the observed increase in test use outlined above is not congruent with observations 
made about the existing primary test accuracy evidence base.  Primary studies of test 
accuracy are characterised by poor reporting, poor quality and lack of contextual fit 3,34-38. In 
addition the existing evidence base is characterised by evaluations of single tests divorced 
from diagnostic pathways which does not assist or encourage decision makers to consider 
test replacement or addition based on demonstrable gains in accuracy.  
Systematic reviews of test accuracy currently represent a small proportion of all systematic 
reviews (an estimated 4% in 2004 39) but they are increasing in number 40-42 and prominence 
as a resource for decision makers. Systematic reviews of test accuracy offer the opportunity 
to mitigate against limitations in the primary evidence base by improved framing of questions, 
in particular inclusion of a comparative element. However the extent to which systematic 
reviews of test accuracy are realising their potential in this respect has not been investigated. 
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Similarly, although limitations of primary studies are proposed to present challenges to 
review conduct, it is not known the extent to which contextual, quality and reporting 
limitations documented for primary test accuracy studies are impacting on the quality of 
systematic reviews of test accuracy.  
The considerable statistical challenges associated with meta-analysis of test accuracy data 
have encouraged a rapid evolution in statistical methods for synthesising data over the last 
10 years 5 accompanied by an increasing repertoire of metrics and graphics. Indeed 
advancement of statistical techniques appears to have occurred without consideration of the 
accessibility of meta-analytic summaries of test accuracy to decision makers. There is a 
need to investigate the extent to which existing meta-analytic summaries of test accuracy are 
understood by decision makers because of the potential to mislead those attempting to apply 
the results of these reviews in practice 6,43,44 (TAR18). 
 
1.4 Clinical problem solving 
Clinical problem solving and behavioural decision theory are frameworks within which to 
consider the relationship between accessibility and relevance of test accuracy information, 
decision making and testing behaviour. 
As the potential health benefits, health risks and economic implications associated with 
investigative techniques have expanded there has been an accompanied increase in 
research attempting to explain and improve clinicians’ decision making, including judgements 
about the use of diagnostic tests.  
Problem solving can be characterised by two distinct modes of cognition: intuitive and 
analytical.  Hamm 1988 45 proposed a cognitive continuum framework to represent six 
different approaches to problem solving ranging from intuitive judgement (‘un-criticised 
private judgements’) which are rapid, largely unconscious and characterised as inconsistent 
and moderately accurate to analytical approaches which are slow, conscious, likely to 
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combine information using organising principles, consistent and more accurate (see figure 
1.4). Hamm proposed that the precise nature of the decision making task induced a 
particular problem solving approach (intuition inducing to analytical inducing) and that 
accuracy in decision making was determined by the clinician’s expertise in choosing a 
problem solving approach appropriate to each task; ill-structured tasks induce intuition and 
well-structured tasks an analytical approach. 
Fig 1.4: The Cognitive Continuum 
 
Modes 5 and 6 in the cognitive continuum (see figure 1.4) are seen as problem solving 
approaches adopted in practice settings with minimal direct support from empirical research. 
Modes 1-4 involve the use of formal decision analytic frameworks including probabilities and 
utilities. Modes 1-3 would draw on probabilities and utilities estimated from empirical 
research whereas mode 4 would involve subjective estimates.  
(Hamm 1988) 
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Hamm 45 suggests that tasks should not be seen as always externally controlled and that the 
nature of task features may be open to manipulation by the clinician as problem solver. 
However manipulation requires clinicians to be able to use the tools and knowledge 
information systems that are available to them. Institutional and social contextual factors may 
also impact on the problem solving approach adopted so that for example, staff training, 
knowledge management and the time available for each patient will impact on whether a 
clinician can adopt an intuitive or an analytical approach to problem solving and whether they 
are able to manipulate the task. It is argued that knowledge constraints in the use of modes 
1-3 should be viewed as a lost educational opportunity 46. 
However based on the observation that problem solving strategies differ between novices 
and experts, alternative theorists have proposed a theory of expert cognition where the 
problem solving approach is based on expertise rather than task, social or institutional 
factors. This theory proposes that more experienced clinicians adopt increasingly intuitive 
approaches whereas novices rely on guiding principles and rules to make sense of clinical 
presentations and as a consequence are more likely to adopt an analytical approach. Indeed 
there remain many problem solving strategies, particularly those of experts, which are rapid, 
automatic and not well understood 47.  
Expertise as defined by Kassirer 47 is likely to be underpinned by clinical experience in a 
speciality, knowledge about the evidence base and sources of information to help with 
decision making, as well as experience in decision making per se. Indeed if the definition of 
‘expert’ includes mastery of a particular domain of knowledge then it would be expected that 
problem solving strategies may not be generalisable across medical specialities and in 
particular between specialists and generalists.  
Adopting a qualitative approach using verbal rather than mathematical rules to explain 
behaviour, process tracing research also highlights the importance of subject-specific 
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expertise. Process tracing approaches have also demonstrated that probabilistic reasoning is 
a prominent feature of clinical problem solving but suggest that the relative contribution of 
intuitive and analytic thinking vary at different stages in the decision making process rather 
than only being dependent on the structure of the decision making environment 48,49 (see 
figure 1.5).  
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Fig 1.5: Diagnostic strategies used by 6 General Practitioners across a total of 300 
consultations 
 
 
 
 
 
 
 
 
 
 
 
 
 
                               
 
RULE DEFINITION 
Restricted rule outs Learning the most common (probable) causes of a 
presenting problem and a shortlist of serious diagnoses 
which must be ruled out. 
 
Stepwise refinement Diagnostic refinement based on either anatomical location 
of the problem or the putative underlying pathological 
process. 
 
Probabilistic reasoning The specific but probably imperfect use of symptoms, signs, 
or diagnostic tests to rule in or rule out a diagnosis and 
requiring knowledge of the degree to which a positive or 
negative test result adjusts the probability of a given 
disease. 
 
Pattern recognition fit Symptoms and signs are compared to previous patterns 
and a disease is recognised when a pattern fits. 
 
Clinical prediction rule A formal, validated version of pattern recognition based on 
the probability of a diagnosis in the presence of a pattern of 
symptoms, signs and test results.   
 
Notes to fig 1.5: (P) Involves manipulation of probabilities either formally or informally 
          
  Heneghan, C. et al. BMJ 2009;338:bmj.b946 48 
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It is therefore unlikely that problem solving ability will be dependent entirely on experience in 
problem solving per se but rather mastery of a particular (speciality-specific) domain of 
knowledge. With increasing experience a less analytical and more intuitive approach might 
be taken, except in novel clinical situations. In addition the relatively more structured 
environments of the medical specialities in secondary care may be more suited to an analytic 
approach than the less structured, diverse and less well-defined clinical decision making 
environment in generalist, primary care settings. Medical knowledge tends to be organised 
according to disease rather than individual signs and symptoms, an organisation better 
suited to specialist settings and requiring knowledge of the relative probabilities of disease 
for its application 49. 
Dowie 50 proposes that differences in the way decision tasks are structured and the cognitive 
modes employed, as proposed in the cognitive continuum model (see figure 1.4), explain 
much of the difference in research and practice cultures that hinders implementation of 
research findings. This is in contrast to the more traditional explanations of weaknesses in 
research dissemination or practitioner attitudes and motivations. Research activity is 
described as ‘truth driven’  and is characterised by well-structured, highly analytic 
environments, whereas practice based decision making is characterised by complexity and 
lack of structure which encourages intuition, implicit assumptions about outcomes such as 
test performance, and integration of ‘value judgements’. Dowie 50 suggests that the difference 
between the task structure of researchers and practitioners produces an evidence gap - 
researchers are unable to represent their findings in a way that is relevant to practitioners; an 
observation that has been made by others 51. Decision analysis (mode 4 figure 1.4) is 
proposed as a form of system-aided judgement which could act as a potential bridge 
between the research and practice cultures and assist with the implementation of research 
findings. Indeed evidence based medicine is viewed as a mechanism for introducing 
quantification into medical (including diagnostic) decisions whilst leaving a substantial role for 
clinical judgement 52,53. 
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The extent to which evidence based medicine has achieved its aims with respect to 
diagnostic decision making, particularly the extent to which decision makers seek and use 
quantitative test accuracy information, is unclear. Certainly the relative lack of guidance 
concerned with the use of tests compared to treatments (see figure 1.2 above) presents a 
challenge to those attempting to integrate test accuracy evidence into their practice. 
Probabilistic reasoning will almost certainly play a role in diagnostic decision making 
although its use is likely to vary depending on the skill and expertise of the decision maker, 
subject-specific experience, the structure of the problem, availability of evidence and 
contextual factors that determine utility judgements. However the existence of intuitive 
judgement as a legitimate problem solving approach calls into question the degree to which 
formal, quantitative probability revision is a necessary pre-requisite for informed diagnostic 
decision making.  
  
1.5 Behavioural decision analysis: a framework for considering 
diagnostic decision making  
 
The introduction of evidence into diagnostic decision making requires knowledge about the 
way in which clinicians solve problems. As probabilistic reasoning is proposed to be a 
prominent part of diagnostic decision making and the paradigm on which evidence based 
medicine is based, behavioural decision analysis provides a useful framework for considering 
how this might be facilitated. Diagnostic decision making is a term that can be used to 
encompass the integration and application of test accuracy information and other pertinent 
contextual considerations, into decisions about the use of tests and the interpretation of test 
results. 
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1.5.1 Normative Decision Theory 
Decision analysis seeks to determine the best course of action, under conditions of 
uncertainty and has applications in situations when choices need to be made between clearly 
defined courses of action.  Moving beyond the initial narrow economic concept, optimality is 
seen as conditional on context 54.  Normative decision theory proposes that when faced with 
a number of choices, the rational procedure is to place a value on each outcome, multiply 
this by the probability of the outcome occurring to derive an expected value, and make a 
choice that will result in the highest total expected value; expected values distinguish the 
right from the wrong decision.  
Most tests are imperfect and merely adjust the probability of having a disease rather than 
confirm its presence or absence.  Test accuracy information is an expression of the 
probability (risk) of one of four possible outcomes of testing. These four outcomes are 
illustrated by the 2x2 diagnostic contingency table (figure 1.6): 
Fig 1.6: The 2x2 Diagnostic contingency table 
 
 DISEASE +VE 
(verified by a 
reference standard 
test) 
DISEASE -VE 
(verified by a 
reference standard 
test) 
INDEX TEST 
RESULT 
+VE 
TRUE POSITIVE FALSE POSITIVE 
INDEX TEST 
RESULT 
-VE 
FALSE NEGATIVE TRUE NEGATIVE 
 
Each possible testing outcome (True Positive, True Negative, False Positive, False Negative) 
has a value attached which will be determined by the context in which a test is being used. 
For example the relative values associated with true positives and false negatives will 
increase as the target disease increases in seriousness and those of true negatives and 
false positives will increase as the toxicity of management of positive test results increases.  
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Fig 1.7 Diagrammatic representation of a normative guide to decision making applied 
to testing 
 
 
(Adapted from Matcher 2007 55 and Kassirer 1989 56) 
 
1.5.2 Departures from normative decision making: behavioural decision 
analysis 
 
According to normative decision theory, an individual is expected to make a decision based 
on maximising the expected value of the outcomes possible from competing choices. In 
order to make an optimal decision it is assumed that individuals will be fully informed, fully 
rational and able to compute accurately. Behavioural decision analysis is based on the notion 
that due to limitations of working memory in complex decision making environments, 
(bounded or limited rationality) 57, humans simplify complex problems using heuristics and as 
a result introduce errors at subsequent stages in the decision making process: hypothesis 
generation; probability estimation and revision and assessment of utility (for example the 
consequences of testing itself, correct and incorrect diagnoses). Errors and biases can be 
divided into those associated with probability estimation and revision (cognitive biases) and 
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those associated with emotional reactions to uncertainty, the utility associated with testing 
per se and the consequences of different testing outcomes (motivational biases) (ETA36);58,59 
 
1.5.2.1 Fully informed and able to compute accurately: cognitive errors and biases 
 
Fully informed 
In order to make appropriate decisions about test use and interpretation of test results, 
information about the probability of disease prior to testing and information about test 
accuracy is needed. This information is most commonly communicated quantitatively either 
as single event probabilities (the probability of the occurrence of a test result or the 
probability of the presence of a disorder prior to testing (pre-test probability) after testing 
(post-test or posterior probability)) or communicated as conditional probabilities (the 
probability of the presence or absence of x disorder given y test result or the probability of 
having y test result in the presence or absence of x disorder). Verbal expressions of 
probability require standardisation for application: for example a numerical equivalent of low, 
medium or high pre-test probability and a numerical definition of what constitutes a poor, 
moderate or highly accurate test. Problems with standardising the language of risk are well 
rehearsed 60,61.  
The extent to which diagnostic decision makers can be regarded as fully informed will 
depend on an assessment of their knowledge of the information required to undertake 
probability revision and sources of that information; accuracy of pre-test probability 
estimation (in the absence of external evidence) and the extent to which quantitative 
probabilistic expressions of the uncertainty associated with testing (test accuracy 
information) is understood.   
Only one test accuracy measure, the Likelihood Ratio (LR), has guidelines for interpretation 
reflecting the magnitude of change in pre to post-test probability it conveys 62 (see table 1.8) 
However the extent to which these are a reliable guide to the clinical utility of a test across  
different settings has not been evaluated in practice. Table 1.8 compares features of the 
18 
 
more commonly used test accuracy summary measures with respect to their interpretation 
and application.
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Table 1.8: Characteristics of commonly used test accuracy metrics 
TEST  ACCURACY 
METRIC 
STATISTICAL MEANING & 
PROPERTIES 
CLINICAL APPLICATION CONTEXTUAL CONSTRAINTS  
              DISEASE AS REFERENCE CLASS                                                       ESTIMATION OF THE PROBABILITY OF DISEASE IN INDIVIDUALS          
Sensitivity  
(true positive 
fraction) 
-The proportion of people with 
disease who test positive. 
TP/(TP+FN) 
-Values closer to 1 (100%) 
indicate increasing accuracy 
-Disease as reference class* 
-Requires discrimination and 
calibration 
SnNOUT (sensitivity high, negative test result, rule out 
disease) (Sackett 1997 (TTA27)is suggested as a 
heuristic . 
Estimation of the post test probability of disease in 
individuals is possible but requires probability revision 
using the formula of Bayes’ theorem **. 
Indication of the ability of a test to rule out disease and 
therefore may help with decisions about test use when 
downstream consequences of a –ve test result are 
considered > than the downstream consequences of a 
+ve test result. 
No guidelines for translation of quantitative estimates 
of sensitivity into a measure of their diagnostic utility.   
Accuracy varies according to spectrum 
of patients therefore cannot be assumed 
to be portable across different 
populations. 
The SnNOUT rule may mislead as 
prevalence increases because the 
absolute number of FNs becomes large. 
 
Specificity  
(true negative 
fraction) 
-The proportion of people with 
disease who test positive. 
TN/(TN+FP) 
-Values closer to 1 (100%) 
indicate increasing accuracy 
-Disease as reference class* 
-Requires discrimination and 
calibration 
SpPIN (specificity high, positive test result, rule in 
disease)(Sackett 1997 (TTA27) is suggested as a 
heuristic . 
Estimation of the post test probability of disease in 
individuals is possible but requires probability revision 
using the formula of Bayes’ theorem **. 
Indication of the ability of a test to rule in disease and 
therefore may help with decisions about test use when 
downstream consequences of a +ve test result are 
considered > than the downstream consequences of a 
-ve test result. 
No guidelines for translation of quantitative estimates 
of specificity into a measure of their diagnostic utility.   
Accuracy varies according to spectrum 
of patients therefore cannot be assumed 
to be portable across different 
populations. 
The SpPIN rule may mislead as 
prevalence decreases because the 
absolute number of FPs becomes large. 
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Table 1.8 continued 
TEST  ACCURACY 
METRIC 
STATISTICAL MEANING & 
PROPERTIES 
CLINICAL APPLICATION CONTEXTUAL CONSTRAINTS  
          TEST RESULT AS REFERENCE CLASS                                                   ESTIMATION OF THE PROBABILITY OF DISEASE IN INDIVIDUALS 
Positive predictive 
value (PPV) 
The proportion of individuals 
testing positive who have 
disease. 
TP/(TP+FP) 
-Values closer to 1 (100%) 
indicate increasing accuracy) 
-Test result as reference class* 
Requires discrimination and 
calibration 
Allows estimation of the probability of disease in 
individuals based on test result* and is therefore 
viewed as clinically intuitive. 
Setting specific PPVs negate the need for pre-post test 
probability revision: the post test probability of disease 
following a positive test result =PPV. 
No guidelines for translation of quantitative estimates 
of PPV into a measure of their diagnostic utility.   
Accuracy depends on prevalence of 
target disease which exacerbates 
observed variation in estimates of 
accuracy due to spectrum variation.  
As prevalence decreases, the PPV 
decreases. 
Negative predictive 
value (NPV) 
The proportion of individuals 
testing negative who do not 
have disease. 
TN/(TN+FN) 
-Values closer to 1 (100%) 
indicate increasing accuracy 
-Test result as reference class* 
Requires discrimination and 
calibration 
Allows estimation of the probability of disease in 
individuals based on test result* and is therefore 
viewed as clinically intuitive. 
Setting specific NPVs negate the need for pre to post 
test probability revision: the post test probability of 
disease following a negative test result is 1-NPV. 
No guidelines for translation of quantitative estimates 
of NPV into a measure of their diagnostic utility.   
Accuracy depends on prevalence of 
target disease which exacerbates 
observed variation in estimates of 
accuracy due to spectrum variation.  
As prevalence decreases, the NPV 
increases. 
Likelihood ratio  
(LR) 
-Probability of a test result in 
diseased individuals divided by 
probability of same test result 
in non-diseased individuals 
LR+ve     
                FP(FP+TN) 
TP/(TP+FN) 
LR-ve      
                TN(FP+TN) 
FN/(TP+FN) 
-Accuracy increases as LR 
values differ from one (>1 for 
LR+ and <1 for LR-). 
-Test result as reference class* 
-Requires discrimination and 
calibration 
The degree to which the probability of disease 
changes following a test result*. 
Multi-level likelihood ratios allow linkage of test 
accuracy with the degree of abnormality of a test 
result. 
 Estimation of the post test probability of disease in 
individuals is possible but requires probability revision 
using the formula of Bayes’ theorem **. 
Graphical tools can be used to simplify the conversion 
of odds to probabilities with likelihood ratios (Fagans 
nomogram (Fagan 197563).  
The likelihood ratio scale is non linear and therefore is 
not intuitive to interpret. 
Clinical utility guide available (Jaeschke 200662). 
LR convey magnitude of change in 
probability therefore in situations where 
pre-test probability is very low or very 
high, LRs alone may be misleading with 
respect to the value of a test. 
Accuracy varies according to spectrum 
of patients therefore cannot be assumed 
to be portable across different 
populations. 
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Table 1.8 continued 
TEST  ACCURACY 
METRIC 
STATISTICAL MEANING & 
PROPERTIES 
CLINICAL APPLICATION CONTEXTUAL CONSTRAINTS  
           OVERALL DISCRIMINATION OF A TEST                                DOES NOT ALLOW ESTIMATION OF PROBABILITY OF DISEASE IN INDIVIDUALS 
Test accuracy Proportion of total diagnostic 
judgements that are correct. 
(TP+TN)/N 
-Values closer to 1 (100%) 
indicate increasing accuracy) 
 -Requires discrimination  
Overall discrimination of a dichotomous test.  
Does not allow estimation of probability of disease in 
individuals. 
Useful if comparing 2 tests with similar properties. 
No guidelines for translation of quantitative estimates 
of test accuracy into a measure of diagnostic utility.   
Accuracy varies with spectrum therefore 
cannot be assumed to be portable 
across different populations. 
Implicitly values FN and FP equally.  
Error rate Proportion of total diagnostic 
judgements that are test 
errors. (FN+FP)/N 
-Values closer to 0 (0%) 
indicate increasing accuracy 
-Requires discrimination  
Overall discrimination of a dichotomous test. Does not 
allow estimation of probability of disease in an 
individual. 
Useful if comparing 2 tests with similar properties. 
No guidelines for translation of quantitative estimates 
of error rates into a measure of diagnostic utility.  
Accuracy varies with spectrum and 
cannot be assumed to be portable 
across different populations. 
Implicitly values FN and FP equally.  
Diagnostic odds ratio 
(DOR) 
The cross product ratio of the 
2x2 diagnostic table. 
 (TPXTN) / (FNxFP). 
-Accuracy increases the more 
the DOR increases from one 
Requires discrimination 
Overall discrimination of a dichotomous test. 
Does not allow estimation of probability of disease in 
an individual.  
Useful if comparing 2 tests with similar properties. 
No guidelines for translation of quantitative estimates 
of the DOR into a measure of diagnostic utility. 
Accuracy varies with spectrum and 
cannot be assumed to be portable 
across different populations. 
Implicitly values FN and FP equally. 
Relatively constant with changes in test 
threshold. 
Area Under the 
Curve (AUC) 
-Area under the Receiver 
Operator Characteristic curve 
(ROC curve) 
- AUC 0.5: a non-informative 
test; AUC 1: a perfect test 
-Requires discrimination 
Overall discrimination of a dichotomous test. 
Does not allow estimation of probability of disease in 
an individual. 
Useful if comparing 2 tests with similar properties. 
No guidelines for translation of quantitative estimates 
of AUC into a measure of diagnostic utility. 
Accuracy varies with spectrum and 
cannot be assumed to be portable 
across different populations. 
Implicitly values FN and FP equally. 
Relatively constant with changes in test 
threshold.  
Notes to table 1.8: TP: true positive; TN: true negative; FP: false positive; FN: false negative. *Test result as reference class: TP as a proportion of test +ve 
results and TN as a proportion of test –ve results. Disease as reference class: TP as a proportion of diseased individuals and TN as a proportion of non 
diseased individuals. **Bayes’ theorem : P(D+| X)=  
             (P(D+) X P(X|D+) + P(D-) X P(X|D-)) 
     (P(D+) X P(X | D+))          
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Table 1.8 illustrates that test accuracy metrics can be subdivided into those that allow the 
estimation of disease probability in individuals and those that provide information only on the 
overall discriminatory ability of test. The former are more aligned to decision making at the 
bedside (interpretation of test results) whereas the latter may be more useful for decisions 
about testing policy, with the caveat that such comparisons of test performance implicitly 
value false positive and false negative test errors equally. 
Of those metrics that allow the estimation of disease probability at the bedside, those that 
communicate test accuracy with test result as reference class might be considered more 
clinically intuitive than those with disease status as reference class, on the basis that a 
diagnosis is made on the basis of a test result; disease status is unknown at the time testing 
is performed. 
 
Able to compute accurately 
The normative rule for updating of opinion (pre-test probability of a disorder) with imperfect 
information (uncertainty conveyed by measures of test accuracy) is Bayes’ theorem (see 
notes to table 1.8 above). The derived post-test probability becomes the pre-test probability 
for any subsequent tests.  In clinical medicine a final diagnosis is usually reached following a 
number of tests which may be applied sequentially or simultaneously. This complicates 
Bayes’ theorem and makes its application increasingly impractical, particularly where 
diagnostic tests are not independent (as is often the case). Linear and logistic regression 
play a role in deriving clinical prediction rules under such circumstances but they are not 
exhaustive in their coverage, they are disorder rather than symptom based which may limit 
their applicability in generalist settings and there are many problems with their derivation, 
validation and portability across settings and populations 64. Prediction models are not seen 
as substitutes for medical decision making by doctors 65.  
The ability to compute accurately will therefore depend on the complexity of the problem and 
the knowledge, skill and preferences of the decision maker 45,48. Cognitive shortcuts 
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(heuristics) have been observed to introduce systematic errors during the processing of 
probabilities. Box 1.9 outlines common biases which are believed to overlap and interact. 
Understanding the impact of these cognitive biases on diagnostic decision making would be 
necessary if educational interventions to improve probability revision were to be pursued. 
Box 1.9: Cognitive errors identified by the decision making literature 59,66-71 
 
 
COGNITIVE  ERROR / BIAS 
 
Base rate neglect  
DESCRIPTION 
The tendency to ignore information about base rate 
(the pre-test probability) of an event. Base rate 
neglect has been observed to occur more frequency 
when dealing with low prevalence conditions / low 
frequency events. Base rate neglect may underlie 
the observation that sensitivity and specificity are 
confused with positive and negative predictive 
values (for example individuals given information 
about sensitivity assume this is the post-test 
probability of having disease thereby effectively 
ignoring pre-test probability (base rate)). 
Conjunction Fallacy The tendency to judge that the conjunction of two 
events is more probable than one of the events in a 
direct comparison. The explanation for the 
existence of this heuristic is purported to be due to 
judgements of representativeness (similarity to 
stereotypes). 
Availability heuristic The tendency to overestimate the probability of 
events that come easily to mind, for example that 
observed recently or that which is memorable. 
Confirmatory bias The tendency to look for information that fits pre-
existing expectations and to dismiss information 
that contradicts pre-existing information. 
 
Hindsight bias 
Assignment of the posterior probability to disease 
(after testing) to the prior probability resulting in 
overconfidence in initial diagnoses and a tendency 
to ignore diagnostic cues. 
 
The unpacking effect 
An increase in the subjective probability assigned to 
an event when its description is more detailed. 
 
Sub-additivity 
Overestimation of probabilities leading to the sum of 
the probabilities of competing hypotheses 
exceeding 1.0. 
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1.5.2.2 Fully rationale: Motivational errors and biases 
 
Individuals can be considered rational if they base decisions on reason and knowledge rather 
than emotional response. Objectivity when processing information about the value of 
different outcomes is compromised by prior beliefs, expectations and the value (utility) 
attached to risks. Professional utility may be affected by many factors including fear of 
litigation 11,19, financial motives 19 and risk preference11.  
Estimation of probabilities has been shown to be distorted in risky decision making, 
depending on the perceived seriousness of the outcome 10. An individual’s risk preferences 
are therefore unlikely to be fixed, but dependent on context and the time frame being 
considered.  
Different attitudes to gains and losses have also been observed to impact on values attached 
to risk; a departure from behaviour predicted by normative decision theory. This is outlined 
by prospect theory 72 which describes how people think of possible outcomes relative to a 
reference point (the framing effect). Losses from a reference point are perceived as worse 
than gains and as a result risk attitudes to gains are different to risk attitudes to losses. 
Framing of outcomes positively (as gains) or negatively (as losses) can therefore affect the 
values placed on them – individuals are more likely to choose an option framed as a gain 
from a reference point compared to the same option framed as a loss from the same 
reference point. Thus option A, with an 80% chance of not having disease X (a gain) would 
be preferred to option B, with a 20% chance of having disease X (a loss). Prospect theory 
predicts that when faced with gains individuals tend to be risk averse but when faced with 
losses they tend to be risk takers.  
In healthcare decision making the healthcare professional as agent, acting on behalf of the 
patient, introduces complexity into the notion of utility, incorporating both patient and 
professional values 10. With professional as agent, the extent to which patient utility is 
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incorporated in decision making will depend on an accurate assessment of patient utility by 
professionals, itself dependent on effective communication of uncertainty in the consultation.  
Rational decisions about testing should be concerned with maximising the outcome for the 
recipient of the test; the patient. However there is a utility associated with testing decisions 
for professionals as well as patients. For example Hozo (2008)73 introduced the notion of 
regret to incorporate professional utility into diagnostic decision making: the difference in 
utility between the best possible action in retrospect (which may be the action taken) and the 
utility of the action taken. Relevant to the concept of professional utility are the relative values 
placed on acts of commission and acts of omission. Traditionally harm resulting from inaction 
(omission) is viewed as more morally acceptable in comparison to harm resulting from action 
(commission) as commission carries with it notions of intent 74. This phenomenon is termed 
omission bias 75. Indeed it has been argued that omission bias may be responsible for the 
majority of medical errors, a large proportion of which are errors concerned with diagnosis 75.  
Performing a test could be considered clearly as an act (a commission) and not performing a 
test an act of omission. However when considering a management decision based on a test 
result the existence of test errors adds complexity to the assessment of whether an act is 
one of commission or omission. Initiating treatment or further testing following a positive test 
result might be considered an act of commission if the positive test result is a false positive 
but not if it is a true positive. Similarly, not initiating further treatment or testing on the basis of 
a negative test result might be viewed as an act of omission if the negative test result is a 
false negative. Assessment by decision makers of the nature of an action (commission or 
omission) following a test result will therefore be complicated by a requirement for knowledge 
about test error rates and assessment of the relative utility associated with each type of test 
error. 
 In summary the consideration of professional and patient utility in healthcare decision 
making, particularly where these may be incongruous, introduces complexity into the 
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definition of optimality as defined by Einhorn and Hogarth 1981 54 and may not be well 
represented by traditional economic behavioural decision theory. The fact that testing is 
associated with four possible outcomes, each with its own utility, magnifies this complexity. 
The threshold approach to clinical decision making as proposed by Pauker 76 is a useful 
model for illustrating the incorporation of utility in decisions about test use (see fig 1.10 
below).  
Fig 1.10: Diagrammatic illustration of the test and test-treat threshold model (Pauker 
1980) 76 
 
 
(a)Test with greater accuracy or lower direct risks associated with testing 
 
Withhold 
Treatment 
 
TEST 
   
Treat 
  
 
 
 
 
 
(b)Test with lower accuracy or greater direct risks associated with testing 
 
Withhold Treatment 
 
 
TEST 
 
Treat 
 
 
 
 
 
 
 
Pre test probability of disease 
Pre test probability of disease 
0 
0 
1 
1 
Test threshold † Test -treat threshold 
 
Test threshold † Test - treat threshold 
 
Notes to Fig 1.10:  
Test threshold: probability of disease at which the utility associated with testing to determine the 
subsequent treatment decision = utility of withholding treatment without testing first. 
Test-treat threshold: probability of disease at which the utility associated with testing to determine 
the subsequent treatment decision = utility of administering treatment without testing first. 
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Figure 1.10 illustrates how testing context might impact on decisions about test use and in 
the application of a given test result. The model assumes that for a particular disease and its 
associated treatment, there exists a therapeutic probability threshold (the probability of 
disease at which the utility associated with administering treatment is equal to the utility 
associated with withholding treatment). The therapeutic (probability) threshold is determined 
by the risks associated with untreated disease and the risks associated with treatment itself. 
Pauker 76 extended the treatment threshold concept to incorporate the utility associated with 
testing, which for a particular test is determined by the risks associated with administering 
the test and the risk of test errors (false positives and false negatives). The test threshold is 
defined as the probability of disease at which there is no difference in the utility associated 
with withholding treatment without testing first or testing first to determine the subsequent 
treatment decision. The test-treat threshold is defined as the probability of disease at which 
there is no difference in the utility of administering treatment without testing first, or testing 
first to determine the subsequent treatment decision. At probabilities of disease higher than 
the test threshold but lower than the test-treat threshold, the balance of utility is in favour of 
testing to determine the subsequent treatment decision. At probabilities higher than the test-
treat threshold the balance of utility is in favour of treating without testing first. For a given 
disease and associated treatment, tests with higher accuracy (and therefore a lower risk of 
test errors) and /or lower risks associated with test administration, result in a decision to test 
prior  to determining a management approach over a larger range of disease probabilities 
than tests with lower accuracy and/or higher risks associated with their administration.  
The implication for research is that judgements about the quality of diagnostic decision 
should incorporate utilities and not rely on demonstration of accurate probability revision 
alone. Optimising the utility from testing requires an appreciation of the downstream 
consequences of each of the four possible outcomes of testing and a comparison of their 
probabilities for each specific testing context. 
 
 28 
 
1.5.3 Application of information about test accuracy in clinical practice 
This chapter has outlined the gap between testing practice and that predicted from clinical 
need and the existing evidence base. Variables that have been investigated as potential 
modifiers of test ordering behaviour explain a small amount of the observed variation in 
testing and the potential contribution of informed diagnostic decision making appears to have 
received little attention in this respect. This is despite the fact that probabilistic reasoning is 
proposed to be a prominent part of diagnostic decision making and the paradigm on which 
evidence based medicine is based. Contextual considerations are likely to be particularly 
important for decisions about test use and in the application of test results. Clinical context 
encompasses variables that are potential modifiers of test accuracy. These include factors 
that shape the spectrum of the population to be tested (for example severity of the target 
disorder, co-morbidities, the stage in a testing pathway that an index test is being used as a 
proxy for prior tests received and features of the healthcare setting that might impact on test 
conduct), as well as variation in test technology, application and interpretation that are 
independent of healthcare setting, prevalence of the target disorder and the intended role 
and application of the test under evaluation including consideration of the downstream 
consequences of test results. Knowledge concerning the extent to which test accuracy 
measures effectively convey the uncertainty associated with testing to decision makers and 
the degree to which the testing context is represented by test accuracy evidence is important 
if interventions are to be designed with the aim of reducing the observed gap between 
evidence and testing practice. 
  
1.5.4 Thesis outline 
The following chapters represent an investigation of the extent to which the test accuracy 
evidence base supports informed diagnostic decision making. The framework for this 
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investigation will draw on the assumptions of behavioural decision theory: a decision maker 
who is fully informed, fully rational and able to compute accurately. 
   
 Chapter 2 presents a review of the existing empirical and non empirical literature 
concerning understanding and application of test accuracy measures by decision 
makers, complemented by a review of the more established risk communication 
evidence base. The scope of the review will be comprehensive with respect to use of 
test accuracy evidence and information about pre-test probability (fully informed); the 
role and adequacy of probability revision in practice (able to compute accurately) and 
the influence of utility judgements on decision making (fully rational).  
 Chapter 3 presents an epidemiological mapping exercise of existing test reviews with 
respect to coverage of disease topic areas, representation of healthcare setting and 
review purpose. The mapping exercise will measure the extent to which secondary 
test accuracy evidence is fit for purpose to fully inform decision makers across 
different healthcare settings. 
 Chapter 4 presents a review of the degree to which clinical context shapes the 
conduct and reporting of existing test accuracy reviews. The focus of the review will 
be to assess the extent to which secondary test accuracy evidence provides 
information to inform decisions in specific testing contexts (fully informed) (fully 
rational). 
 Chapter 5 is a survey of use, understanding and application of test accuracy 
measures in a sample of primary care clinicians. The survey aims to assess the 
degree to which test accuracy evidence is sought and used in practice (fully informed) 
(able to compute accurately) as well as gaining an insight into the diagnostic decision 
making process beyond probability revision, (fully rationale) and exploring the 
purported centrality of probability revision as a pre-requisite for informed decision 
making.  
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Chapter 2: Review of literature concerned with the understanding 
and application of test accuracy and risk measures 
 
 
2.1 Abstract 
Background 
The widespread belief that decision makers have difficulty understanding and applying test 
accuracy information has not been based on a systematic interrogation of the evidence base 
to allow quantification or characterisation of the extent of the problem. 
Aims and objectives: 
To comprehensively ascertain literature pertinent to the understanding and application of test 
accuracy measures in order to identify facilitators and barriers to their use by decision 
makers.  
Methods 
Bibliographic searches were conducted in 2003, 2005, 2007 and 2010, across 11 databases 
representing medicine, psychology and education. Searches were iterative, purposive and 
supplemented by reference checking included studies and contact with experts. A narrative 
synthesis of empirical and theoretical test accuracy and risk communication literature was 
undertaken.  
Results 
64 test accuracy and 21 risk communication papers were included. Research is 
characterised by self selected samples, lacks external validity and primary care is under-
represented. Ability to define the most commonly used metrics (sensitivity, specificity, 
predictive values) is poor. Predictive values and test errors are promoted as most intuitive 
although there is no empirical evidence supporting the superiority of a single test accuracy 
metric for diagnostic decision making. Natural frequency and multiple presentation formats 
facilitate understanding. Verbal descriptions and negative test results may be less well 
understood. Self-reported use of measures varies: predictive values 80%, sensitivity and 
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specificity 4% and ROC curves and LRs < 1%.  Pre-test probability and test accuracy 
estimation is inaccurate and highly variable which has implications for probability revision.  
Conclusions 
The emphasis in the literature has been on identifying the best single metric rather than 
identifying an optimal combination and understanding of meta-analytic summary measures 
has not been investigated. Investigation of contextual and motivational influences on test and 
test-treat thresholds is required to identify test accuracy magnitudes that will have most 
impact on diagnostic and therapeutic yield.  
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2.2 Review rationale and aims 
2.2.1 Rationale 
The rationale for the review was to build up a theoretical picture of the proposed strengths 
and weaknesses of existing measures of test accuracy and to summarise existing empirical 
literature examining their interpretation and application.  
 
2.2.2 Aims 
The aims were to comprehensively capture empirical literature concerned with the 
understanding and application of test accuracy measures, whilst a review of theoretical 
perspectives (non-empirical literature) adopted a qualitative approach to searching and 
synthesis, with the aim of providing a representative map of comment and analysis offering 
insights and opinions about characteristics of existing or novel accuracy measures that may 
impact on their interpretation and application. 
 
2.2.3 Objectives 
 
 To assess the extent to which decision makers understand and can apply test 
accuracy metrics 
 To make recommendations for the practice of reporting evaluations of test accuracy, 
particularly systematic reviews and meta-analyses 
 To identify the need for further research.  
 
In anticipation of a paucity of literature specifically concerned with understanding and 
application of test accuracy measures, a review of literature concerned with the 
communication of risk more generally in healthcare settings was planned. Drawing on the 
common theme of communicating uncertainty, the rationale was that a larger body of 
research concerned with the communication of risk may provide insights into formats for 
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presenting probabilistic information that were novel for the communication of test accuracy 
information. Although the focus of this programme of research was the communication of test 
accuracy in systematic reviews, searches were not restricted to summary measures more 
typical or unique to reviews. The challenges in the interpretation of summary measures of 
test accuracy 34,34 are common to both systematic reviews and primary studies as the 
majority of outcome measures in use are shared by both types of research 6,7. 
 
2.3 Review methods 
2.3.1 Methods: Review Search strategy 
In order to fulfil the aims of a review it was anticipated that perspectives from a range of 
disciplines would be relevant so the search strategy included interrogation of the medical, 
psychological and educational literature. In addition the preliminary results of the literature 
search were presented at a national conference (Methods for Evaluating Tests and 
Biomarkers: second international symposium, University of Birmingham, July 2010) as a test 
of face and content validity.  
Bibliographic searches were conducted in 2003, 2005, 2007 and 2010, from inception to date 
in each database. The searches conducted in 2005, 2007 and 2010 were designed to be 
iterative and purposive, building on knowledge and sources of relevant literature obtained to 
date, and in addition an aim of the 2010 search was to update the currency of the previous 
search strategies. During this period literature obtained passively through discussions with 
experts and identified opportunistically by information specialist colleagues was also 
assessed and reference checking of included articles was undertaken. 
Over the period of searching the following bibliographic databases were searched using 
various configurations of text and MESH terms in order to identify published, unpublished 
and on-going work concerned with understanding and interpreting test accuracy measures 
(see appendix 2.1 for search strategies employed 2010): 
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Cochrane methodological register (CMR) 
Science Citation Index (Web of Science)  
Social Science Citation Index (Web of Science)  
Web of Science including Proceedings  
Cochrane library (DARE; HTA; CDSR; Central)  
MEDION Methods database 
MEDLINE 
Embase 
PsycInfo 
ERIC 
ISI proceedings  
ZETOC 
NIHR NETSCC 
CADTH NETCC 
In addition an author search was conducted for authors who had published any empirical 
research concerning understanding of test accuracy by health professionals or who had 
published substantively in related areas.  
 
2.3.2 Methods: Inclusion criteria 
Following completion of the test accuracy reviews and a scope of the risk communication 
literature, a decision was made to restrict the risk review to reviews of empirical studies and 
primary, empirical research updating these reviews (see table 2.1).
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Table 2.1: Inclusion criteria for risk communication literature following scoping searches: Map of risk communication outcome by 
review date and population (Health and Non-Health (N-H) professionals) 
 REVIEW, DATE PUBLISHED AND  SEARCH END DATE  
RESEARCH QUESTION Edwards 
2000 
(1996) 
(ER5) 
 
Kuhberger 
1998 
(1997)  
(ER13) 
 
McGettigan 
1999 
(?) 
(ER16) 
 
Lipkus 
1999 
(1998) 
(ER14) 
 
Edwards 
2001 
(1999) 
(ER6) 
Julien-
Reynier 
2003 
(2002) 
(ER12) 
Epstein 
2004 
(2003) 
(ER10) 
Ancker 
2006 
(2005) 
(ER2) 
Edwards 
2006 
(2005) 
(ER7) 
Edwards 
2008  
(2006) 
(ER9) 
Albada 
2009 
(2007) 
(ER1) 
N-H N-H Health Health 
and N-H 
N-H N-H Health 
and N-H 
Health 
and N-H 
N-H N-H N-H 
 Framing /Risk 
taking attitudes 
 X X X X X  X    
Ta
ilo
rin
g 
Tailored content X     X   X X X 
Tailored 
presentation 
X     X    X  
Graphical presentation    X X  X X    
N
um
er
ic
al
 P
re
se
nt
at
io
n 
Numerical 
presentation 
(Frequencies vs 
probabilities) 
      X X  X  
Numerical 
presentation 
(RR vs AR vs 
NNT) 
  X  X  X     
Numerical 
presentation 
(probability) 
  X X X X   X X  
Verbal presentation   X X X X   X X  
Other presentation 
format 
    X  X   X  
Notes to table 2.1: RR: Relative Risk. AR: Attributable Risk. NNT: Number Needed to Treat. Other presentation format includes: more versus less 
information; lay versus medical; range versus point estimate; presentation order; manipulation of base rates
 37 
 
Literature concerned exclusively with communication of uncertainty in non-healthcare 
settings was not included on the basis that contextual features unique to the healthcare 
setting may substantially affect the interpretation, communication and use of risk and test 
result information. However perceptions and understanding of both health and non-health 
professionals was considered.  At the outset only non-English language studies concerned 
with empirical evaluation of understanding of test accuracy measures were to be considered 
for translation. 
 
2.3.3 Methods: Data extraction, quality assessment and synthesis 
Literature concerned with communication of test accuracy was sub-divided into empirical and 
non-empirical. Empirical literature included any quantitative or qualitative investigation of 
understanding; application; behaviour (effect on test or treatment use or uptake); use of 
measures in practice; preference or attitudes to test accuracy or risk information by 
individuals. Research investigating preferences and attitudes were included as these were 
considered important variables impacting on use and understanding. Non-empirical literature 
comprised opinions about the communication of uncertainty in healthcare testing settings. 
Empirical studies were tabulated, making a distinction between risk and test accuracy 
research and health professionals and non-health professionals. Information was extracted 
on study setting, study design, type and presentation format of test accuracy or risk 
measures and study findings. Methodological quality of papers was not comprehensively 
assessed using formal checklists due to the diversity of the literature included. For reviews 
the adequacy of question formulation, search strategy, study flow, quality assessment and 
presence of double data extraction were assessed in addition to consideration of external 
validity. For Randomised Controlled Trials (RCTs), adequacy of randomisation, allocation 
concealment, similarity of groups at baseline, blinding and attrition were assessed. For other 
study designs assessment of selection and measurement bias was undertaken where 
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possible. The aim was to provide an indication of the applicability and quality of evidence in 
the field. Empirical findings were synthesised drawing on the assumptions of normative 
decision theory: the expectation that (diagnostic and treatment) decisions are made with the 
aim of maximising the value of the outcomes possible from competing choices. This requires 
a decision maker who is fully informed, fully rational and able to compute accurately (see 
1.5.2). For the purposes of synthesis, these decision maker attributes were mapped to the 
outcomes outlined in table 2.2. For empirical research, outcomes of interest were defined a 
priori whereas for non empirical, theoretical papers the outcomes presented in table 2.3 
represent the result of thematic coding. 
The method of qualitative synthesis chosen for literature concerned with theoretical 
perspectives (non-empirical) was on the basis of the desired synthetic product 77: 
The impact of moderators of understanding and application of test accuracy information in 
healthcare settings.  
By definition theoretical, non empirical literature represents second order interpretations of 
phenomena based on observation or empirical research conducted by the authors. The aim 
of this qualitative synthesis was therefore twofold: firstly to translate second order 
explanations (conceptual themes) across individual articles; secondly to develop a line of 
argument analysis, taking into consideration the perspectives of different research traditions 
and differences in theoretical assumptions. This approach borrows from applications of meta-
ethnography as applied to non-ethnographic studies 78 and critical interpretive synthesis 79. 
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Table 2.2: Mapping of normative decision theory assumptions to outcomes 
considered in the reviews of test accuracy and risk communication 
 Test accuracy literature 
outcomes 
General risk communication 
literature outcomes 
Fully informed 
Estimation of pre-test probability 
or test accuracy 
Estimation of baseline or 
intervention/exposure risk 
Accuracy of pre-test probability or 
test accuracy estimation as 
measured by one or more of the 
following: 
-Perception (size relative to a  
reference point) 
-Quantitative or semi-quantitative 
estimation 
-Precursor of change in testing / 
treatment /other  behaviour 
Accuracy of risk estimation as 
measured by one or more of the 
following: 
-Perception (size relative to a  
reference point) 
-Quantitative or semi-quantitative 
estimation 
-Precursor of change in testing / 
treatment /other behaviour 
Test accuracy metrics Risk metrics 
Familiarity / Understanding of test 
accuracy measures as indicated by 
one or more of: 
-Preference 
-Use in practice 
-Comprehension 
-Appreciation of contextual variation 
in test accuracy 
-Consideration of downstream 
consequences of test results on 
patient outcomes 
- Precursor of change in testing / 
treatment /other  behaviour 
Familiarity / Understanding of risk 
measures as indicated by one or 
more of the following: 
-Preference 
-Use in practice 
-Comprehension 
-Appreciation of contextual baseline 
variation in risk 
-Behaviour change following risk 
communication 
-Precursor of change in testing / 
treatment /other behaviour 
Fully rational 
Consideration of patient and 
professional utility in the decision 
making process (anxiety / attitude / 
affect / framing effects) 
Consideration of patient and 
professional utility in the decision 
making process (anxiety / attitude / 
affect / framing effects) 
Able to compute 
accurately 
-Ability to undertake probabilistic 
reasoning as indicated by one or 
more of: 
-Quantitative or semi-quantitative 
adjustment in disease probability pre 
to post testing.  
- Precursor of change in testing / 
treatment /other  behaviour 
-Ability to undertake risk manipulation 
and compare risks as indicated by 
one or more of: 
-Quantitative or semi-quantitative 
manipulation of risk measures 
-Precursor of change in testing 
/treatment /other  behaviour 
 
Initial themes for synthesis of non-empirical literature included familiarity, understanding and 
use of existing test accuracy measures, probabilistic versus frequentist expressions of 
uncertainty, contextual considerations including knowledge about disease prevalence and 
attitudes to risk and probabilistic reasoning. These were generated a priori and expanded as 
additional themes emerged from the literature. In order to assist with the development of a 
line of argument analysis, literature was considered in date order and according to authors’ 
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profession as far as could be gleaned from published affiliations. Second order interpretation 
themes from authors were grouped, translated across articles and linked to the three 
assumptions underlying normative decision theory.  A priori themes that were not 
represented in the literature included familiarity of decision makers with measures of test 
accuracy and the extent of use of test accuracy measures in practice. 
Table 2.3: Organisation and linking of 2nd order interpretation themes 
2nd order interpretation themes 3rd order interpretations 
Collapsing of themes Assumptions 
underlying 
normative 
decision theory 
Likelihood Ratio (LR) Test 
accuracy 
measures 
   Fully informed 
Sensitivity and Specificity    
Global measures of test accuracy    
Predictive values (PVs)    
Graphical methods of expressing 
test accuracy 
   
2x2 table    
Test errors Contextual 
factors 
  
Patient and setting-specific factors 
that might impact on test 
use/interpretation 
   Fully rational 
Estimation of pre-test disease 
probability 
   Fully informed 
Decision maker attitudes to risk   Attitudes 
to risk 
 Fully rational 
Probabilistic versus frequentist 
expression of uncertainty 
   Probabilistic 
reasoning  
Able to compute 
accurately 
Pre to post-test probability revision 
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Fig 2.4: Review Study flow 
 
  
-Bibliographic searches:  
N=16491 
-Reference checks and 
experts: N=274 
Excluded not relevant:  
Title and abstract: N=13 805 
Duplicates: N=2508 
Excluded non-English N=7 
Excluded non-medical setting: 
N=7 
Empirical test 
accuracy: 
 N=33 
Non-Empirical 
test accuracy: 
N=34 
Empirical risk: 
N=11 reviews 
N=10 studies 
Health 
professional 
empirical 
test 
accuracy:  
N=26 
reporting 27 
studies 
Non-health 
professional 
empirical 
test 
accuracy:  
N=7 
reporting 16 
studies 
Biblio: 
N=14 
Expert / 
Citation: 
N=19 
Health 
professional 
non-
empirical 
test 
accuracy:  
N=25 
Biblio: 
N=8 
Expert / 
Citation: 
N=26 
Health 
professional 
risk:  
N=1 review 
Health and  
non-health 
professional 
risk:  
N=3 reviews 
N=1 study 
Biblio:  
N=15 
Expert/ 
Citation:  
N=6 
Non-health 
professional 
risk:  
N=7 reviews 
N=9 primary 
studies 
reporting 12 
studies 
Non-health 
professional 
non-
empirical 
test 
accuracy:  
N=9  
Excluded not risk or test 
accuracy communication:  
N=317 
Full papers 
obtained: 
 N=419 
Included N=88 
Primary studies 
included in risk reviews 
and not considered 
further: N=33 
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2.4 Results: Non-empirical test accuracy literature  
Table 2.5 documents the author affiliation, date, publication details and discussion themes of 
the 34 articles by 30 unique authors. Most articles identified were published in general 
medical journals by clinicians, 16/25 of whom were affiliated with an academic institution. 
The majority of literature identified was published in the last two decades (88% after 1990), 
the rapid increase during the 1990s coinciding with the introduction of the Evidence Based 
Medicine (EBM) movement 80 which promotes the integration of external evidence with 
individual expertise for medical decision making 81. 
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Table 2.5: Non-empirical literature: Date, place of publication and discussion themes 
Author, Year & 
place of 
publication 
Title Test accuracy 
measures 
Contextual factors including 
knowledge of pre-test 
probability 
Attitudes to risk Probabilistic reasoning  
(TTA1) Akobeng 
2007(a) 
(C) 
Acta Paediatrica  
Understanding 
diagnostic tests 1: 
sensitivity, specificity 
and predictive values 
 -Sensitivity, specificity, 
PVs and 2x2 table 
-SnNOUT and SpPIN 
heuristics 
-Graphical 
presentation of test 
accuracy 
-Prevalence effects   
(TTA2) Akobeng 
2007 (b) 
(C) 
Acta Paediatrica 
Understanding 
diagnostic tests 2: 
likelihood ratios, pre and 
post-test probabilities 
and their use in clinical 
practice 
-Advantages of LRs 
-Disadvantages of 
sensitivity and 
specificity 
  -Graphical tools 
(nomogram) for probability 
revision 
(TTA3) Benish 2003 
(C) 
Methods of 
Information in  
Medicine 
Mutual information as an 
index of diagnostic test 
performance 
-Mutual information as 
a novel test accuracy 
measure 
-Contextual modifiers of 
diagnostic information 
  
(TTA4) Bianchi 
2006 
(C) 
BMJ 
Evidence based 
diagnosis: does the 
language reflect the 
theory? 
-Test accuracy 
language 
- 2x2 table, PVs and 
prevalence  
-Disadvantages of 
sensitivity and 
specificity  
-Spectrum effects 
-Prevalence effects 
 
 -Test accuracy language 
as a barrier to probabilistic 
reasoning 
-Confirmatory bias 
(TTA5) Daniel  
1993 
(C) 
Medical  Decision  
Making 
Graphic representation 
of numerically calculated 
PVs: an easily 
comprehended method 
of evaluating diagnostic 
tests 
-Advantages and 
disadvantages of 
sensitivity and 
specificity  
-Graphical tools for 
test comparisons.  
  - Limitations of existing 
test accuracy measures for 
probability revision 
 
 
 
 44 
 
Table 2.5 continued 
Author, Year & 
place of 
publication 
Title Test accuracy 
measures 
Contextual factors including 
knowledge of pre-test 
probability 
Attitudes to risk Probabilistic reasoning  
(TTA6) Doust  
 2010 
(CA) 
BMJ 
Using probabilistic 
reasoning 
-SnNOUT and SpPIN  
-Graphical f test 
accuracy presentation 
 -PVs  
-Test errors  
-Prevalence effects and test 
errors 
 
 -Qualitative and 
quantitative probabilistic 
reasoning 
(TTA7) Dujardin 
1994 
(CA) 
European Journal 
of Epidemiology 
Likelihood ratios: a real 
improvement for clinical 
decision making? 
-Advantages and 
disadvantages of LRs, 
PVs, sensitivity and 
specificity 
-Test errors 
-Spectrum effects 
 
 -Advantages of LRs for 
probabilistic reasoning 
(TTA8) Falk  
2009 
 (C) 
BMJ 
Diagnosis in General 
Practice: Clinical 
Prediction Rules 
-Sensitivity, specificity 
and LR interpretation 
-Healthcare setting and the two 
dimensions of test accuracy 
 -Clinical prediction rules  
-Sequential testing 
(TTA9) Gigerenzer  
1995  
(A) 
Psychological 
Review 
How to improve 
Bayesian reasoning 
without instruction: 
frequency formats 
   - Frequentist expression 
facilitates probability 
revision 
 
(TTA10) Gigerenzer   
1996 
(A) 
Medical Decision 
Making 
The psychology of good 
judgment: frequency 
formats and simple 
algorithms 
   -Human cognitive 
algorithms. 
 - Frequentist expression 
facilitates probability 
revision 
-Satisficing algorithms and 
heuristic reasoning 
(TTA11) Gigerenzer 
2003 
(A) 
BMJ 
Simple tools for 
understanding risks: 
From innumeracy to 
insight 
    - Frequentist expression 
facilitates probability 
revision  
-Reference class 
confusion: sensitivity & 
PPV 
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Table 2.5 continued 
Author, Year & 
place of 
publication 
Title Test accuracy 
measures 
Contextual factors including 
knowledge of pre-test 
probability 
Attitudes to risk Probabilistic reasoning  
(TTA12) Gill  
2005  
(A) 
BMJ 
Why clinicians are 
natural Bayesians 
- Advantages of LRs -Estimation of pre-test 
probability 
 - Bayesian reasoning  
-Frequentist expression of 
uncertainty 
-Semi-quantitative vs 
quantitative probabilistic 
reasoning 
-Sequential testing  
(TTA13) Gorry  
1978  
(A) 
The New England 
Journal of 
Medicine 
The diagnostic 
importance of the 
normal finding 
   -Semi-quantitative pre to 
post test probability 
revision 
 -Frequentist probabilistic 
reasoning implicit 
(TTA14) Grimes 
 2005  
(CA) 
Lancet 
Refining diagnosis with 
likelihood ratios 
- Advantages and 
disadvantages of LRs,  
sensitivity and 
specificity.  
LR non-linear scale 
may complicate  
interpretation 
  -Facilitation of probability 
revision with LRs 
-Graphical tools 
(nomogram) for probability 
revision 
(TTA15) Halkin  
1997  
(C) 
Quarterly Journal 
of Medicine 
Likelihood ratios: getting 
diagnostic testing into 
perspective 
- Advantages of LRs 
 
-Spectrum effects  -Quantitative versus 
qualitative probabilistic 
reasoning.   
(TTA16) Henderson 
1998 
(CA) 
BMJ 
Test accuracy is 
example of redundant 
information 
-Advantages and 
disadvantages of 
global measures of 
test accuracy 
-Consideration of two 
dimensions of test 
accuracy 
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Table 2.5 continued 
Author, Year & 
place of 
publication 
Title Test accuracy 
measures 
Contextual factors including 
knowledge of pre-test 
probability 
Attitudes to risk Probabilistic reasoning  
(TTA17) Hoffrage 
2002  
(A) 
Cognition 
Representation facilities 
reasoning: what natural 
frequencies are and 
what they are not 
   - Frequentist expression 
facilitates probability 
revision 
-Natural and normalised 
frequencies 
(TTA18) Kassirer 
1989  
(C) 
New England 
Journal of 
Medicine 
Our stubborn quest for 
diagnostic certainty: a 
cause of excessive 
testing 
 -Erroneous estimation of pre-
test probability 
-Attitudes to 
uncertainty. 
-Attitudes to 
uncertainty as a 
modifier of test use 
-Categorical / quantitative 
expressions of uncertainty 
-Limitations of medical 
training for probability-
orientated thinking 
(TTA19) Klein  
2005  
(A) 
BMJ 
Five pitfalls in decisions 
about diagnosis and 
prescribing 
   -Cognitive biases in 
diagnostic decision making  
 
(TTA20) Knottnerus 
1985 
  (CA) 
Journal of the 
Royal College of 
General 
Practitioners 
Interpretation of 
Diagnostic Data - An 
Unexplored Field in 
General-Practice 
 -Healthcare setting as a 
moderator of pre-test 
probability and test accuracy 
-Pre-test probability estimation. 
- Secondary care focus of 
medical training 
  
(TTA21) Loong 
 2003  
(CA) 
BMJ 
Understanding 
sensitivity and specificity 
with the right side of the 
brain 
-Graphical 
presentation of test 
accuracy  
  -Graphical presentation of 
test accuracy facilitates 
probabilistic reasoning 
(TTA22) McCowan 
2006 
(CA) 
British Journal of 
General Practice 
Diagnosis and 
diagnostic testing in 
primary care 
 -Contextual difficulties in 
primary care 
 -Secondary care focus for test 
accuracy research 
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Table 2.5 continued 
Author, Year & 
place of 
publication 
Title Test accuracy 
measures 
Contextual factors including 
knowledge of pre-test 
probability 
Attitudes to risk Probabilistic reasoning  
(TTA23) Miettinen 
1998  
(CA) 
Journal of Clinical 
Epidemiology 
Evaluation of Diagnostic 
Imaging Tests: 
Diagnostic Probability 
Estimation 
   -Use of logistic regression 
in probabilistic reasoning 
(TTA24) Moons  
2003  
(A) 
Academic 
Radiology 
Sensitivity and 
Specificity Should be 
De-emphasized in 
Diagnostic Accuracy 
Studies 
-Importance of 
reference class for 
interpretation of 
conditional 
probabilities 
-Spectrum effects 
 
  
(TTA25) Pewsner 
2004  
(A) 
BMJ 
Ruling a diagnosis in or 
out with "SpPIN" and 
"SnNOUT": a note of 
caution 
-Advantages and 
disadvantages of 
sensitivity and 
specificity 
-Advantages and 
disadvantages of LRs 
   
(TTA26) Richardson 
2003 
(CA) 
Journal of 
General Internal 
Medicine 
Could our pre-test 
probability estimates 
become evidence 
based? A prospective 
survey of hospital 
practice 
 -Pre-test probability estimation  
-Translation of research to 
practice 
  
(TTA27) Sackett  
1998 
 (CA) 
Evidence Based 
Medicine 
On some clinically useful 
measures of the 
accuracy of diagnostic 
tests 
 -Importance of 
reference class for 
interpretation of 
conditional 
probabilities 
- Advantages of LRs  
-Pre-test probability estimation 
-Contextual modifiers of test 
and test-treat thresholds 
 -Graphical tools 
(nomogram) to facilitate 
probabilistic reasoning 
(TTA28) Sonis  
1999  
(CA) 
Family Medicine 
How to use and interpret 
interval likelihood ratios 
-Advantages and 
disadvantage of LRs 
-ROC curves 
-Secondary care focus for 
research on pre-test probability 
-Spectrum effects 
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Table 2.5 continued 
Author, Year & 
place of 
publication 
Title Test accuracy 
measures 
Contextual factors including 
knowledge of pre-test 
probability 
Attitudes to risk Probabilistic reasoning  
(TTA29) Sox  
1986  
(CA) 
Annals of Internal  
Medicine 
Probability theory in the 
use of diagnostic tests: 
An introduction to critical 
study of the literature 
-SnNOUT and SpPIN 
heuristics 
-Healthcare setting as a 
moderator of pre-test 
probability.  
-Heuristics introduce bias in 
pre-test probability estimation 
 -Graphical aids to 
probability revision 
-Test-treat thresholds 
- SnNOUT and SpPIN 
heuristics 
(TTA30) Sox  
2006(b) 
 (CA) 
Annals of  
Internal  Medicine 
Better care for patients 
with suspected 
pulmonary embolism 
-Test accuracy 
language 
-Clinical prediction rules for 
improving pre-test probability 
estimates 
  
(TTA31) Stengel  
2003  
(C) 
Journal of 
Medical 
Screening 
A likelihood ratio 
approach to meta-
analysis of diagnostic 
studies 
-Advantages 
/disadvantages of 
sensitivity, specificity 
&LRs 
-Graphical test 
accuracy presentation 
-Meta-analysis of test 
accuracy 
   
(TTA32) Summerton 
2008 
(CA) 
British Journal of 
General Practice 
The medical history as a 
diagnostic technology 
-Advantage/ 
disadvantages of PVs  
& LRs 
-Prevalence effects 
-Pre-test probability estimation 
 
 - Sequential testing 
-Bayes’ theorem 
-Logistic regression  
(TTA33) Van den 
Ende  
2005 
(CA) 
The Lancet 
The trouble with 
likelihood ratios 
-Disadvantages of LRs 
 
  -LRs and probabilistic 
reasoning  
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Table 2.5 continued 
Author, Year & 
place of 
publication 
Title Test accuracy 
measures 
Contextual factors including 
knowledge of pre-test 
probability 
Attitudes to risk Probabilistic reasoning  
(TTA34) Zaat   
1992 
 (CA) 
Medical Care 
General practitioners' 
uncertainty, risk 
preference and use of 
laboratory tests 
  -Contextual, cultural 
and person-specific 
modifiers of attitudes 
to uncertainty 
-Attitudes to 
uncertainty modify 
test use 
 
Notes to table 2.5: A: author affiliation included an academic institution; C: Author qualifications included MD or DR with affiliation to a clinical placement; 
LRs: Likelihood ratios; PVs: predictive values; two dimensions of test accuracy performance of test in diseased and non-diseased populations or 
discriminatory value of a positive or negative test result.
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2.4.1 Results: Non-empirical test accuracy literature: fully informed  
 
2.4.1.1 Having test result as reference class for interpretation of conditional 
probabilities  
 
Having the test result (predictive values (PVs) and likelihood ratios (LRs)) as opposed to the 
disease state (sensitivity and specificity) as the reference class for interpretation of 
conditional probabilities was emphasised as intuitive: 
“In our view, a single test’s sensitivity and specificity are of limited value to clinical 
practice....They are reverse probabilities with no direct diagnostic meaning. In practice, of 
course, patients do not enter a physician’s examining room asking about their probability of 
having a particular test result given that they have or do not have a particular disease; rather 
they ask about their probability of having a particular disease given the test result. The 
predictive value of test results reflects this probability of disease, which might better be called 
post-test probability.....In our view these parameters (sensitivity and specificity) are of limited 
relevance to practice, and their estimation should not necessarily be pursued in diagnostic 
research.” (TTA24) 
 
“As clinicians our interest isn’t in the vertical columns (of the 2x2 diagnostic contingency 
table) ....if we knew what column our patient was in we wouldn’t need the diagnostic test. We 
want to know the horizontal significance of this test result” (TTA27) 
 
“Diagnostic tests are mainly used in clinical medicine to answer the Bayesian question, 
“What is the probability that the patient has the disease given an abnormal test?” not “What 
is the probability of an abnormal result given that the patient has disease?”” (TTA12) 
“This is because sensitivity and specificity are defined on the basis of people with or without 
a disease. However because the patient would have presented to you with a set of 
symptoms rather than a diagnosis, you would not know at the time whether the patient has a 
disease or not and cannot, therefore, apply these parameters to them.” (TTA2) 
 
“A clinician will not start from diseased or not diseased, but from a positive or negative test. 
Therefore sensitivity and specificity are intuitively not so evident as the likelihood ratio.” (TTA7) 
 
 
2.4.1.2 Limitations introduced by having a fixed threshold of test accuracy 
 
A minority of authors introduced the potential limitation of adopting a single fixed diagnostic 
threshold and multi-level LRs and the Receiver Operator Characteristic Curve (ROC curve) 
were discussed with respect to expressing the relationship between diagnostic threshold and 
test accuracy: 
“..a newer way of expressing (a test’s) accuracy with likelihood ratios reveals its even greater 
power and.....shows us how we can be mislead because the old sensitivity-specificity 
approach restricts us to just 2 levels (positive and negative) of the test result.” (TTA27). 
 
“When test results with continuous or ordinal outcomes are dichotomized for calculation of 
sensitivity and specificity, valuable information is lost, because results that are markedly 
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abnormal are lumped together with results that are only mildly abnormal. Interval likelihood 
ratios, however, assign a specific value to each of level of abnormality, and this value can be 
used to calculate the post-test probability of disease for a given level of a test.” (TTA28) 
 
“Collapsing multiple categories into positive and negative loses information. Likelihood ratios 
enable clinicians to interpret and use the full range of diagnostic test results.” (TTA14) 
 
The use of the ROC curve to illustrate the effects of changing thresholds on the two 
dimensions of test accuracy was also noted: 
 
“In addition, sensitivity and specificity are not fixed values because they can be and should 
often be, altered by moving the decision threshold. This aspect is best examined by means 
of analysis of receiver operating curves.” (TTA16) 
 
2.4.1.3 Contextual factors influencing the interpretation and application of summary 
test accuracy metrics 
 
Throughout the period covered by the review of theoretical literature there was an emphasis 
on the non-portability of PVs as a consequence of their mathematical dependence on 
prevalence.  
 
 “...predictive values are of course useless in other settings where the prevalence rate or pre-
test probability is different..... PPV and NPV will be determined by the combination of the 
sensitivity and the specificity values of a test for a given disease and by disease prevalence.” 
(TTA7) 
 
“Although the positive and negative predictive values are the clinically useful measures, they 
are not generally reported in studies of the accuracy of diagnostic tests as predictive values 
vary greatly with changes in pre-test probability.” (TTA6) 
 
“Both PPV an NPV vary with changing prevalence of disease. It will therefore be wrong for 
clinicians to directly apply published predictive values of a test to their own populations when 
the prevalence of disease in their population is different from the prevalence of disease in the 
population in which the published study was carried out.” (TTA2) 
 
“Considerable confusion has been the consequence (of the belief that there are universal, 
standard predictive values) and clinicians continue to misunderstand this issue.” (TTA7) 
 
“...the positive predictive value... often makes the most intuitive sense to clinicians, and yet it 
is a constant source of misunderstanding between GPs and our secondary care colleagues. 
It is imperative to be aware that the predictive value is affected by prevalence.” (TTA32) 
 
“...likelihood ratios are portable. By contrast, predictive values of test are driven by the 
prevalence of the disease in question.” (TTA14).  
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By contrast the non-portability of all test accuracy metrics as a function of population 
spectrum received relatively less attention and the result was to undermine the value of PVs 
in this respect: 
 
“It is well known that post-test probabilities depend on disease prevalence and therefore vary 
across populations and across subgroups within a particular population, whereas sensitivity 
and specificity do not depend on the prevalence of disease. Accordingly the latter are 
commonly considered characteristics or constants of a test. Unfortunately, it is often not 
realised that this is a misconception.... in fact there can be no generally valid estimates of a 
test’s sensitivity, specificity or likelihood ratio that apply to all patients of a particular 
population, nor should such values be sought.” (TTA24) 
 
“Specificity, like sensitivity, is often considered an intrinsic property of a test and therefore 
independent of the population under study. As specificity is determined by unaffected 
individuals who have positive results, however, it is in fact dependent on the characteristics 
of the comparison population.” (TTA4) 
 
“Like sensitivity and specificity, likelihood ratios values can change with different settings.” 
(TTA7) 
 
The different approach to diagnosis adopted in generalist and specialist setting was also 
noted with implications for test application and interpretation: 
 
“In summary- in general practice sick people need to be distinguished from healthy people 
and in hospital healthy people need to be distinguished from sick people. That the validity of 
tests and the interpretation of symptoms should be directly related to the populations 
consulting and to the degree of clinical differentiation of the disease at reporting has only 
recently received attention in the literature.” (TTA20) 
 
“Whether a clinician wishes to rule in or rule out a disorder is likely to be specific to the 
setting of care and the nature and severity of the target disorder. For instance, clinical 
prediction rules may be used in primary care to rule out a disorder, provide reassurance or 
adopt a watchful waiting strategy. ....Ruling in a diagnosis is desirable in a secondary care 
setting where the emphasis is usually on establishing a firm diagnosis and starting 
appropriate treatment or conducting more expensive and invasive diagnostic tests.” (TTA8) 
 
 
There was recognition that an acceptable level of test accuracy would be context dependent 
and this was exclusively articulated using test errors; the relative values placed on false 
negatives and false positives: 
 
“Positive and negative predictive values may not be equally important to diagnostic test users 
in individual use situations. The costs of false positives and false negative errors may be very 
different in given situations.” (TTA5) 
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“Knowledge of both indices (sensitivity and specificity) is required to appraise test precision 
fully. However one might think of clinical situations in which only one of these characteristics 
is of real interest.” (TTA31)  
 
“What is the optimal cut off point for a test? The answer depends on the subjective values 
attached to false positive and false negative results.” (TTA20) 
 
“ ...the feelings of uncertainty regarding medical problems can differ depending on the 
situation, not only because one physician may be faced with more complicated puzzles than 
the other but also, and primarily because the consequences of a vague and uncertain 
diagnosis may vary in each situation.” (TTA34)  
 
 
The view that without quantification of test errors the SpPIN (high specificity, low number of 
false positives, positive test result rules in a disorder) and SnNOUT (high sensitivity, low 
number of false negatives, negative test result rules out a disorder) mnemonics (TTA27) may 
mislead as a guide to the usefulness of a test: 
 
“We make errors by believing false positive and false negative test results....When the 
prevalence or pre-test probability is low, the probability that a positive test result is a false 
positive becomes quite high. This is often the case in general practice.” (TTA6)  
 
“...one might be tempted to choose test A as a better confirmatory test because of its higher 
specificity. However test B yields the greater number of correct diagnoses in a population 
where the pre-test likelihood of disease is high.” (TTA5). 
 
 
There was a suggestion that the 2x2 diagnostic contingency table may mislead with respect 
to the portability of test accuracy metrics because it allows the derivation of both PVs and 
metrics not mathematically dependent on prevalence: 
 
“The use of the 2x2 table to teach these concepts (sensitivity, specificity, PPV and NPV) also 
frequently creates the erroneous impression that the positive and NPVs calculated from such 
tables could be generalised to other populations without regard being paid to different 
disease prevalence.” (TTA2) 
 
“One of the potentially confusing aspects of predictive values is that it seems to be 
determined by simple calculations with the 2x2 box, similar to sensitivity and specificity and 
therefore it may be misconstrued as a characteristic of  the test itself.” (TTA4) 
 
 
The only novel measure of test accuracy presented in the theoretical literature: the “Mutual 
index as an Index of Diagnostic Test Performance”, was in the context of quantifying the 
setting-specific information provided by diagnostic test:  
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“Because I (D;R) (mutual information) is dependent on pre-test probabilities, knowledge of 
the setting in which a diagnostic test is employed is a necessary condition for quantifying the 
amount of information it provides.” (TTA3) 
 
 
2.4.1.4 The language of test accuracy 
 
The non linearity of the likelihood ratio scale was suggested as a potential source of 
confusion about the magnitude of change in probability they convey: 
 
“Likelihood ratios are not linear... This has important implications. Intuitively the clinician 
rates the discriminative strength of the LR+ of 100 as ten times that of an LR+ or 10, which is 
an overestimation” (TTA7) 
 
“ ..the counterintuitive scale of likelihood ratios. Why is a test with a likelihood ratio of 100 not 
10 times more powerful than a test with a likelihood ratio of 10” (TTA33) 
 
 
The observation that test accuracy descriptor terms often do not represent how test accuracy 
measures are to be applied was suggested as a source of confusion concerning their 
interpretation and application: 
 
 “Referring to the ‘predictive value of a test’ gives the false impression that a test’s predictive 
power stands alone and can be applied to any patient... the predictive value is a 
characteristic of a test result in a specific patient, not of the test result in general, nor of the 
test itself.” (TTA4) 
 
“... the absence of an appropriate language for clinical logic. Instead of indicating what it 
means for clinicians, the word ‘likelihood ratio’ states where it comes from... For years we 
have tried in vain to introduce (likelihood ratios) in clinical teaching in four continents... Never 
in 20 years of teaching clinical logic, have we found a clinician who used the word “positive 
likelihood ratio”.” (TTA33) 
 
“ Although interest in evidence based medicine has increased in recent years, and is taught 
in most medical schools, evidence based strategies have been adopted inconsistently into 
routine care.... it is worth considering whether the manner in which we verbally communicate  
these ideas (about diagnostic testing) may represent a fundamental (yet reparable) 
hindrance to diagnostic reasoning.” (TTA4). 
 
In addition there was considerable discussion about the importance of using test accuracy 
measures that encompass all information about the discriminative power of a test to inform 
diagnostic decision making: 
 
“LRs summarise the information of both sensitivity and specificity and give the discriminative 
power of a test.” (TTA7) 
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 “...(it is) a common misperception that sensitivity and specificity can be considered in 
isolation.” (TTA4) 
 
“Reliance on sensitivity and specificity frequently leads to exaggeration of the benefits of 
tests.” (TTA14) 
 
Methods for simultaneously presenting both dimensions of test accuracy were suggested to 
assist with the interpretation and application of test accuracy information. Dot graphics were 
presented as examples to illustrate the relationship between the two dimensions of test 
accuracy conveyed by sensitivity and specificity, positive predictive value (PPV) and negative 
predictive value (NPV) and positive likelihood ratio (LR+) and negative likelihood ratio (LR-).  
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“What follows are diagrams that were useful for me in attempting to visualise sensitivity, 
specificity and their cousins’ positive predictive value and negative predictive value.” (TTA21) 
(figure 2.6) 
 
Fig 2.6: Dot graphic illustrating the two dimensions of test accuracy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(TTA21)(Loong, BMJ 2003; 327:716-718) 
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Similarly a likelihood scatter plot was proposed as a method for representing both 
dimensions of test accuracy: 
 
“Our objectives were to develop a clearly arranged graphical presentation of the results from 
individual diagnostic studies... We hypothesised that this method of graphical presentation 
could be easily interpreted, especially by readers already used to the “classic” forest plots of 
therapeutic meta-analyses.  
The matrix presentation enables a quick visual impression of the strengths and the 
weaknesses of a diagnostic test in either direction.” (figure 2.7) (TTA31) 
 
 
Fig 2.7: Likelihood Ratio Scatter Plot 
 
Likelihood ratio scatterplot matrix meta-analysis. Unfilled circles represent individual studies. The filled 
circle shows the weighted summary likelihood ratios (random-effects model). Error bars represent 95% 
confidence intervals. 
(TTA31)(Stengel et al, J Med Screen 2003;10:47–51) 
 
2.4.1.5 Facilitating decisions about test use and testing policy 
 
Discussion of the strengths and weaknesses of test accuracy measures in the theoretical 
literature reviewed was almost exclusively from the perspective of the bedside rather than 
the perspective of the development of testing policy.  
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There was recognition that the prevailing architecture of test accuracy research was 
concerned with evaluation of tests in isolation and not their role or contribution to testing 
pathways: 
 
“Test research merely quantifies the ‘characteristics’ of a test rather than the test’s 
contribution to estimate the diagnostic probability of disease presence or absence. By 
‘diagnostic’ research we refer to studies that aim to quantify a test’s added contribution 
beyond the test results readily available....Moreover the focus (of test research) is on the 
value of a single test rather than on the value of that test in combination with other, previous 
tests.” (TTA24). 
 
The existence of a scale with which to judge the clinical utility of a test’s accuracy was 
viewed as an advantage of LRs:  
 
“By convention, marked changes in prior disease probability can be assumed in positive 
likelihood ratios exceeding 10.0 and negative likelihood ratios below 0.1....since no threshold 
values of sensitivity or specificity are available that would allow either the adoption or the 
rejection of the routine application of a diagnostic procedure likelihood ratios appear as 
preferable indices of test performance, at least in the setting of clinical decision making.” 
(TTA31) 
 
 
Global test accuracy measures were suggested to facilitate comparisons between tests to 
inform decisions about test use: 
 
“To evaluate the performance of a diagnostic test...Our goal is to find a number that 
summarises the performance of the diagnostic test.” (TTA3) 
 
 “This aspect (decision thresholds) is best examined by means of analysis of receiver 
operating curves,,,such analyses are provided in reports on diagnostic tests and allow the 
comparisons of one test with another.” (TTA16)  
 
However there was also recognition that consideration of both dimensions of test accuracy 
was important for decisions about test use. Test accuracy measures that did not 
communicate information separately on the two dimensions of test accuracy were seen as 
inadequate in isolation for diagnostic decision making: 
 
“Although (LRs) together contain all the information given by sensitivity and specificity and 
are sufficient for most clinical decisions, sensitivity and specificity are still necessary when 
false positives or false negatives have to be avoided as much as possible. The same LR+ 
can be the result of the combination of very different values for sensitivity and specificity.” 
(TTA7)  
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Similarly, several authors noted that global measures do not communicate information about 
the two dimensions of test accuracy: 
 
“The problem that occurs in a meta-analysis of diagnostic studies is the multi-directional 
performance of the diagnostic instrument regarding its ability to detect (specificity) or exclude 
(sensitivity) the characteristic of interest. Multi-dimensional outcomes cannot be summarised 
well by a single estimate.” (TTA31) 
 
“(Test accuracy) condenses two fundamental test variables- sensitivity and specificity-which 
apply to diseased and non diseased populations, respectively. So what is the point of 
merging these populations when all our efforts are directed at distinguishing between them?” 
(TTA16) 
 
 
2.4.1.6 Pre-test probability estimation  
 
Pre-test probability was either generically conceptualised as the prevalence of disease 
reflected by healthcare setting or as a combination of prevalence estimated form healthcare 
setting and the results of clinical history and examination: the point at which tests, other than 
history and clinical examination, were being considered. 
 
It was suggested that considering the results of clinical history and examination as 
contributing to pre-test probability estimation rather than considering the accuracy of 
individual components might reduce inappropriate testing, particularly in primary care where 
disease prevalence is low. 
 
“Dismissing (a test) for its low likelihood ratio risks setting clinicians on a slippery slope 
towards clinical impotence. If we pursued this reasoning...many, perhaps most, other 
questions of examinations might also prove minimally useful. But this conclusion follows only 
by considering each test in isolation. Instead, suppose we applied the arbitrary minimally 
useful positive likelihood ratio of 2 to each of the above 16 tests. If all returned positive the 
aggregate likelihood ratio could reach 65 356.” (TTA12)  
 
“Unfortunately for the primary care clinician the reduced magnitude of the prior odds is 
compounded by the finding that many items in the medical history have positive likelihood 
ratios that are too small to be clinically useful. For a number of inexperienced doctors this 
may perhaps account for some of their tendency to order an increasing number of diagnostic 
tests.” (TTA32) 
 
“There are particular diagnostic challenges for GPs in primary care: the pre-test probability of 
disease is lower.” (TTA22) 
 
 60 
 
For this reason the potentially important contribution of clinical history and examination was 
emphasised: 
 
“When diagnosis is viewed as a processing pathway founded on a robust medical history, it 
becomes clear that in some situations investigations may become unnecessary.” (TTA32) 
 
 
The importance of pre-test probability estimation for diagnostic decision making and an 
appreciation of its variation with healthcare setting were highlighted: 
 
“One of the specific skills of a general practitioner is to understand the pre-test probabilities 
of disease in his or her clinical setting...The difference in pre-test probabilities between 
primary and secondary care is one reason why clinicians find it difficult to move between test 
settings.” (TTA6). 
 
“Pre-test probabilities for the same target disorder can vary widely among and within 
countries and among primary, secondary and tertiary care settings.” (TTA27) 
 
 
The impact of pre-test probability on test error rates was also highlighted:  
 
 
“When the prevalence of disease is low, the probability that a positive test is a false positive 
becomes quite high. This is often the case in general practice...” (TTA6). 
 
 
The literature acknowledged that clinicians are inaccurate in their pre-test probability 
estimation: 
“Some say clinicians can generate post-test probabilities on the basis of clinical 
experience...Yet research has shown that that clinicians’ estimates of probability vary widely 
and are often inaccurate....by itself, clinical experience appears insufficient to guide accurate 
probability estimation.” (TTA26) 
 
 
Also that pre-test probability estimation was often qualitative rather than quantitative: 
“We are not arguing that the Bayesian approach is a perfect means of reaching a diagnosis. 
Admittedly, the definition of pre-test odds of a disease for a given patient is inherently 
subjective.” (TTA12) 
 
 Concern was expressed that undergraduate medical training and test accuracy research has 
a secondary and tertiary care rather than a primary care focus and this was suggested to 
contribute to difficulty in pre-test probability estimation and the application of test accuracy 
estimates in generalist settings: 
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 “...most of the existing data on pre-test probabilities were obtained from tertiary care 
populations and may not be generalisable to primary care populations.... This highlights the 
need for research on pre-test probabilities in primary care settings.” (TTA28) 
  
“Attention must be paid to the differences in clinical stages encountered in general practice 
and specialist practice. It is concluded that a large part of the diagnostic field of general 
practice has still to be discovered and developed.” (TTA20) 
  
“Frontline clinicians are gaining increasing access to high quality evidence about diagnostic 
tests....Using this evidence requires more than knowing a test’s discriminatory power. 
Clinicians also need to estimate pre-test probabilities for the disorders being considered. But 
where do these pre-test probabilities come from?” (TTA26) 
 
 
Several approaches were proposed to assist clinicians with pre-test probability estimation 
including compilation of a catalogue of setting-specific LRs for individual components of the 
clinical history and examination and computer based decision support: 
 
“The medical history is more than a nostalgic relic of little relevance to modern practice. 
However there is now an urgent requirement for careful consideration to be given to how, 
where and for whom this diagnostic technology is being used. A key component of this 
initiative would be the development of a library of setting-specific likelihood ratios and kappa 
for individual feature and combinations of items of medical history and information.” (TTA32) 
  
 “Computer based decision support can be linked to the electronic health record...such a 
system could also tell the physician how to estimate the pre-test probability.” (TTA30) 
 
“...the accurate recall and implementation of (decision) rules can be facilitated by computer 
based decision clinical decision support systems that quantify diagnostic and prognostic 
information and provide clinicians with patient specific recommendations.” (TTA8) 
 
 
 
2.4.2 Results: Non-empirical test accuracy literature: Fully rational  
The impact of motivational biases on testing behaviour received limited attention in the 
literature identified here. Testing was portrayed as a risk averse behaviour and it is proposed 
that health professionals may not be aware of the limitations of testing in reducing 
uncertainty or in estimating the degree to which testing reduces uncertainty.  
It was suggested that the observed increase in testing may be due to a ‘stubborn quest for 
diagnostic certainty’ and a manifestation of risk aversive behaviour: 
 
“...some physicians order all the tests that may be even remotely applicable in a given clinical 
situation. Such a practice may comfort the patient and enhance the physician’s belief that all 
diagnostic avenues have been pursued, but more tests do not necessarily produce more 
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certainty...Despite the limitations of our diagnostic procedures we continue to test 
excessively, partly because of our discomfort with uncertainty.” (TTA18) 
 
 
Further it was suggested that risk averse behaviour manifest by excessive testing may be a 
symptom of difficulties with probabilistic reasoning: 
 
“...why are clinicians uneasy with uncertainty? (Clinicians) have been taught to think 
categorically. When (clinicians) try to think in terms of probabilities, (they) often falter. 
(Clinicians) disregard uncertainty or behave as if it doesn’t exist; use inexact expressions 
such as ‘probable, ‘occasional’ and ‘likely’”. (TTA18) 
 
 
Healthcare setting, the utility associated with different test outcomes and variation between 
individuals was proposed to be an important modifier of attitudes to uncertainty. Attitudes to 
risk and the size and significance of uncertainty were suggested to be context-dependent:  
 
“... feelings of uncertainty regarding medical problems can differ depending on the situation, 
not only because one physician may be faced with more complicated diagnostic puzzles than 
the other, but also, and primarily because the consequences of a vague and uncertain 
diagnosis may vary in each situation.” (TTA34) 
 
“(No-treatment- no test and test-treatment) thresholds vary amongst diseases and individual 
patients.” (TTA27) 
 
 
It is suggested that uncertainty may be larger in generalist settings, whilst the  
consequences of an uncertain diagnosis may be greater in specialist settings: 
 
“...further research should take into account the fundamental differences between the 
significance of uncertainty and risk taking in the minds of GPs and specialists.” (TTA34).  
 
“GPs generally deal with far greater diagnostic uncertainty than their hospital based 
colleagues, this being part of the gate keeping role of primary care.” (TTA22) 
 
 
Further personality and cultural differences were suggested as important modifiers of 
attitudes to risk: 
“Some physicians find it difficult to tolerate any diagnostic uncertainty...The cultural 
differences between physicians in American hospitals and Dutch GPs are 
considerable...there is a difference in opinion regarding the use of the laboratory between 
American and European physicians.” (TTA34) 
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2.4.3 Results: Non-empirical test accuracy literature: able to compute 
accurately 
 
The emphasis in the literature was that diagnostic problem solving should be based on 
quantitative probability revision rather than being a more qualitative process. However there 
was an appreciation of the complexity of probability revision and a suggestion that the 
process required for evidence based diagnostic decision making was less familiar to 
clinicians compared to other aspects of evidence based medicine: 
“We (clinicians) use probabilistic reasoning intuitively whenever we consider the likelihood of 
a patient having a disease in the light of new information.” (TTA6) 
  
“...clinicians apply Bayesian reasoning in framing and revising different diagnoses without 
necessarily undergoing, or requiring, any formal training in Bayesian statistics... Bayesian 
reasoning is a natural part of clinical decision making... Bayesian approaches are a powerful 
and intuitive approach to the differential diagnosis” (TTA12). 
 
“Many trainees appreciate the concepts of sensitivity and specificity and learn how to 
combine the “art” of the history and physical examination with the “science” of diagnostic 
testing without explicit use of quantitative probability theory. Nevertheless it seems that 
quantitative reasoning is neither intuitive nor well understood.” (TTA4) 
 
“Choosing the appropriate test.... for a particular diagnostic setting is often difficult for 
medical decision makers... Various schemes including nomograms based on Bayes’ 
theorem, probability ratios, receiver operating curves and formal decision analysis have been 
used to compare the performances of various tests available in a given setting. These 
methods are often cumbersome, limited to a single disease prevalence and not intuitive to 
interpret.” (TTA13) 
 
“Despite general awareness of the other concepts of evidence based medicine, the 
estimation of pre-test probability and adjustment of disease probability in the setting of 
thresholds for testing and treating is not commonplace.” (TTA4) 
 
 “...(in undertaking probability revision using Bayes’ theorem) the physician violates the 
statistical requirement that the tests operate independently....his reflects the reality that there 
is some redundancy in our clinical evaluations.” (TTA12) 
 
 
It was suggested that improving the use of quantitative probabilistic reasoning ability would 
improve diagnostic decision making: 
“We (clinicians) should not be satisfied with descriptions of probabilities that are vague, 
subject to varying interpretations and not adaptable to calculations. Instead we should be 
more quantitative and teach how to combine numerical representations of probabilities and 
risks....We (clinicians) shun probability-orientated thinking (and are) taught to think 
categorically...( the consequences of which are that clinicians) judge the likelihood of 
diseases erroneously and combine data on probabilities inaccurately...Our shunning of 
probability-orientated thinking is reflected in our textbooks, which are rife with absolutes.” 
(TTA18). 
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2.4.3.1 Facilitation of the process of probabilistic reasoning  
 
Several examples of strategies to assist with the quantitative probabilistic reasoning process 
were suggested including the use of clinical prediction models for integrating the results of 
multiple tests: 
 
“...a Bayesian approach to diagnosis: estimating a clinically likely pre-test probability for a  
target disorder, then applying a likelihood ratio derived from the presence or absence of the 
clinical features of the rule (similar to applying a test result), which in turn enables a revised 
estimate of clinical probability.” (TTA8) 
 
 
LRs were suggested to simplify the conversion from pre to post-test probability in comparison 
to the use of sensitivity and specificity, mostly with reference to the use of Fagan’s 
nomogram (figure 2.8), a graphic tool to simplify this conversion:  
 
“Bayesian approaches are a powerful and intuitive approach to the differential diagnosis...the 
pre-test odds of a hypothesis being true multiplied by the weight of the new evidence 
(likelihood ratio) generates post test odds of the hypothesis being true.” (TTA12) 
 
“The probability of disease given a positive or negative test result (post-test probability) is 
usually obtained by calculating the likelihood ratio of the test result and using formulas based 
on Bayes’ theorem or a nomogram, to convert the estimated (pre-test probability) into a post-
test probability which takes the (test) result into account.” (TTA25) 
 
“Calculation of positive predictive value and negative predictive value with sensitivity and 
specificity is quite time consuming...Likelihood ratios...are intuitive; they simplify the 
predictive value calculation and the overall evaluation of sequential testing.” (TTA7) 
 
“If a disease’s pre-test probability is known or can be estimated, likelihood ratios allow for 
direct calculation of post-test probability using a formula that can easily be derived from 
Bayes’ theorem. This is the major advantage of likelihood ratios, and gives it superiority over 
predictive values for given prevalence, which have to be calculated by the rather complicated 
Bayes’ theorem.” (TTA7)  
 
“The Fagan’s nomogram is a useful and convenient graphical tool that allows likelihood ratios 
to be used in conjunction with a patient’s pre-test probability of disease to estimate the post-
test probability of disease.” (TTA1) 
 
“...there’s an easier way to manipulate all these probabilities↔odds calculations and a 
nomogram for doing so.” (figure 2.8) (TTA27) 
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Fig 2.8: Likelihood ratio nomogram 
 
 
A minority of authors did not agree that pre to post-test probability revision was simplified 
using LRs: 
 
“the complex chain of calculations involved. Clinicians should transform probabilities into 
odds, multiply by a series of likelihood ratios, and finally reconvert odds to probabilities.” 
(TTA33) 
 
“The need to convert back and forth between pre-test probability/pretest odds and post-test 
odds/predictive value may be confusing, but fortunately Fagan’s nomogram obviates all the 
calculations.” (TTA7) 
 
 
A graphical illustration of post-test probabilities derived using a single estimate of test 
accuracy over a range of pre-test probabilities was promoted as a means of facilitating 
decisions about test use in different populations, defined according to the prevalence of 
disease (figure 2.9) (TTA5;TTA6;TTA29): 
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 “The graphic analysis of numerically calculated predictive values that we describe...provides 
a simple, reliable method for comparing the predictive values of available test options at 
disease prevalence relevant to the use of the proposed test.” (TTA5) 
 
 
Fig 2.9: Graphical illustration of pre to post-test probability 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(TTA6)Doust J, BMJ 2009; 339:1080-1083 
 
2.4.3.2 Test accuracy presentation format as a means of facilitating probabilistic 
reasoning 
 
The contribution of non-health professionals to the theoretical literature reviewed was 
concerned with representation of test accuracy information. 
Rather than the belief that errors in probability revision result from inherent limitations in our 
“cognitive processes” (ability to perform the arithmetic required for probability revision) or 
motivational biases “passion and desire”, (TTA9; TTA17) frequentists propose that errors in 
probability revision arise as a result of how probabilistic information is presented: 
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“In the 1990s, intuitive Bayesian reasoning began to be seen in a new light, that is, from an 
ecological angle....one can facilitate reasoning from the outside by changing the external 
representation from probabilities and relative or normalised frequencies, to natural 
frequencies” (TTA17) 
 
 
The premise of the frequentist philosophy is that natural frequency representations facilitate 
probabilistic reasoning by mimicking natural sampling, removing reference class confusion 
as a result of use of a single reference class and removing the need to incorporate base 
rates (pre-test probability) in calculations. 
 
Natural sampling 
Natural frequency representations of probabilistic information (see table 2.10) facilitate 
probabilistic reasoning by mimicking natural sampling (acquisition of data by direct 
experience): 
 
“...organisms did not acquire information in terms of probabilities and percentages until very 
recently. We assume that as humans evolved, the natural format was frequencies as actually 
experienced in a series of events...the sequential acquisition of information by updating 
frequencies.” (TTA9) 
 
“...because information was experienced during most of the existence of Homo sapiens in 
terms of discrete cases, for example three out of 20 cases rather than 15%.” (TTA10) 
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Table 2.10: Comparison between natural frequency, normalised frequency and probabilistic expression and equivalent test 
accuracy expression (adapted from Gigerenzer 1995;1996(TTA9; TTA10)) 
Natural Frequency Expression Normalised (relative) frequency 
expression 
Probabilistic expression 
(% / decimal) 
Test accuracy expression 
In a population of 100, 10 
individuals will have disease X and 
90 will be unaffected by disease. 
 
 
Of the 10 individuals with disease, 
8 will test positive with test A. 
 
 
 
 
 
Of the 90 individuals without 
disease, 80 will test negative with 
test A but 10 will test positive. 
 
 
 
 
 
How many patients who test 
positive will have disease? 
In a population of 100, 10 
individuals will have disease X and 
90 will be unaffected by disease. 
 
 
Of every 100 individuals with 
disease 80 will test positive with 
test A. 
 
 
Of every 100 individuals without 
disease, 89 will test negative.  
 
 
AND 
 
Of every 100 individuals without 
disease 11 will test positive. 
 
 
How many patients who test 
positive will have disease? 
The prevalence of disease is 10% 
(0.1). 
 
 
 
The probability of testing positive 
with test A if you have disease X is 
80% (0.8). 
 
 
The probability of testing negative 
with test A if you do not have 
disease X is 89% (0.89). 
 
AND 
 
The probability of testing positive 
with test A even if you do not have 
disease is 11% (0.11). 
 
What is the probability of having 
disease X if you test positive with 
test A?                                                                        
Pre-test probability.  
 
 
 
 
The true positive rate (sensitivity). 
 
 
 
 
The true negative rate (specificity). 
 
 
 
 
 
The false positive rate 
(1-sensitivity). 
 
 
Positive predictive value or post 
test probability given a +ve test 
result.
Answer: 
8/ (8+10) = 8/18. 
Answer: 
((80/100) x (10/100)) + 
(80/100) x (10/100) 
((11/100) x 90/100)) 
Answer:  
(0.8 x 0.1)+(0.11 x 0.9) 
(0.8) x (0.1) 
 
Notes to table 2.10: Normalised frequencies: expression in relation to a constant (normalised) denominator and do not carry inherent information about the 
base rate (prevalence) in contrast to natural frequencies.
 69 
 
Reference to a single reference class 
In a natural frequency format, all frequencies explicitly refer to the same reference class and 
the base rate (disease prevalence) can be ignored, whereas conditional probabilities refer to 
more than one reference class which may cause confusion: 
 
“Conditional probabilities such as sensitivity and specificity refer to different classes (the 
class of people with and without illness respectively), which makes their mental combination 
difficult.” (TTA11) 
 
One suggested manifestation of difficulties in the manipulation of more than one reference 
class was confusion between the concepts of sensitivity and PPV and specificity and NPV: 
 
“’If a woman has breast cancer the probability that she will have a positive result on 
mammography is 90%’. This statement is often confused with: ‘If a woman has a positive 
result on mammography the probability that she has breast cancer is 90%’”. (TTA11). 
 
 
2.4.3.3 Systematic errors in probability revision  
 
There was recognition that systematic errors are introduced into probability revision by 
heuristics (cognitive short-cuts used for complex problems) (also see box 1.9):  
 
“Psychologists have shown that rapid decision making is aided by heuristics – strategies that 
provide shortcuts to quick decisions- but they have also noted that these heuristics frequently 
mislead us. Good decision making is further impeded by the fact that we often fall prey to 
various cognitive biases...Even worse it is common for people who are particularly prone to 
cognitive biases to believe that they are good decision makers. The greatest obstacle to 
making correct decisions is seldom insufficient time but distortions and biases in the way 
information is gathered and assimilated.” (TTA19). 
  
“To use Bayes’ theorem wisely, one must be aware of pitfalls in estimating probability.” (TTA29) 
 
“...clinicians’ memories are fallible and their thinking is prone to numerous biases.” (TTA26) 
 
 
Heuristics that were described include base rate (pre-test probability) neglect: 
 
“...it is important to be aware of base rates of the occurrence of a particular condition and to 
avoid giving too much weigh to one piece of information.” (TTA19) 
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Placing undue weight on diagnoses that come easily to mind, are significant or unusual (the 
availability heuristic): 
 
“They (doctors) should ask if their decision is influenced by any salient pieces of information 
and, if so, whether these pieces of information are truly representative or simply reflect 
recent or otherwise memorable experiences.” (TTA19) 
 
 
The tendency to pursue, and take notice of information that fits with a pre-existing 
expectation about the correct diagnosis (confirmatory bias or anchoring): 
“In taking medical histories, doctors often ask questions that solicit information confirming 
early judgements. Even worse, they may stop asking questions because they reach an early 
conclusion, thus failing to unearth key data.” (TTA19) 
 
 
“Many experiments have shown that clinicians do not adjust their initial estimate enough to 
take account of new information.” (TTA29) 
 
 
In addition it was suggested that clinicians often have a misplaced confidence in their 
diagnostic ability: 
“Research has shown that almost all of us are more confident about our judgements than we 
should be. Since medical diagnoses typically involve some uncertainty, we know that almost 
all doctors make more mistakes in diagnosis than they think they do.” (TTA19) 
 
 
2.4.3.4 The place of probability revision in clinical practice  
 
Accompanying the debate concerning the intuitive nature and complexity of probabilistic 
reasoning there was an appreciation that formal probability revision may not be 
commonplace in clinical practice: 
“Despite their usefulness in interpretation of clinical findings, laboratory tests and imaging 
studies, likelihood ratios are little used. Most doctors are unfamiliar with such ratios and few 
use them in practice.” (TTA14) 
 
“Simplifying aids such as the Fagan nomogram are rarely used, should be done for every 
test and need published likelihood ratios.” (TTA33). 
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Although the emphasis of the majority of literature was quantitative probabilistic reasoning, 
informal, semi-quantitative estimation was proposed as an acceptable alternative to formal 
quantitative probabilistic reasoning by several authors: 
 
“(Clinicians) need to have a sense of both the pre-test probability of disease and the 
diagnostic accuracy of test results. We do not need to be able to do these calculations 
exactly.” (TTA6). 
 
“Whilst we rarely know what the sensitivities, specificities or likelihood ratios are for these 
tests. At best clinicians carry a general impression about their usefulness.” (TTA12)  
 
 
Similarly Gorry (1978) (TTA13) suggests ranking the relative probability of false negative test 
results for each competing diagnosis to arrive at the most probable diagnosis: 
 
“...if properly interpreted, the normal value may help to differentiate among diagnoses that 
yield normal results with different frequencies.” (TTA13) 
 
 
Gigerenzer (1996) (TTA10) proposes the use of satisficing algorithms as an alternative to formal 
probability revision in situations where application of Bayes’ theorem and logistic regression 
for the integration of information about sequential, often interdependent tests becomes  
“mathematically complex and computationally intractable – at least for the human mind.”: 
 
“...simple algorithms that exploit the structure of information to make good inferences under 
constraints of limited time and knowledge...non linear, non compensatory and work with the 
principle we call ‘one good reasoning’, that is, they base inference on only one predictor (the 
first identified as discriminating between two or more differential diagnoses) as opposed to 
an integration of several (predictors).” (TTA10) 
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2.5 Results: Empirical test accuracy literature  
For results tabulated by study see appendix 2.2 
 
Characteristics of included studies 
Twenty six papers reporting 27 studies were concerned with the understanding and 
application of test accuracy in health professionals or medical students whilst seven papers 
reporting 16 studies were concerned with understanding and application in non-health 
professionals. The literature spanned 1978 to 2010, although 2/3rds of papers were 
published after 1995. This may be a reflection of the emergence of the evidence based 
medicine movement in the early 1990’s and the promotion of the integration of quantitative 
external evidence into medical decision making 80. 
The majority of health professional samples were self-selected, convenience samples from 
medical education courses or sampling methods were unclear or not reported. The 
exceptions were one study based on a random sample from a professional register, 
obtaining a 91% response rate (ETA29) and one study carried out as part of a medical 
undergraduate OSCE examination (ETA31). It is therefore likely that the review findings 
represent more motivated practitioners. Eleven studies comprised secondary care clinician 
samples, four comprised primary care clinician samples (one conducted in the setting of an 
army clinic), five comprised a mixture of primary and secondary care clinicians, two were 
restricted to medical undergraduates and two study samples were a mix of health and non-
health professionals. In one study the setting was unclear. Of the studies conducted on 
primary and / or secondary care clinician samples seven also included medical 
undergraduates and five also included professions allied to medicine. 
Most studies of non-health professionals were undertaken on students (13/16), one on a 
patient sample (ETA17), one on women attending for screening (ETA1) and one on females from 
the general population (ETA10). One study on women eligible for screening achieved an 85% 
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response rate (ETA1). Other samples were either self-selected, incentivised or the method of 
sampling was unclear. 
Three health professional studies were conducted in the UK (ETA4; ETA18; ETA30) and six in the 
rest of Europe. The majority of research was undertaken outside of Europe: USA (N=16), 
Japan (N=1), Israel (N=1) where medical education may differ. In addition due to differences 
in healthcare organisation, particularly the absence of a primary care gate-keeping system, 
the spectrum of patients, prevalence of disorders and testing culture (TTA34) will not be 
generalisable to the UK or the rest of Europe. Of the 16 non-health care professional studies, 
ten were undertaken in the USA, one in Australia four were undertaken in the UK and one in 
France. 
Only six of twenty seven of the health professional studies evaluated self reported use of test 
accuracy information in practice (ETA27; ETA7; ETA29; ETA21; ETA34; ETA36), three undertaken in the 
USA, one in Belgium and two in the Netherlands.  All other studies investigated the 
application of test accuracy metrics to hypothetical scenarios which were self-administered in 
the form of questionnaires. All non-health professional studies assessed the use of test 
accuracy using hypothetical scenarios. 
 
Study Designs and Quality 
Five of the health professional studies were randomised controlled trials (RCTs), three of 
which were considered to be of good quality (ETA4; ETA28; ETA32) although likely to be 
underpowered. Four health professional studies were controlled trials (ETA3; ETA9; ETA12; ETA27). 
Only one within-subject comparison with N of 6 (ETA12) was reported adequately enough to 
allow an assessment of moderate quality. Of the remaining 18 health professional studies, 15 
were modifications of cross sectional design of which two were supplemented by qualitative 
interviews (ETA29; ETA30). One study was a cohort study (ETA21) and one study employed both 
cross sectional and cohort study designs (TTA34). One study was qualitative using covert 
observation (ETA14). 
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One non-health professional study was an RCT (ETA1) which was judged to be of good quality. 
Eight studies were controlled trials (ETA8) for which poor reporting precluded assessment of 
study quality. One study was a face-face qualitative interview study of moderate quality 
(ETA10). The remaining five non-health professional studies were cross sectional in design. 
 
2.5.1 Results: Empirical test accuracy literature: Fully informed  
 
2.5.1.1 Test accuracy information  
 
Thirteen studies were concerned with test accuracy measures; 10 in health professionals 
(ETA2; ETA9; ETA14; ETA18; ETA22; ETA25; ETA29; ETA30; ETA33; ETA34) and three in non-health professionals 
(ETA1; ETA10; ETA17).  Three studies were concerned with the relationship between sensitivity, 
specificity and false negatives and false positive rates; seven with sensitivity and specificity; 
two with predictive values (PVs); three with test errors, two with likelihood ratios (LRs) and 
one with Receiver Operator Characteristic (ROC) curves. 
 
Comprehension: definition of test accuracy metrics 
 Whilst some studies reported the majority of respondents were familiar with definitions of 
sensitivity and specificity (75-98%) (ETA9; ETA14; ETA33) and PVs (61%) (ETA33) other studies 
provided evidence of confusion of sensitivity with positive predictive value (PPV), specificity 
with negative predictive value (NPV), false positive rate with 1- PPV and false negative rate 
with NPV (ETA2; ETA29). Similarly, although Gigerenzer (1998) (ETA14) observed a high level of 
recognition of the link between sensitivity and false negative test results (75% of 
respondents), only 25% of respondents recognised the relationship between specificity and 
false positives.  
One study compared respondents’ familiarity with diagnostic and effectiveness metrics and 
found performance was worse for diagnostic metrics (ETA2). 
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Comprehension: estimating the accuracy of named tests 
Those authors attempting to elicit estimates of the sensitivity and specificity of named tests 
generally observed high levels of error (ETA25; ETA22; ETA17). Accuracy was neither consistently 
over nor underestimated. Interestingly Noguchi (2002) (ETA25) observed a large discrepancy 
between estimates of a test’s sensitivity (3% underestimate) compared to its specificity (21% 
underestimate). Reid (1998) (ETA29) demonstrated that estimates of test accuracy were based 
largely on clinicians’ own clinical experience of test use, rather than published estimates.  
The one study eliciting non-health professional estimates of test accuracy for named tests 
(ETA17) demonstrated clustering of estimates and suggested this was a reflection of a lack of 
understanding of test accuracy properties and their application. 
 
Preference: test accuracy metric 
Four authors investigated reported health professionals’ use of test accuracy measures in 
practice. ROC curves and LRs were reported to be used by <1% of clinicians and sensitivity 
and specificity by < 4% (ETA29; ETA34). By contrast PVs were reported to be used by 80% of 
clinicians in one study, partly on the basis that these measures were intuitive for quantifying 
test errors and provided a direct estimation of post-test probability without the need for 
complicated calculations (ETA29) (see 2.5.3.2 below). However, it is important to note that in 
this study, respondents’ self reported use referred to the way they conceptualised the 
performance of a test based on their own experience of using it rather than use of published 
estimates of PVs to inform their testing practice. In fact these respondents confused the 
definition of sensitivity and PPV and specificity and NPV (ETA29) suggesting that they did not 
rely on published test accuracy estimates. Other authors have demonstrated that information 
about test errors are a prominent part of decisions concerning test use (ETA30; ETA18). 
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Preference: presentation format  
One non-health professional study investigated the preference of a female population sample 
for information about post-test probability when receiving information about the results of 
mammography (ETA10). Information presented as normalised frequencies or percentages was 
perceived as being about ‘other’ people. There was no clear preference for verbal or graphic 
representations. Verbal descriptions of post-test probability were suggested as helpful 
accompaniments to numerical representations, although wide variability (10-90%) in 
numerical definitions of verbal probabilities was observed. 
 
Behaviour 
The one study investigating the use of test accuracy information in non health professionals 
demonstrated that providing information about test errors and mortality and morbidity risk 
resulted in a reduction in the number of women intending to attend for screening (ETA1) 
although it not possible to distinguish the effects of test accuracy and risk information on 
intended behaviour.  
 
2.5.1.2  Pre-test probability  
Twelve health professional studies (ETA5; ETA11; ETA12 ; ETA14; ETA18; ETA21; ETA22; ETA25-ETA28;ETA34;) and 
two non-health professional studies (ETA17; ETA10) were concerned with estimation or use of pre-
test probability.  
 
Comprehension: defining pre-test probability 
Two health professional studies (ETA12; ETA14) conceptualised pre-test probability as the 
prevalence of disease in the presenting population, four studies as the probability of disease 
following clinical history (ETA11; ETA18; ETA25; ETA33) and six studies as the probability of disease 
following clinical history and examination (ETA5; ETA21; ETA22; ETA26;-ETA28). In one study (ETA34) it was 
unclear what information was used to estimate pre-test probability. 
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Comprehension: pre-test probability estimation 
The majority of studies concerned with pre-test probability (n=11) were concerned with the 
accuracy of pre-test probability estimation by health professionals for a range of diseases. 
Between-person variation in quantitative, pre-test probability estimation for a common 
scenario was considerable (75-100%) in three studies (ETA11; ETA14; ETA18) and 20-25% in two 
studies (ETA26; ETA28). Overestimation rather than underestimation was a feature of studies (ETA5; 
ETA25; ETA27; ETA18) with overestimation of atypical or severe and less probable diagnoses (the 
availability heuristic) reported by three studies (ETA5; ETA11; ETA25). An educational intervention 
designed to improve the accuracy of pre-test probability estimation was effective in reducing 
overestimation but had no effect on subsequent test use (ETA27).  
One non-health professional study demonstrated a clustering of quantitative estimates (37-
50%), regardless of disease (ETA17).  
Three studies concerned with contextual modifiers of pre-test probability estimation all 
demonstrated appropriate directional adjustment by clinicians (ETA21; ETA22; ETA33). 
 
Preference  
One health professional study investigated the preferred presentation format for pre-test 
probability information (ETA34). The majority of health professionals studied used verbal, 
categorical descriptions of pre-test probability (52%), followed by frequentist and percentage 
expressions. However 76% stated that they did not find pre-test probability estimation useful 
for diagnostic decision making. 
One qualitative study in non-health professionals did not demonstrate a preference for the 
presentation of pre-test probability in educational materials to encourage patient involvement 
in decisions about screening (ETA10). 
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2.5.2 Results: Empirical test accuracy literature: Fully rational  
Only two studies were concerned with the investigation of motivational biases on testing 
behaviour (ETA21; ETA36). Both studies were observations of actual practice in primary care 
settings. 
In the context of investigating primary care clinicians’ approaches to test use and 
interpretation in low prevalence settings, Houben (2010) (ETA21) observed that the emphasis of 
testing in primary care was to rule out disease and that this was most often done to reassure 
the clinician (62% of tests ordered), followed by reassurance for the patient (20% of tests 
ordered). Only 19% of tests were performed to confirm suspected disease. Only 9% of 
abnormal test results were pursued. It is unclear whether this represents an appreciation of 
the magnitude of test errors in low prevalence populations or confirmatory bias. 
In the context of investigating reasons for variation in test use in primary care, Zaat (1992) 
(ETA36) did not find an association between individual attitudes to risk and self-reproach and 
laboratory test use. 
 
2.5.3 Empirical test accuracy literature: Able to compute accurately 
The majority of empirical studies (32/33 papers, 40/43 studies) included an examination of 
the ability of respondents to manipulate information to derive the probability of disease 
following testing; 16 studies (17 papers) in health professionals  (ETA2; ETA6; ETA7; ETA9; ETA11; ETA14; 
ETA20-ETA23; ETA25; ETA28; ETA29; ETA32-ETA34),14 studies (6 papers) in non-health professionals (ETA8; 
ETA10; ETA13 (x3); ETA15 (x7); ETA17; ETA19) and two in a mixed health and non-health professional 
sample (ETA3;ETA4).  
Most of these papers (25) required respondents to estimate post-test probability either 
quantitatively or semi-quantitatively. Six of 25 studies required respondents to estimate post-
test probability on the basis of pre-test probability and test accuracy represented as 
sensitivity and specificity (ETA3; ETA4; ETA23; ETA32-ETA34). Eight papers (16 studies) required 
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respondents to estimate post-test probability on the basis of pre-test probability and one or 
more of false positive rate, false negative rate, true positive rate (sensitivity) and true 
negative rate (specificity) (ETA 2; ETA6; ETA9; ETA8; ETA13 (x3); ETA15 (x7); ETA20; ETA32). Five studies required 
respondents to estimate post test probability on the basis of clinical experience of disease 
prevalence and test accuracy (ETA14; ETA17; ETA19; ETA22; ETA25). Two studies compared the utility of 
different test accuracy metrics and graphics for probability revision (sensitivity and specificity 
(%), a plain language explanation of LRs and a graphical representation of test accuracy 
(ETA28; ETA33). In addition, six of these 25 papers included a comparison of test accuracy 
presented as one or more of natural frequencies, normalised frequencies or % (ETA4; ETA20; 
ETA32; ETA8; ETA13; ETA15). 
 
2.5.3.1 Comprehension: ability to undertake probability revision 
 
Ability to derive post-test probability was poor, (average of < 46% across studies, range 0% - 
73%) with correct estimates above 33% achieved only by academic clinicians. It is unlikely 
that these studies were adequately powered to detect differences by medical speciality or 
between health professionals and non-health professionals. With the exception of the above 
average performance of academic clinicians there were no consistent patterns observed 
across participant groups. 
 
2.5.3.2 Comprehension: the effect of presentation format on probability revision 
 
More correct responses were obtained when test accuracy was presented as natural 
frequencies compared to normalised frequencies or percentages. The exceptions to this 
observation were studies that employed partitioning or explication of subsets of information 
(ETA8; ETA13; ETA15). In studies employing partitioning or explication of subsets the difference 
between natural frequencies, normalised frequencies and percentage presentation was 
attenuated. Features of incorrect responses when information was presented as normalised 
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frequencies or percentages were base rate neglect (ETA2-ETA4; ETA6; ETA8; ETA9; ETA13; ETA20; ETA22; 
ETA33) and reference class confusion (sensitivity is confused with PPV and specificity with 
NPV) (ETA7; ETA14; ETA15; ETA29). A feature of incorrect responses when information was presented 
as natural frequencies was neglect of test accuracy information (ETA4; ETA8; ETA13; ETA20). Two 
studies observed that base rate neglect was inversely associated with pre-test probability 
and concluded this was a result of respondents’ difficulty handling very small percentages or 
proportions (ETA19; ETA23). 
 
2.5.3.3 Comprehension: The different effect of positive and negative test results on 
probability revision 
 
The majority of studies concerned with probability revision were restricted to probability 
revision following a positive test result. Only seven of 32 studies included an investigation of 
disease probability estimation following both positive and negative test results (ETA7; ETA11; ETA21-
ETA23; ETA25; ETA28), all in health professionals samples. The findings of three of the seven 
studies suggested that respondents had relatively more difficulty deriving the probability of 
disease after a negative test result (1-NPV) compared to a positive test result (ETA7; ETA22; 
ETA23). The results of an additional three of the seven studies suggested confirmatory bias, 
whereby a test result had an impact on estimates of post-test probability, only if it concurred 
with pre-test probability estimates, (box 1.9), was operating (ETA11; ETA21; ETA25).   
 
2.5.3.4 Comprehension: The effect of test accuracy metric for probability revision 
 
The two studies comparing the utility of different test accuracy measures rather than different 
presentation formats to facilitate probability revision compared sensitivity and specificity as 
percentages and a verbal description of LRs; one study also included a graphical 
presentation of test accuracy. Stuerer (2002) (ETA33) demonstrated that a verbal description of 
LRs reduced error in estimating post-test probability compared to sensitivity and specificity 
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whereas Puhan (2005) (ETA28) found no difference in the accuracy of post-test probability for 
different test accuracy measures. 
 
2.5.3.5 Comprehension: Clinical experience alone as a basis for post-test probability 
estimation 
 
Seven health professional studies (ETA11; ETA14; ETA21; ETA25; ETA22; ETA32; ETA33) and one non-health 
professional study (ETA17) investigated the ability of respondents to estimate post-test 
probability based on clinical experience alone without provision of pre-test probability or test 
accuracy information.  
Only one health professional study demonstrated a majority of respondents were able to 
adjust pre to post-test probability, in the correct direction, on the basis of clinical experience 
alone, following a positive test result (ETA22) this finding was not replicable for negative test 
results (2.5.3.3 above). Two studies demonstrated a minority of health professionals were 
able to accurately estimate post-test probability following a positive test result on the basis of 
clinical experience (ETA14; ETA33). In two health professional studies there was evidence of 
confirmatory bias (ETA11; ETA25), whereby a test result (positive or negative) had an impact on 
estimates of post-test probability, only if it concurred with pre-test probability estimates (box 
1.9). 
One non-health professional study (ETA17) demonstrated clustering and overestimation of post-
test probability estimates across a variety of diseases and test results and concluded this 
reflected a lack of appreciation of the use of test results.  
  
2.5.3.6 Preference: use of probability revision in practice 
 
One health professional study (ETA29) surveyed clinicians about their use of Bayes theorem for 
probabilistic reasoning in practice. Only 3% of respondents reported using Bayes theorem for 
probability revision whilst 80% of respondents reported using predictive values as the basis 
for estimating post-test probability. 
 83 
 
2.5.3.7 Behaviour: impact of probability revision on practice 
 
In one health professional study relying on respondents’ own estimates of test accuracy, 
confirmatory bias was observed to influence test ordering behaviour as well as 
comprehension (ETA21). One study demonstrated no difference in patient management when 
respondents were given test accuracy information or relied on their own test accuracy 
estimates for post-test probability estimation (ETA32).  
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2.6 Results: Empirical risk literature  
For results tabulated by study see appendix 2.3. 
Characteristics of included studies 
Eleven reviews and 10 papers reporting 13 studies were concerned with the understanding 
and communication of medical risks. Table 2.1 (2.3.2) illustrates how primary studies 
updating the review of reviews were chosen for inclusion on the basis of review date, health 
or non-health professional samples and research question addressed. One review was 
concerned with health professionals’ understanding, seven reviews and 12 primary studies 
with non-health professionals’ understanding and three reviews and one study with health 
and non-health professionals understanding. The literature spanned 1996 to 2009 and as for 
the test accuracy literature, this is likely to reflect the promotion of the integration of 
quantitative external evidence into medical decision making as part of the evidence based 
medicine movement 80. 
The country of origin of included studies was not reported for 7/11 reviews. For the 
remainder of reviews, 50% to 98% of included studies originated from the USA (ER1; ER6; ER7; 
ER9). Six of the ten primary studies represented respondents from the USA, two Europe, one 
Norway and North America and one Australia. 
Eight of the 13 primary studies were conducted using face to face or self-completed paper 
questionnaires, four on line and one by telephone. Ten studies were conducted in general 
adult populations and three in medical settings or in individuals at high risk of disease.  In 
10/13 included studies, greater than 50% of the sample had had higher education.  
Included studies in 4/10 reviews and 11/13 primary studies were concerned exclusively with 
hypothetical presentation of risks, two reviews and two primary studies were concerned with 
presentation of risks in actual practice (ecological), three reviews were concerned with 
presentation of risks in both hypothetical and practice settings and in one review this 
information was not reported.  
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Types of risk portrayed by included studies 
Literature was concerned with risks associated with a variety of healthcare decisions. 
Included studies in 2/10 reviews and 2/13 primary studies were concerned with presentation 
of testing risks alone (for example survival ‘risk’ associated with uptake of screening), one 
review and nine primary studies with intervention risks alone (for example risk of morbidity, 
mortality and adverse effects), and six reviews and one primary study a combination of two 
or more of testing risks, intervention risks and population risks (for example the population 
risk of developing a disorder). Two reviews included presentation of medical and non medical 
risks (ER2; ER13). In six of the 11 reviews no information was provided about the population 
characteristics of included studies. Two reviews were concerned with screening populations 
(low risk, high risk, workplace and self selected (ER1; ER7). Two reviews were concerned with 
risk communication in the context of cancer genetics. One third of the studies included in the 
single review concerned with health professionals’ understanding of risks (ER16) were 
conducted at educational events and are therefore likely to represent  highly selected 
samples.  
 
Study Quality: Health professional samples 
One review concerned exclusively with undergraduate medical students and health 
professionals from a range of health care settings (ER16) was of moderate quality, although 
included studies were described as generally being of poor quality.  
 
Study Quality: Non-health professional samples 
 Five of the seven reviews of non-health professionals were judged to be of high quality (ER1; 
ER5-ER7; ER9) although only one reported the quality of included studies as good (ER7).Two of 
seven reviews of non-health professionals were of low quality (ER12; ER13). Of the 12 primary 
studies of non-health professionals reported in nine papers, two were RCTs judged to be of 
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good quality (ER8; ER18), five were RCTs judged to be of poor quality or poor reporting 
precluded quality assessment (ER3; ER4; ER11; ER19 (x2)) and five studies were cross sectional in 
design (ER15; ER20 (x3); ER21).  
 
Study Quality: Mixed health and non-health professional studies 
Three reviews of mixed patient and undergraduate medical student samples (ER2; ER10; ER14) 
were of poor quality and for the one cross sectional study including patients and physicians 
poor reporting precluded quality assessment (ER17).  
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2.6.1 Results: Empirical risk literature: Fully informed (comprehension, 
accuracy of perception, preference, behaviour change) 
 
Several indicators of the extent to which individuals are fully informed about risk have been 
utilised in the risk communication literature. 
 
Comprehension and accuracy of perception 
Although a distinction is made in the literature between comprehension and perception, 
measures of comprehension were often not clearly reported, were variable and were often 
semi-quantitative. In addition risk perception was almost exclusively informed by risk 
information provided to respondents rather than based on participants’ own experience. 
There is therefore likely to be a significant overlap between comprehension and perception 
as reported in the literature here.  
 
Preference 
Interestingly of the minority of studies investigating the relationship between preference and 
comprehension, no association was observed for patients (ER15) or health professionals (ER2). 
This was suggested to be due, at least in part, to respondents applying heuristics selectively 
to presentation formats most familiar to them (ER2).  
 
Behaviour change 
With the exception of three reviews (ER1; ER6; ER7) investigation of behaviour change in the risk 
communication literature has been restricted to measurement of intended rather than actual 
behaviour. Evidence on intended behaviour would be expected to more closely reflect 
comprehension than actual behaviour; the latter would be expected to vary according to 
contextual factors, including those acting as motivational biases. These relationships were 
not examined formally in the literature reviewed. 
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2.6.1.1 Numerical versus verbal presentation of risk 
 
Comprehension and perception 
Three reviews included an investigation of the effects on comprehension of numerical versus 
verbal presentations of risk (ER6; ER9; ER16). McGettingan (1999) (ER16) demonstrated increased 
consistency of ratings of effectiveness in health professional samples with numerical 
compared to verbal presentations of risk. Similarly one review of health professionals (ER16), 
two reviews of non-health professionals (ER7; ER12) and one primary study of non-health 
professionals (ER20) demonstrated greater consistency in behaviour for numerical compared to 
verbal risks. This observation may be a reflection of the difficulties in standardising verbal 
descriptions of risk magnitude 60,61. Numerical presentations of risk are observed to result in 
greater comprehension compared to verbal presentations in non-health professional samples 
(ER6; ER9). Verbal presentations of risk have been observed to improve accuracy of perception 
compared to numerical risk presentation formats (ER20) and relative risk presentations to result 
in overestimation of risk (ER16; ER21).  
 
Behaviour 
Evidence concerning the direction of effect of verbal versus numerical presentation of risks 
on behaviour is inconsistent. Two reviews of non-health professional studies observed an 
increase in behavioural uptake with verbal compared to numerical presentation of risks of 
harm (developing disease); one for preventive behaviour uptake not otherwise specified (ER12) 
and one for screening uptake (ER7). One primary study of non-health professionals (ER20) 
observed a decrease in treatment acceptance when risk of harms (treatment side effects) 
were presented verbally compared to numerically whereas one review of non-health 
professional studies (ER6)  demonstrated a decrease in treatment acceptance with numerical 
presentation of risks of harms (treatment side effects) compared to verbal presentation. This 
apparent inconsistency may be due to contextual features of the risk scenarios including 
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perception of the nature of the risk or differences between respondents in attitudes to risk 
and comprehension. 
 
2.6.1.2 Graphical presentations of risk 
 
Comprehension  
Two reviews including studies of both health professionals and non-health professionals (ER2; 
ER14) and two non-health-professional studies (ER8; ER21) included an investigation of graphical 
risk communication on comprehension. One study of non-health professionals demonstrated 
improved comprehension with pictographs compared to normalised frequency or percentage 
representations of risk (ER21) whilst two reviews of health professional and non-health 
professional samples did not find evidence for an improvement in comprehension with the 
addition of graphics to numerical presentations of risk (ER8; ER14). Features of graphical 
presentations of risk that have been shown to improve comprehension in both health 
professional and non-health professional samples include part-whole representations 
compared to non part-whole representations (ER2), block versus random icon displays in 
pictographs (ER2) and for comparison of risks, risk ladders (ER14). 
 
Perception 
There is some evidence from health professional and non-heath professional studies that 
provision of graphical, numerical and verbal information about risk improves accuracy of 
perception over either presentation format alone (ER14; ER19; ER12). However, graphical 
presentations did not result in improved accuracy of perception over numerical presentation 
formats in non-health professional samples (ER6; ER21). One review of health professional and 
non-health professional studies suggested that pictographs resulted in overestimation of risk 
compared to other graphical presentations (ER10). 
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Behaviour 
There has been limited investigation of the effects of graphical presentation of risks on 
behaviour in health professional and non-health professionals (ER2). Presentation of harms 
(risk of developing disease) has been observed to increase preventive behaviour uptake 
when presented as pictographs or bar charts compared to numerical presentation. Graphical 
part-whole relationships have not been shown to have an effect compared to non- part-whole 
graphical representations of harm on preventive behaviour uptake.   
 
2.6.1.3 Frequentist versus probabilistic presentation of risk 
 
Comprehension and perception 
A high level of comprehension (70%) was observed in one motivated non-health professional 
sample when risk was presented both in normalised frequency and percentage format (ER15). 
Although normalised frequencies (constant denominator) were observed to improve 
comprehension compared to frequencies presented with a constant numerator (1/n) in one 
review of health professionals and non-health professionals (ER2) a later study of non-health 
professionals did not observe a similar effect on accuracy of perception (ER19). 
Natural frequencies were observed to improve comprehension in comparison to normalised 
frequencies in both non-health professional and health professional samples (ER17; ER3) and in 
comparison to comparative measures (Relative Risk Reduction (RRR); Number Needed to 
Treat (NNT); Attributable Risk (AR); Tablets Needed to Take (TNT)) in another non-health 
professional sample (ER3). Frequencies (not otherwise specified) were observed to improve 
comprehension compared to probabilistic representations in a review of non-health 
professional studies (ER12).  
One review of non-health professionals (ER6) observed base rate neglect with manipulation of 
risk denominators.  
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A review of non-health professionals and health professionals suggests that frequentist 
representations of risk are perceived as pertaining to self and probabilistic representations to 
others (ER10). 
Although one review and one primary study representing health professionals and non-health 
professionals observed a decrease in comprehension with lower compared to larger 
magnitudes of probability (ER21; ER14) this observation was not replicated for accuracy of 
perception (ER21). 
 
2.6.1.4 Comparative risk measures (Relative Risk (RR); Relative Risk Reduction 
(RRR); Attributable Risk (AR); Attributable Risk Reduction (ARR); Number 
Needed To Treat (NNT); Tablets Needed To Take (TNT)) 
 
One review of health professional and non health professional studies (ER10) and three non 
health professional samples (ER8; ER18; ER21) were concerned with comparisons of comparative 
risk measures.  
 
Comprehension and perception 
Overall, 44% of a non-health professional sample were able to identify the more effective 
treatment when risk was presented either as RR, AR or NNT (ER18). 
An improvement in comprehension with absolute risk measures compared to relative risk 
measures was observed in medical students but the finding was not replicable in patients 
(ER10). Use of absolute measures of risk (AR, NNT) was observed to lessen comprehension 
compared to relative risk in two non-health professional samples (ER18; ER21).  
One review of health professional studies (ER16) and one primary study of non-health 
professionals (ER21) demonstrated a magnification of perception of risk with relative risk 
compared to absolute risk (AR and NNT) measures. 
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Behaviour 
One review of health professionals (ER16) and three primary studies in non-health 
professionals (ER3; ER6; ER11) included a comparison of comparative risk measures on 
behaviour. All report greater uptake of screening or acceptance of treatment with relative 
compared to absolute risk measures.  
 
2.6.1.5 More versus less information 
 
Comprehension 
One primary study of non-health professionals observed that presentation of multiple 
numerical risk metrics was perceived as unhelpful although this did not result in a detectable 
difference in comprehension or accuracy of perception (ER8).  
 
Behaviour 
One review of non-health professional studies observed an increase in treatment uptake with 
increasing explanation of data concerning risks of treatment benefit but no effect concerning 
risks of treatment harm (ER6).  
 
2.6.1.6 Tailored versus non-tailored presentation 
 
Content tailoring and presentation tailoring 
There was a lack of clarity in many reviews about the exact nature of tailoring of information 
that was the focus of investigation in primary studies. Content-tailored and non-content- 
tailored risk information is closely aligned to presentation of absolute rather than relative risk 
measures whereas tailoring of risk presentation is a more heterogeneous concept that 
encompasses presentation format, respondent preference and factors that are perceived to 
affect motivational biases. 
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Comprehension and perception 
Five reviews of non-health professionals included an investigation of the effects of tailoring 
information on comprehension.  
Three reviews demonstrated an improvement in comprehension with content-tailored 
compared to non-content-tailored information (ER1; ER5; ER7) and one review an improvement in 
comprehension with tailored compared to non-tailored-information (content or presentation 
not clearly specified) (ER9). One review did not find any effects of tailoring (not clearly 
specified) on comprehension (ER12). 
The effect of tailoring information on accuracy of perception is observed to be mixed, with 
some studies reporting an improvement in perception with content-tailored versus non-
content-tailored information (ER5; ER7) and some studies reporting inconsistent effects with 
content-tailored information (ER1) or any type of tailoring (content or presentation) (ER12). 
 
Behaviour 
One review (ER1) suggested that tailoring risk information had inconsistent effects on 
screening behaviour when communicating risks of harms (developing disease), although 
these conclusions were based on studies heterogeneous for the type of tailoring (content 
only; content and presentation; presentation only). Three reviews (ER6; ER7; ER12) observed 
content-tailored risk information to increase uptake of screening compared to non-content-
tailored information when communicating risks of harms (developing disease).  
 
2.6.1.7 Anchoring to familiar risks / lay versus medical terminology 
 
Comprehension and perception 
One primary study demonstrated that anchoring of health risks to familiar non-health risks 
(ER8) resulted in improvements in comprehension whilst one review demonstrated improved 
comprehension with the use of lay compared to medical terminology (ER6).  
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Behaviour 
Use of lay terminology has been observed to increase treatment uptake compared to use of 
medical terminology when presenting treatment harms (ER6). 
 
2.6.2 Results: Empirical risk literature: Fully rational  
One review of health professionals (ER16), four reviews of non-health professionals (ER5; ER6; 
ER12; ER13), four primary studies of non-health professionals (ER3; ER19; ER20; ER21) and one review 
including health professional and non-health professional studies (ER2) were concerned with 
the effects of risk presentation on anxiety and affect and the effects of framing of risk 
information and attitudes to risk on comprehension, perception, preference and behaviour. 
 
2.6.2.1 Numerical versus verbal presentation 
Anxiety 
Numerical presentation of risks appears to decrease anxiety compared to verbal presentation 
in health professionals and non-health professionals and across a variety of health care 
decisions (ER6; ER20). 
 
2.6.2.2 Comparative risk measures (RR, RRR, AR, ARR, NNT, TNT) 
Anxiety 
One study of non-health professionals demonstrated that presentation of Absolute Risk (AR) 
metrics resulted in less anxiety than presentation of Relative Risk (RR) (ER21) which is 
coherent with the finding that perception of risk is magnified when presented in relative rather 
than absolute terms (see above) (ER16; ER21). 
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2.6.2.3 Lay versus medical terminology 
Anxiety 
One review of non-health professional studies demonstrated that use of lay terminology 
concerning potential side effects of a drug resulted in increased anxiety compared to medical 
terminology (ER6). 
 
2.6.2.4 Vivid (personalised) versus abstract (population) descriptions of risk 
Anxiety 
One review of non-health professional studies demonstrated no difference in anxiety for vivid 
compared to generic based descriptions of risk (ER6). 
 
2.6.2.5 Graphical presentation 
Affect 
One study of non-health professionals demonstrated negative affect was significantly higher 
with the use of a graphic to present risk information (the Paling scale) (appendix 2.3) 
compared to frequencies with a constant numerator (1/n) followed by a pictograph graphic or 
normalised frequencies (with a constant denominator) (ER20). 
 
2.6.2.6 Framing (loss versus gain and positive versus negative frames)  
 
The effects of positive framing (communicating effects in positive terms, for example survival) 
and negative framing (communicating effects in negative terms, for example mortality were 
investigated in both health professional (ER16) and non-health professional studies (ER3; ER6; ER12; 
ER2; ETA10; ER13). In addition one review of non-health professionals (ER6) made a distinction 
between positive and negative framing and loss and gain framing; the latter defined as 
emphasising benefits over losses or losses over benefits respectively.  
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Comprehension and perception 
McGetiggan (1999) (ER16) demonstrated an increase in the perception of treatment benefit by 
health professionals with positive framing of risk of benefit. 
 
Behaviour 
Loss framing and negative framing have both been observed to increase uptake of screening 
by patients (ER6; ER12) whilst positive framing has been observed to increase treatment use by 
professionals (ER16). Temporal considerations may also add complexity to interpretation of 
framing effects on behaviour. Negative framing (mortality) was observed to result in risk 
aversion in the short-term (avoidance of potentially toxic treatment) whereas positive framing 
(survival) resulted in risk taking in the short-term in the context of survival curve interpretation 
(ER2). These apparently contradictory observations may be a reflection of the complexity of 
defining optimality when considering both professional and patient utility: differences in the 
definition of loss and gain, risk and certainty. Positive and negative framing effects appear to 
have a greater effect on intended behaviour for business and gambling domains compared to 
health and social domains (ER13) making the application of prospect theory (1.5.2.2) to 
healthcare settings problematic. As an illustration, testing was conceptualised as risk 
aversive behaviour by many authors contributing to the non-empirical test accuracy literature, 
on the basis that it results in greater certainty about the presence or absence of disease 
(2.4.2). In the risk literature, uptake of screening was considered risk taking in the short-term 
on the basis that screening may reveal the presence of disease that would otherwise not be 
apparent to an individual. The fact that a review of the effects of intervention risks and testing 
risks on behaviour found no consistent effect of positive or negative framing effects (ER6) is 
likely to be a reflection of the complexity associated with defining optimality in healthcare 
rather than the absence of a framing effect.  
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2.6.2.7 Attitudes to risk 
 
Comprehension, perception, anxiety and behaviour 
Different types of healthcare decision and individual variation in attitude to risks may modify 
the effects of risk presentation. For example in a review of non-health professional studies 
comparing the effects of different types of medical decisions, intervention risks had greater 
effects on comprehension, perception, anxiety and behaviour compared to testing risks (ER5). 
Further, individual variation in attitudes to risk type, risk magnitude, type of outcome and 
associated costs have been observed to modify the effects of risk presentation and the 
effects of framing on intended behaviour (ER16; ER3; ER13).  
 
2.6.3 Results: Empirical Risk literature: Able to compute accurately 
(manipulation of risks; comparison ≥ 2 risks)  
 
Three studies in non-health professionals (ER4; ER11; ER18) and one review (ER2) and one study in 
health and non-health professionals (ER17) examined the ability of respondents to 
quantitatively or semi-quantitatively manipulate risk measures. 
  
2.6.3.1 Frequentist versus probabilistic presentation 
 
Comprehension and perception 
In a study of non-health professionals, 57% overall were able to correctly mathematically 
manipulate risks although percentage presentation of risk resulted in the largest number of 
correct responses followed by normalised frequency presentation and least for frequencies 
with a constant numerator (1/n) (ER4). 
 
2.6.3.2 Comparative risk measures (RR, RRR, AR, ARR, NNT, TNT) 
 
Comprehension  
Although only 13% of a non-health professional sample were able to correctly manipulate 
comparative risk measures, RRR was demonstrated to result in a larger number of correct 
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responses followed by ARR, followed by a combination of measures and least for NNT (ER18). 
The authors suggest that this counterintuitive finding (ARR are easier to manipulate 
mathematically) may be due to the fact that RRR are familiar representation of probabilities 
to non-health professionals – for example they are encountered when adjusting retail prices 
during sales.  
Correct responses of between 52% and 87% were observed in a highly selected sample of 
health and non-health professionals for manipulations of RRR, ARR, RR and baseline risk to 
derive treatment effects. Overall health professionals achieved more correct responses 
compared to non-health professionals (ER17). 
 
Behaviour  
Manipulation of RRs was observed to result in more risk aversive behaviour compared to 
manipulation of ARs in one non-health professional sample (ER11). This is consistent with the 
observation of magnification of perception of risk with RR compared to AR (ER16; ER21). 
 
2.6.3.3 Graphical 
 
Comprehension 
One review including studies of health and non-health professional demonstrated an 
improvement in correct responses for probability problems when information was presented 
as pictographs (part-whole information) compared to numerical representation (probabilities 
or percentages (ER2). 
 
2.7 Strengths and limitations: Literature reviews 
The breadth and iterative nature of the search strategy is likely to have captured the key 
areas that have been discussed and researched to date. The relatively recent development 
of test accuracy research methods and application is reflected in the literature identified. In 
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addition, continued opportunistic literature acquisition since completion of the formal 
searches and a check for face and content validity at a recent international diagnostic test 
symposium, (Methods for Evaluating Tests and Biomarkers: second international 
symposium. University of Birmingham. July 2010) provides some reassurance that key 
evidence has not been missed and that for the review of theoretical literature, saturation had 
been reached.  
However given the challenges of searching the test accuracy literature 82-84 and the breadth 
of disciplines covered it is possible that relevant studies have been missed despite the 
comprehensiveness of the literature searches.  
 
2.7.1 Non Empirical test accuracy literature 
It is inevitable that exclusive use of the published literature and the relatively large proportion 
of articles accessed as a result of reference checking and experts may have limited the 
perspectives represented by this review, despite the breadth of the bibliographic database 
search strategy. Reliance on the published literature may also have resulted in under-
representation of the perspectives of practising clinicians as it is unclear the time which 
clinician authors included in these reviews spend in clinical practice or the degree to which 
their opinions are informed by the perspectives of clinical colleagues, particularly those 
affiliated with academic institutions. Further, conclusions regarding the strength, order and 
discipline-specific nature of the line of argument presented, depend on the assumption that 
the literature identified is representative. However, despite these potential limitations this 
qualitative synthesis provides a point of reference to appraise the extent to which empirical 
investigation of the understanding and application of test accuracy measures reflects and 
reinforces the issues raised. 
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2.7.2 Empirical test accuracy literature 
The empirical test accuracy literature identified is limited in volume and quality and is 
heterogeneous; many of the observations reported are based on the findings of a very small 
number of studies and are not supported by consistency. Although the findings of older 
studies may not reflect current knowledge, particularly given the impact of the evidence 
based medicine movement and the fact that diagnostic research is likely to be less familiar to 
clinicians compared to effectiveness research (ETA2), 60% of empirical test accuracy studies 
identified were conducted in the last two decades. 
 
2.7.3 Empirical risk literature 
The review of risk communication relied heavily on existing reviews. Relying on reviews 
rather than primary studies restricts consideration of outcomes to those considered by review 
authors which may not coincide with the themes raised by the test accuracy literature. 
However, the range of outcomes considered across the numerous reviews undertaken in the 
risk communication literature suggests that they are a comprehensive reflection of issues 
investigated in primary studies.  
Although risk reviews were varied with respect to the outcomes they considered, it is likely 
that some degree of duplication in inclusion of primary studies occurred. It is considered that 
this is unlikely to have an impact on the conclusions drawn from this review, providing 
included primary studies were representative of the evidence available.   
Variability in presentation formats across studies limited comparability. For example, for the 
investigation of the effect of presentation of risks as frequencies, there was a lack of a 
consistent distinction between natural frequencies and normalised frequencies which alone 
has been shown to result in differences in comprehension of treatment risks, testing risks 
and understanding of test accuracy 85. The use of reviews may therefore obscure 
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associations if effect modifiers are not taken into consideration, as was observed for a review 
of framing effects across a variety of medical decision making contexts (ER6).  
 
2.8 Quality and applicability of included literature  
 
2.8.1 Quality 
Included reviews and primary empirical studies were of variable quality. For empirical risk 
reviews considered high quality only one reported the quality of included studies as mostly 
good (ER7). The majority of empirical test accuracy studies were cross sectional in design and 
study reporting precluded quality assessment in a large proportion of included studies.  
 
2.8.2 Applicability 
The empirical test accuracy research is largely congruent with the theoretical literature. 
However this may be a reflection of the similar and highly selected nature of both samples. 
As would be expected, comprehension, accuracy of perception and ability to manipulate risks 
were associated with numeracy and education (ER4; ER15; ER10; ER18). Similarly, empirical test 
accuracy studies attempting to distinguish between the ability of academic and practising 
clinicians demonstrate large differences in ability (ETA2; ETA3; ETA18). 
The review of non-empirical test accuracy literature is therefore likely to represent the 
perspectives of experts rather than practising clinicians and the reviews of empirical studies 
to overestimate comprehension, accuracy of perception and ability to manipulate risks, with 
less clear impact on preference for metric and presentation format.  
Findings are almost exclusively based on hypothetical scenarios and self-reported practice. 
The generalist perspective was under-represented in both the non-empirical and empirical 
test accuracy evidence base.  Unique aspects and challenges posed by the early stages of 
the diagnostic work up in primary care settings, such as the different emphasis of test use 
(an emphasis on ruling out disease rather than reaching a definitive diagnosis) and symptom 
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rather than disease based investigation is not represented. The observations that test 
accuracy terms concerned with the absence of disease (specificity) and negative test results 
are less well understood and that manipulation of small probabilities cause difficulty may 
therefore reflect the restricted testing context represented by the literature rather than a 
generic problem. Research concerning the use, understanding and application of test 
accuracy information should be undertaken mindful of the potential differences in patient 
spectrum, testing culture and types of challenges encountered in generalist compared to 
specialist settings. Representation of both settings is required in order to address needs 
specific to either group as well as to facilitate evidence based testing across entire care 
pathways.  
In addition to a specialist contextual focus, UK practice was under-represented in the 
empirical test accuracy and risk literature. The majority of evidence originated from the USA 
where medical education differs and healthcare organisation and cultural differences may 
limit generalisability, particularly with respect to behaviour.  
The non-empirical test accuracy literature was almost exclusively concerned with the use of 
test accuracy measures for decision making at the bedside and an assumption that 
probability revision is a pre-requisite for informed diagnostic decision making with limited 
consideration of their utility to guide testing policy. The requirements of policy makers and 
interpretation of meta-analyses of test accuracy were not well represented and there was 
relatively little attention given to the use of test accuracy measures to facilitate test 
comparisons or evaluation of multiple tests in a testing pathway. Comparisons between tests 
and testing policy are more likely to be decided on the basis of reviews, where global 
measures of test accuracy have the potential for greater application.  
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2.9 Conclusions 
Whilst there is widespread belief that clinicians have difficulty applying test accuracy 
information, this has not been based on a systematic interrogation of the evidence base. As 
a result it has not been possible to date to quantify or characterise the extent of the problem 
in order to identify characteristics of existing test accuracy measures or expressions of 
probability more generally that might facilitate their understanding and application. This 
review represents the first attempt to bring together evidence pertinent to the facilitation of 
evidence based diagnosis and the findings provide a framework for further research.  
 
2.9.1 A decision maker who is fully informed? 
 
 
2.9.1.1 Desirable properties of test accuracy metrics: sensitivity, specificity and 
predictive values 
 
The majority of non-empirical test accuracy articles were concerned with one or more of 
sensitivity, specificity and PVs with frequent comparison to LRs. The features of test 
accuracy measures that are perceived to impact on the ease and appropriateness with which 
they are interpreted and applied include: 
 Having the test result (rather than disease status) as the reference class for 
interpretation of conditional probabilities. 
 Discrimination between the two dimensions of test accuracy and quantification of test 
errors (ability to rule in or rule out a diagnosis or the value of a positive test result 
separate to a negative test result) 
 Portability across populations 
 
Predictive values are repeatedly described as the more intuitive of the test accuracy metrics 
on the basis that they have a test result rather than disease status as reference class. 
However they are subsequently dismissed on the basis that they are mathematically 
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dependent on prevalence. This dismissal of PVs on the basis of their dependence on 
prevalence has been fuelled by a relative neglect of the effects of population spectrum as a 
modifier of all test accuracy metrics. The result has been a lack of empirical investigation of 
how PVs impact on understanding and application of test accuracy information. 
Familiarity with metrics as measured by the empirical test accuracy literature was not a good 
indicator of understanding and available research suggests that sensitivity and specificity, 
although predominant metrics in test accuracy research, are not well understood and their 
practical application is difficult. One empirical study investigating the use of test accuracy 
metrics in practice reported that sensitivity and specificity were used by 4% of respondents 
compared to 80% respondents reporting to use PVs (ETA29).   
There are important parallels to be drawn between the development of outcome reporting for 
primary test accuracy research and those for meta-analyses of test accuracy. Sensitivity and 
specificity have been shown to be the most commonly used test accuracy metric in meta-
analyses of test accuracy 6 . As for primary test accuracy studies this is likely in part to have 
been based on a misperception that sensitivity and specificity are fixed properties of tests 
and that their use will reduce heterogeneity. However recent research suggests that directly 
deriving PVs from meta-analyses produces similar estimates to PVs derived indirectly from 
summary estimates of sensitivity and specificity 86 . In addition the use of PVs may mitigate 
against partial and differential verification bias and have advantages in situations when it 
would be unethical or impractical to verify index test negatives, such as the application of 
tests for screening.  The complex relationship between prevalence, spectrum and 
heterogeneity requires further research 51,87,88. It is possible that metrics that are not 
mathematically dependent on prevalence (sensitivity, specificity and LRs) may offer no great 
advantage in this respect.  
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2.9.1.2 Likelihood ratios, ROC curves and test accuracy metrics common to 
systematic reviews 
 
Investigation of the ability of respondents to define and interpret more recently introduced 
test accuracy metrics such as LRs and those more common to systematic reviews of test 
accuracy (for example ROC curves, AUC and Forest plots) were almost entirely absent from 
the empirical and non-empirical test accuracy literature and the reported use of these metrics 
is < 1% (ETA29).  The relative lack of consideration of global measures and development of 
testing policy may reflect a lack of familiarity with these measures, as a result of the relatively 
recent increase in volume of test accuracy reviews 39,42. The relatively recent emergence of 
systematic reviews of test accuracy may also explain the emphasis in the literature on the 
use of test accuracy information for diagnostic decision making at the bedside rather than to 
support testing policy. 
 
2.9.1.3 Complimentary use of test accuracy metrics 
 
Lacking from the literature identified was discussion of how test accuracy measures might be 
used in a complimentary way to assist with diagnostic decision making. Comparison of test 
accuracy measures was approached with the aim of advocating a single, preferred metric 
rather than identifying a suite of metrics that would be complimentary in terms of presentation 
format and conveying different aspects of test accuracy (for example the two separate 
dimensions of test accuracy; the overall discrimination of a test; the relationship between pre-
test probability and the clinical utility of a test). Similarly, there was very limited discussion of 
the links between different test accuracy measures (for example the similar information 
provided by sensitivity, NPV and LR- or specificity, PPV and LR+) that might help decision 
makers make sense of the multiple outcome measures in use 43. The potential role of the 2x2 
diagnostic table as a test accuracy presentation format that could be used to illustrate the 
relationship between summary test accuracy metrics as well as an explicit representation of 
test errors in a natural frequency format appears to have been overlooked. 
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2.9.1.4 Estimation of pre-test probability and test accuracy 
 
The literature mostly conceptualises the clinical history and examination as characteristics of 
patients contributing to ‘pre-test’ probability. This may be a feature of the secondary care 
focus of the literature reviewed (see 2.8.2 above) which may serve to undermine the 
contribution of the clinical history and examination as diagnostic tests in their own right.  
There is a need for greater consistency in the use of the term ‘pre-test probability’ in order to 
provide contextual clarity. As a concept, pre-test probability needs to reflect spectrum, 
including specification of the point in the diagnostic pathway that the test is to be used. 
Findings from the empirical test accuracy literature do suggest that clinicians are aware of 
contextual modifiers of pre-test probability although accuracy of pre-test probability 
estimation and knowledge of the accuracy of tests used in practice appears poor with wide 
variability and a tendency to overestimation.  
The importance of accurate pre-test probability and test accuracy estimation will depend on 
the extent to which formal probabilistic reasoning takes place as part of the diagnostic 
decision making process (see 2.9.3.1 below).  
 
2.9.2 A decision maker who is fully rational? 
There was very limited consideration of motivational biases in diagnostic decision making in 
both the non-empirical and empirical test accuracy literature. Discussion in the non-empirical 
literature included consideration of individual and contextual variation in attitudes to risk as a 
modifier of decision making behaviour. The empirical test accuracy literature was restricted 
to two studies in generalist settings and no association was found between individual 
practitioners’ attitudes to risk and test ordering although it is unclear whether this is due to 
limitations of the measurement tools used or confounding. Patient and practitioner motivation 
were observed to be important modifiers of test use in these studies and patient and 
practitioner reassurance were viewed as legitimate reasons for testing. 
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Testing was portrayed as a risk aversive behaviour in the non empirical test accuracy 
literature and one contributory factor to the observed increase in testing (2.4.2).  Explicit 
quantification of test errors is one method of conveying the degree to which a test reduces 
uncertainty but is not a feature of any existing summary test accuracy metrics and may serve 
to obscure the uncertainty associated with the testing process. Consideration of factors that 
impact on test and test treatment thresholds is an important aspect of the evaluation of the 
proposed role of new tests.  
 
2.9.3 A decision maker who is able to compute accurately 
2.9.3.1 Probability revision in practice 
 
Both the non-empirical and empirical test accuracy literature is dominated by consideration of 
methods for simplifying probability revision. Although difficulties with undertaking quantitative 
probability revision were discussed, this was from the perspective that this was the problem 
solving approach to be aspired to, both by clinical and non-clinical authors. Approaches 
proposed by clinicians were grounded in probabilistic expression of uncertainty and 
probability revision using Bayes theorem whereas psychologists proposed a frequentist 
approach to probability revision. The emphasis on probability revision is likely to be a 
reflection of the promotion of the integration of quantitative evidence into clinical decision 
making endorsed by the Evidence Based Medicine Movement 81. With the exception of 
academic respondents, quantitative probability revision appears poor, even in these 
predominantly highly selected samples. 
Existing efforts to integrate test accuracy information into the diagnostic decision making 
process have been based on an assumption that quantitative test accuracy information is 
sought but not understood. This review raises questions about the extent to which clinicians 
seek quantitative estimates of test accuracy and pre-test probability and the extent to which 
formal probability revision is used in practice. For example the absence of effect on test use 
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of an intervention to improve the accuracy of probability revision (ETA27) and reported use of 
Bayes’ theorem in practice by respondents in one study of 3% (ETA29) suggest formal 
probability revision may not be commonplace in diagnostic decision making. The impact that 
quantitative estimates of test accuracy might have on diagnostic and therapeutic yield 
requires consideration of not only the extent to which test accuracy information is understood 
but also the perceived added value of the information over clinical experience alone. A single 
study found no difference in patient management between clinicians provided with 
information about pre-test probability and test accuracy and those who were expected to rely 
on their own experience (ETA32) suggesting that clinical experience of test use rather than use 
of test accuracy estimates from the published literature are used in practice. Although 
evidence concerning the effect of clinical experience, as measured by years since 
completion of training, on the ability to undertake probabilistic reasoning is limited and 
conflicting (ETA2; ETA6; ETA11), the impact of individual and setting-specific variations in test and 
test-treatment thresholds has not received attention in this respect.  
 
2.9.3.2 The impact of test accuracy metric and presentation formats on probability 
revision  
 
On the basis of two studies in the empirical test accuracy literature, sensitivity and specificity, 
LRs and a graphical representation of test accuracy could not be distinguished with respect 
to their ability to facilitate probability revision.  
There was a large body of evidence supporting the effect of presentation format on the 
probabilistic reasoning ability. The advantages of natural frequency presentation format is 
proposed to be as a consequence of their natural separation of reference classes (thereby 
avoiding reference class confusion) and simplification of probability revision by negating the 
need to incorporate base rates. The empirical literature here suggests that clear definition 
and partitioning of reference class may be the more important characteristic, which has 
implications for the use of sensitivity and specificity for probability revision.  
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Reflecting the importance of reference class, most studies from the psychological literature 
avoided the use of summary measures such as sensitivity and specificity; true positive rates 
(sensitivity) and true negative rates (specificity) rates were described as ‘defective 
partitioning’ (ETA15) due to the fact they refer to the disease as reference class. Instead false 
negative rates (1-sensitivity) and false positive rates (1-specificity) were commonly used 
reflecting test result as reference class. Indeed despite the finding by one study (ETA29) that 
practising clinicians used PPVs (PPV and 1- NPV) for information on the post-test probability 
of disease, the potential value of PVs as a summary test accuracy metric that avoids the 
requirement for probability revision has not been discussed or addressed by the empirical or 
non-empirical literature. 
 
2.9.3.3 The impact of negative test results on probability revision 
 
Three of the five studies in the empirical test accuracy literature investigating respondents’ 
ability to interpret and use negative test results found respondents’ had problems interpreting 
and using negative results. It has been suggested that clinicians’ ‘insensitivity’ to negative 
test results may reflect problems processing absent problems, epidemiological terminology 
(negative predictive value) linking negative findings to the absence rather than the presence 
of disease (ETA7) and due to an emphasis on the ‘abnormal’ by patients.  However, this finding 
should be interpreted with caution as all of these studies were conducted solely with 
secondary care clinicians where the emphasis of testing is proposed to be ruling in disease 
rather than ruling out disease (TTA8).  
 
2.9.4 Contribution of the empirical risk literature 
2.9.4.1 Consistencies with the test accuracy literature 
 
Findings consistent in both the test accuracy and general risk literature include:  
 difficulty with the comprehension of low probabilities (2.5.3.3)  
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 presentation of frequencies result in greater comprehension than percentages and 
natural frequencies appear to have a  more marked effect on comprehension 
compared to  normalised frequencies (2.5.3.3)  
 frequentist representations of risk are perceived as pertaining to self whereas 
probabilistic representations are perceived as pertaining to others (2.5.1.1)  
In addition, in the test accuracy literature, an important feature of natural frequencies 
believed to contribute to their accessibility was the fact they represented sequential 
acquisition of information based on direct experience (2.4.3.2). This may have parallels with 
attempts to facilitate understanding in the risk communication literature by anchoring 
unfamiliar risks to familiar risks (ER8).  
 
2.9.4.2 Inconsistencies with the test accuracy literature 
 
One striking difference between the body of literature concerned with the understanding and 
application of test accuracy measures and that concerned with the understandings and 
application of risk measures is the use of comparative metrics. The risk literature is almost 
entirely concerned with comparison of risks, whereas comparative test accuracy evaluation is 
almost entirely absent from the test accuracy literature. One explanation for this observation 
may be the delay in the development of methods for test evaluation relative to evaluations of 
interventions including the relatively more recent emergence of test accuracy reviews 39,42 
(2.9.1.2 above). However in the absence of any risk literature concerned with understanding 
and application of single intervention risks, it is likely that this observed difference between 
the test and risk literature, at least in part, reflects barriers to rigorous test evaluation, such 
as the relatively more rapid pace of technological advancements in testing compared to 
drugs 18 and the relatively less lax regulatory system for the introduction of tests compared to 
drugs which does not encourage comparative evaluation 25. 
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2.9.4.3 Additional insights provided by the empirical risk literature  
 
Characteristics of metrics that facilitate understanding 
Overall comprehension of metrics and the ability to manipulate probabilities was superior in 
the risk communication literature compared to the test accuracy literature. This is supported 
by the one study in the empirical test accuracy literature that compared the ability of health 
professionals and non-health professionals to define and manipulate measures of effect and 
measures of test accuracy (ETA2) (appendix 2.2). Both the test accuracy and risk literature 
were characterised by educated and highly selected samples suggesting selection bias as an 
unlikely explanation for this observed difference.  
 
Familiarity and understanding 
The observed difference may be a reflection of the relative lack of familiarity with test 
accuracy metrics and less advanced understanding of the challenges posed by the use and 
application of test accuracy information compared to information about intervention risks. 
Indeed, the observation that empirical test accuracy studies were almost exclusively 
concerned with health professionals whereas empirical risk studies had a larger proportion of 
studies concerned with non-health professionals might, by itself, suggest that the evidence 
base concerning understanding and application of risk metrics is more advanced than that for 
test accuracy metrics.  
However, if familiarity and the state of evolution of the evidence base were the sole 
explanations for the differences in understanding observed between the test accuracy and 
risk literature, it might be expected that health professionals would be superior to non health 
professionals on the basis of the advantages of medical training. There were no consistent 
differences in comprehension or ability to manipulate probabilities observed between health 
and non-health professional samples in the test accuracy literature and no consistent 
differences in the risk literature with the exception of a single study, where health 
professionals only were selected on the basis of ‘strong’ critical reading skills (ER17). In 
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addition familiarity did not appear to be related to ability to define or use metrics in the test 
accuracy literature (2.9.1.1 above). In conclusion therefore, it is likely that differences in the 
characteristics of test accuracy and intervention risk information are contributing to observed 
differences in comprehension.  
The considerable body of literature concerned with probability revision in the test accuracy 
literature reflected the need to derive the probability of disease consequent on a test result: 
the probability of having disease following a positive test result (equivalent to the PPV) or the 
probability of having disease following a negative test result (equivalent to 1- NPV). For this 
reason conditional probability summary test accuracy metrics with (antecedent) test result as 
reference class (PVs) were emphasised as intuitive for decision making in contrast to 
summary test accuracy metrics with disease class as test result (sensitivity and specificity) 
(2.4.1.1). The observation that comprehension and the ability to manipulate metrics was 
superior in the general risk compared to the test accuracy literature may in part be explained 
by the fact that all summary risk measures share the property of conveying the probability of 
having a condition following exposure to a risk or preventative factor rather than the 
probability of being exposed if you have or do not have a condition; in other words having the 
antecedent event as reference class for conditional probability measures may be a key 
characteristic facilitating understanding.  
 
Comparative metrics 
The body of literature pertaining to communication of risk demonstrated consistent 
overestimation of magnitude of effect with RR representation compared to AR representation 
(ER16; ER6;ER3; ER11; ER21) In addition content-tailored risk information had beneficial effects on 
comprehension and perception (ER1; ER5; ER7) and larger effects on behaviour (ER6; ER7; ER12) 
compared to non-content-tailored information.  
Content-tailored information can be conceptualised as similar to absolute risk information by 
taking into account information on a baseline risk at the point of exposure whereas non-
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content-tailored information is similar to relative risk information. Although comparable 
metrics are currently not widespread in the test accuracy literature, the potential for similar 
misinterpretation can be anticipated.  
 
Graphics as an aid to comprehension 
Use of graphics received limited attention in the non-empirical test accuracy literature. 
Although graphical presentation was proposed as a method for facilitating understanding 
(2.4.1.4) and application (2.4.3.1) of test accuracy information no empirical evidence was 
found to support this; one study of non-health professionals did not identify a preference for 
numeric or graphical presentations of test accuracy information and existing graphics, such 
as ROC curves, do not feature as an aid to decision making for health professionals 
(2.5.1.1).  In contrast a considerable body of literature exists investigating the potential for 
graphics to aid risk communication. Inconsistent evidence for improvement in comprehension 
or accuracy of perception with graphical compared to numerical presentations of risk exists 
(ER2; ER8; ER14; ER21). In one non-health professional study multiple numeric metrics were 
perceived as unhelpful although no effect on comprehension was observed (ER8). There is 
however some evidence that provision of graphical, numerical and verbal information about 
risk improves accuracy of perception over either presentation format alone (ER12; ER14; ER19). 
This latter observation may be a function of maximising accessibility by including a variety of 
presentation formats. Graphic aids have appeal as a medium for the simultaneous 
presentation of the two dimensions of test accuracy and their interdependence and warrant 
investigation for this purpose. However it is clearly important to distinguish between 
complimentary presentation formats and indiscriminate presentation of multiple numerical 
metrics (see also 2.6.1.2; 2.6.1.5). The use of multiple numerical metrics in test accuracy 
evaluations is commonplace 6 although graphics are not prominent in either primary test 
accuracy studies or systematic reviews of test accuracy 89. 
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Contextual and motivational biases 
The evidence available on risk communication includes different types of healthcare risk and 
emphasises risk comparisons. This offers the potential to investigate contextual modifiers of 
understanding and application of risk measures. Indeed this was raised as an important 
modifier of behaviour in the review of non-empirical test accuracy literature (2.4.2). There is 
evidence of contextual and temporal modification to attitudes to risk and risk taking behaviour 
(ER2; ER16; ER13, ER5) reflecting the notion of optimality as conditional on context (1.5.1) but not 
well predicted by behavioural decision theory which is largely based on decision making in 
the financial domain. Individual and contextual modifiers of motivation have implications for 
the potential of evidence based decision making to improve practice. This finding also 
suggests that comprehension or the ability to manipulate probabilistic information may not be 
a good predictor of behaviour.  
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Chapter 3: Mapping the epidemiological characteristics of test 
evaluation systematic reviews  
 
3.1 Abstract 
Background 
There has been a growth in the volume of primary research concerned with testing over 
recent years. Specialist review databases represent a potential complimentary method for 
accessing test evaluation research given the well documented problems with searching for 
test accuracy studies in bibliographic databases. Characterising the test evaluation content 
of existing databases of systematic reviews may help those looking for specific types of test 
evaluation as well as identifying areas where test evaluation research is relatively sparse. 
Methods 
Five specialist review databases (York CRD’s DARE, CDSR and HTA databases, the 
University of Maastricht’s MEDION database and ARIF’s in-house database at the University 
of Birmingham) were interrogated with respect to the proportion of included test accuracy 
reviews, quality assurance, ease of use and currency of databases and the epidemiological 
characteristics of included test accuracy reviews.  Interrogation of databases comprised 
contact with database owners and application of an in-house search strategy for diagnostic 
studies. These complementary methods allowed for validation of the in-house search 
strategy for a proportion of review databases. 
Results 
Review databases varied significantly with respect to their currency. Difficulties identifying 
test accuracy reviews in bibliographic databases are mirrored in the review databases 
interrogated; tagging of test accuracy reviews is currently only conducted in one database 
(ARIF). A combination of 3 databases would be required to achieve an estimated 76% of 
available test accuracy reviews. Medion, HTA and C-EBLM databases were characterised by 
a relatively high proportion of particular disease topic areas. Overall, across databases, tests 
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applied in secondary care settings, (overall only 4% of reviews evaluated tests for use in 
primary care); certain disease topic areas (gastrointestinal, cardiovascular and obstetrics and 
gynaecology) and evaluations of single tests rather than test comparisons, predominate.  
Conclusions 
Issues pertaining to the identification of primary test accuracy research appear to be 
pertinent to identification of test accuracy reviews in general review repositories and the 
considerable ambiguity conveyed by review titles in this investigation also has implications 
for searching. Based on the epidemiological characteristics of test evaluations it is unlikely 
that the existing evidence base reflects the clinical need for evidence. 
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3.2 Rationale 
There has been a growth in the volume of primary research concerned with testing over 
recent years. Evaluation of test accuracy (distinct from test effectiveness or cost-
effectiveness) is almost certainly responsible for the majority of this increase. Trials of test 
and treat combinations have been shown to be rare with an estimated 37 test and treat 
randomised controlled trials published between 2004 and 2007 90. Decision models 
combining estimates of test accuracy with estimates of treatment effectiveness represent a 
practical alternative to trials of test and treat combinations, owing to the methodological and 
practical complexities as well as sample size demands of trials in this area 91. The increase in 
test evaluations is reflected by the increasing number of systematic reviews in the area. 
Systematic reviews are an important resource for summarising existing knowledge and 
underpin guideline development and needs assessment for research activity.  
It is well-documented that using methodological search filters with general bibliographic 
databases to locate studies of test accuracy is at best unreliable 84,92. Specialist review 
databases may represent a complementary and possibly more efficient method for accessing 
test evaluation research. In addition databases of systematic reviews are an important and 
efficient resource to support methodological research. Characterising the test evaluation 
content of existing databases of systematic reviews may help those looking for specific types 
of test evaluation as well as identifying areas where test evaluation research is relatively 
sparse. 
 
3.3  Aims and objectives 
Aims 
The aim of the interrogation of systematic review databases was to establish a repository of 
systematic reviews of test accuracy and compile a representative sample of test accuracy 
reviews for a methodological review reported in chapter 4.   The process of generating a 
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representative sample of reviews offered the opportunity to examine the databases from 
which reviews were sourced in detail and to describe the epidemiology of reviews contained 
in these databases.  
Objectives 
 To characterise existing systematic review databases with respect to the number of 
systematic reviews of test evaluations they contain and to assess the overlap 
between databases. 
 To assess existing systematic review databases with respect to their currency, quality 
assurance and ease of retrieval of test evaluation reviews.  
 To map the following epidemiological characteristics of systematic reviews of test 
evaluations: disease category, review purpose and test application. 
 
3.4 Methods 
Databases making a claim to contain systematic reviews as opposed to narrative reviews 
and commentaries were included for consideration. The extent to which reviews contained in 
a database met the definition of a systematic review was not assessed.  
The following five databases were included: 
 Health Technology Assessment (HTA) database via the Cochrane Library (1998) 
(http://www.thecochranelibrary.com.ezproxyd.bham.ac.uk/view/0/index.html)  
 Database of Abstracts of Reviews of Effects (DARE) via the Cochrane Library (1994) 
(http://www.thecochranelibrary.com.ezproxyd.bham.ac.uk/view/0/index.html)  
 Medion database of diagnostic reviews (University of Maastricht)(1994) 
(http://www.mediondatabase.nl/) 
 International Federation of Clinical Chemists Committee of Evidence Based 
Laboratory Medicine (IFCC C-EBLM) reviews database (established 1996 as 
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personal website of Wytze Oosterhuis, publicly available on the IFCC Web site in 
2004)  
 Aggressive Research Intelligence Facility (ARIF) in house database (University of 
Birmingham 1996). (http://www.arif.bham.ac.uk/databases.shtml). 
Of these specialist reviews databases, Medion and C-EBLM are devoted solely to systematic 
reviews of tests. Inclusion of the ARIF in-house database was on the basis of plans to make 
the database publicly accessible and in addition the author’s familiarity with the database 
facilitated its use as a point of reference for evaluation of the other databases. For those 
databases containing both systematic reviews of interventions and systematic reviews 
concerned with test accuracy (HTA, DARE, ARIF), a strategy for comprehensively capturing 
the test accuracy content was devised. The ARIF database tags diagnostic and screening 
reviews as such on inclusion. At the time of conducting the research test accuracy reviews 
were not denoted by any special indexing in the DARE and HTA databases. A pragmatic 
filter was therefore created in order to retrieve as many test accuracy reviews as possible 
whilst maximising specificity in the absence of reliable methodological search filters 84,92,93. 
Searches of HTA and DARE were limited to MeSH index terms to make them as specific as 
possible. The choice of MeSH terms were based on an analysis of the performance of 12 
validated diagnostic search filters 93. The most frequently used MeSH term used by 11 of the 
12 filters: ‘Sensitivity and Specificity’ (exp) (92% of filters) was combined with the term ‘Mass 
Screening’ in order to capture a variety of testing applications. The MeSH term ‘Diagnosis’ 
(exp) or text word ‘diagnostic’ greatly reduced the specificity of the searches and so were not 
used. The performance of the filter was verified as far as possible with the help of in-house 
searches of DARE and HTA performed by database producers CRD (Centre for Reviews 
and Dissemination, University of York) using their preferred search terms. Diagnostic reviews 
in DARE are coded in-house although at the time of conducting the research this facility was 
not available on the public database interface. The ARIF database was searched using the 
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tag diagnosis as well as the text word screening and false positive hits were identified by 
scrutiny of retrieved records (see appendix 3.1 for search terms used). 
Searches for all systematic reviews of test accuracy in each database were carried out in 
January 2007 for the period 1996-2006. Scrutiny of retrieved records for false positive hits 
(reviews not concerned with test accuracy) also allowed investigation of the specificity of the 
filter (see appendix 3.2 for flow of references). All records for the relevant period in the 
specialist diagnostic reviews databases, Medion and C-EBLM, were included.  Reference 
Manager v 11 for Windows was used to store downloaded records from DARE, HTA and 
ARIF, whilst C-EBLM and Medion were added manually as these databases were not 
compatible with reference management software. 
 
3.4.1  Inclusion criteria 
The focus for the methodological review reported in chapter 4 is systematic reviews of test 
accuracy, either test accuracy reviews conducted in isolation or systematic reviews of test 
accuracy undertaken as part of a broader evaluation of a test’s effectiveness and cost-
effectiveness. Thus the mapping exercise sought to map the epidemiological characteristics 
of reviews of all aspects of test evaluation. 
 
3.4.2 Coding included references 
References were tagged according to their database source. In addition epidemiological 
characteristics of test evaluation reviews were noted based on review title. To ensure 
consistency a pro-forma was used as in some instances a review could be placed in more 
than one category. Appendix 3.3 details the criteria used to code references. 
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3.4.2.1 Disease  
 
The disease topic area or areas the review was addressing were recorded. Classification of 
disease was pragmatic and not based on a specific disease classification system. 
 
3.4.2.2 Review purpose 
 
The purpose of retrieved reviews was coded as ‘test accuracy’ only, ‘costs’ of testing, 
‘effectiveness’ of testing, ‘cost-effectiveness’ of testing, ‘methodological’ test reviews  or 
‘other’, (reviews concerned with test acceptability; methods of test execution ; early test 
development for example promising disease markers, testing strategies; organisation of 
testing programmes; morphological studies). Test accuracy reviews were further sub-divided 
into those concerned with estimation of the accuracy of single test or with estimation of 
accuracy of more than one test. 
 
3.4.2.3 Clinical setting 
 
The clinical setting in which tests were being evaluated was noted. Test setting was defined 
as the likely origin of patients to be tested and not the setting in which the test was to be 
applied. Thus for example ultrasound examination and X-rays are likely to take place in a 
secondary care setting although these tests could be initiated and acted on in primary care. 
Reviews were coded as being concerned with tests to be used in a screening context 
(encompassing population based and targeted screening programmes), over the counter, in 
the community, primary care, secondary care or for use in multiple settings. 
The search facility in Reference Manager was used to identify yield of references by single 
database and database combinations and to map epidemiological characteristics of test 
reviews contained in the databases. 
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3.5 Results 
3.5.1 Performance of pragmatic search filter in general specialist review 
databases  
 
Appendix 3.2 illustrates the performance of the pragmatic filter which performed variably for 
detection of reviews concerned with testing in databases with MESH search facilities (DARE 
and HTA). There were 89 false positive hits for DARE (19% of DARE hits) and 9 in the HTA 
database (3% of HTA hits).  The number of false positives generated by searching the ARIF 
in-house database using the terms diagnosis and screening was low; n=13 (3%). In the HTA  
database, only 16 (5%) of hits were not reviews. In the ARIF database 2, (<1%) of hits had 
been wrongly added to the database as reviews when in fact they were primary research 
(mostly case series). One record from Medion (a letter) had been erroneously included in the 
database. All of the records in the C-EBLM databases were reviews. Both the Medion 
database and the C-EBLM database contained references not concerned with evaluation of 
tests (1% of Medion records and 9% of C-EBLM records), all concerned with describing 
putative causal associations between laboratory based markers and disease. 
The pragmatic filter identified 383 (72%) of the 542 tagged test evaluation reviews identified 
by DARE producers for the period 1996-2006.   Both estimates are important; the pragmatic 
filter estimate of 383 is likely to approximate to the yield from a search of DARE on the public 
interface whilst the database producer estimate is a more valid representation of the number 
of test evaluation reviews within DARE. Reviews identified by in-house producer searching of 
the HTA database yielded fewer hits (n=172) compared to the pragmatic filter (n=333) for the 
period 1996 and 2006. For the purposes of calculating yield of relevant references for single 
databases and across multiple databases an estimate of 333 test evaluation reviews for the 
HTA database was used.  
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3.5.2 Yield of test accuracy reviews by single databases 
The yield of test evaluation reviews identified from searching the public interface of a single 
database would be 664 for the Medion database, 401 for the C-EBLM database, 383 for the 
DARE database and 333 for the HTA database and 490 for the  ARIF database. Using the 
DARE database producer estimate increased the number of reviews that would be identified 
by DARE from 383 to 542 (an additional 159 reviews). (Appendix 3.2) 
 
3.5.3 Duplication across databases 
After removing reviews not concerned with diagnosis and primary research papers Medion 
had the most unique test accuracy review references (references not contained in any other 
database) ( n=328) followed by the HTA database (n=264), C-EBLM database(n= 248) and 
the ARIF database (n=232) (see figure 3.1). DARE had the least number of unique test 
accuracy review references when using the pragmatic search filter (24% of 383: n=93). The 
DARE database producer tagged search yielded 542 references for the same period. 
Extrapolating from the results of searching DARE using the pragmatic filter, an estimated 
24% (130) additional references would be unique to DARE. However this does not change 
the DARE database’s rank order for contribution of unique references (figure 3.1). 
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Appendix 3.4 documents the yield of resources for combinations of 2 and 3 databases. A 
combination of three publicly available databases (C-EBLM, Medion and HTA) yields 1232 
unique references (76% of the total). A combination of Medion and the HTA database or 
Medion and C-EBLM yielded 948 and 952 unique references respectively (~59% of the total). 
The lowest yield of references was obtained by a combination of the DARE and HTA 
databases (561 (35%) using the pragmatic filter on the public interface of DARE or 720 
(40%) based on the DARE database producer tagged estimate). However it must be noted 
that this low yield may be explained by the fact that DARE is a selective, quality assured 
resource. 
 
3.5.4 Characteristics of indexed test accuracy reviews 
This analysis is based on the content of the 1620 test evaluation reviews identified from a 
combination of the pragmatic search filter in DARE and HTA; reviews tagged as ‘diagnostic’ 
in combination with the use of screening as a text word in the ARIF database; all reviews 
contained in Medion and all reviews contained in C-EBLM  for the period 1996-2006. 
Additional references identified by the DARE database producer tagged searches (n=130) 
0 100 200 300 400
Medion
HTA
C-EBLM
ARIF
DARE (host estimate)
DARE
Number of references unique to database
Da
ta
ba
se
Fig 3.1: Unique References According to Review 
Database
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were not available for scrutiny within the time available. Description of review characteristics 
was based on review title and where available review abstract (see appendix 3.5). 
 
3.5.4.1 Disease topic area 
 
Figure 3.2 illustrates a breakdown of reviews according to disease category. Obstetrics and 
gynaecology accounted for between 8% and 18% of reviews across databases, median 13% 
of reviews (18% overall). Cardiovascular disease (‘cardio’) and gastro-intestinal disease (‘GI’) 
accounted for between 9% and 15% of reviews, (15% overall). Ophthalmology was 
prominent in the Medion database (11% citations). The high proportion of reviews concerned 
with infectious disease (‘Infec’) and haematology (‘Haem’) in the C-EBLM database is 
probably a reflection of the laboratory emphasis of this database. The relatively high 
proportion of reviews concerned with genetic testing in the HTA database (12%) may be a 
reflection of this topic area as an emerging health technology 94. It should be noted that the 
separate section of the Medion database devoted solely to reviews concerned with genetic 
testing was not included in this analysis; the number of reviews in the Medion genetics 
section over our period of study was 119 which would increase the proportion of genetics 
reviews contributed by Medion to close to 20% of the total across databases, compared to 
the 1% indicated in figure 3.2.
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Notes to Fig 3.2: Anaes: Anaesthetics; Cardio: Cardiovascular; Cerebro: Cerebrovascular; Derm: Dermatology; Endo: Endocrinology; ENT: Ear, Nose and 
Throat; GI: Gastrointestinal;GU: Genito-Urinary; Haem: Haematology; Immun: Immunology; Infect: Infectious Diseases; Neurol: Neurology; Non-Specific 
(symptoms); Opthal:Opthalmology; Musculo: Musculoskeletal; Resp: Repiratory. 
 
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
100 
Percentage of dat abase 
Disease category 
Fig.3.2 Percentage of each review database accounted for by disease category  
Total  
(N=1620) 
Arif - in - house  
(N=491) 
C - EBLM  
(N=401) 
Medion  
(N=664) 
DARE  
(N=383) 
HTA   
(N=333) 
 129 
 
3.5.4.2 Review purpose 
 
Table 3.3 and figure 3.4 illustrate that most test evaluation reviews were concerned solely 
with the estimation of test accuracy (46%-81% across databases; 85% of all citations). 
Relatively few test evaluation reviews were concerned with evaluation of effectiveness or 
costs alone, or were solely methodological in approach. The HTA database contained the 
highest proportion of test evaluation reviews concerned with cost-effectiveness (36%). 
Sixteen percent, 12% and 11% of test evaluation reviews contained in the C-EBLM, Medion 
and the HTA databases respectively were concerned with effectiveness. The ARIF database 
contained the highest proportion of methodological reviews (24%). The proportion of reviews 
for which the purpose was unclear was high (16-64% across five databases and 38% overall) 
and it is unclear what impact the accurate coding of this subset would have on the 
distribution of review purpose across databases. 
Table 3.3: Content of review databases according to review purpose 
Review 
purpose 
HTA  
(N=333) 
DARE 
(N=383) 
Medion 
(N=664) 
C-EBLM 
(N=401) 
ARIF 
(N=491) 
Total 
(N=1620) 
Test Accuracy 
(1 Test) 
29 
(9%) 
142 
(37%) 
267 
(40%) 
94 
(23%) 
121 
(25%) 
653 
(40%) 
Test Accuracy  
(>1 test) 
17 
(5%) 
112 
(29%) 
271 
(41%) 
175 
(44%) 
143 
(29%) 
718 
(44%) 
Total  Test 
Accuracy 
46 
(14%) 
254 
(66%) 
538 
(81%) 
269 
(67%) 
264 
(54%) 
1371 
(85%) 
Effectiveness 11 
(3%) 
13 
(3%) 
81 
(12%) 
65 
(16%) 
14 
(3%) 
184 
(11%) 
Costs 4 
(1%) 
1 
(0%) 
3 
(0.5%) 
4 
(1%) 
3 
(1%) 
15 
(1%) 
Cost-
Effectiveness 
36 
(11%) 
6 
(2%) 
35 
(5%) 
30 
(7%) 
21 
(4%) 
128 
(8%) 
Methodological 2 
(0.6%) 
0 
(0%) 
8 
(1%) 
4 
(1%) 
10 
(2%) 
24 
(1%) 
Other 18 
(5%) 
18 
(5%) 
70 
(11%) 
49 
(12%) 
32 
(7%) 
187 
(12%) 
Multiple  36 
(11%) 
15 
(4%) 
62 
(9%) 
33 
(8%) 
30 
(6%) 
176 
(11%) 
Unclear 213 
(64%) 
85 
(22%) 
104 
(16%) 
68 
(17%) 
142 
(29%) 
612 
(38%) 
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Notes to fig 3.4: TA: Test Accuracy; Effect: Effectiveness; C-E: Cost-Effectiveness; Method: Methodological review; Multiple: Review with multiple purposes   
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The classification scheme used to describe ‘review purpose’ did not discriminate between 
evaluations of tests at different stages of development. However it was evident from scrutiny 
of titles and abstracts that the C-EBLM database contained a larger proportion of reviews 
concerned with early test development, for example test accuracy employing a case control 
design. This was in contrast to other databases where the predominant type of test accuracy 
evaluation was conducted in a clinical setting, (screening, diagnosis, prognosis or disease 
monitoring). 
 
3.5.4.3 Clinical setting in which tests are applied 
 
Figure 3.5 illustrates that there was a striking preponderance of tests evaluated in secondary 
care and screening contexts across all databases. Overall only 4% of reviews evaluated 
tests for use in primary care (1%-6% across individual databases). Secondary care and 
screening would still dominate as research settings even if all of the reviews coded as 
‘unclear setting’ were in fact evaluations of tests in primary care.  
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Notes to Fig 3.5: OTC: Over The Counter; Com diag: Community diagnosis; Second diag: Diagnosis in secondary care; Multiple: Multiple settings explicitly 
specified; Unclear: Clinical setting unclear 
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3.5.5 Retrieving Test Accuracy Reviews from Review Databases 
Figure 3.6 and appendix 3.5 illustrate the yield of test accuracy reviews and the features of 
the five review databases at the time of conducting the research (2007) and at the time of 
writing (2011).  
With the exception of the IFCC’s C- EBLM database, which is no longer publically available, 
the number of test accuracy reviews has more than tripled in each database over the 
intervening 4 year period. In the absence of sensitive methodological search filters for use in 
general bibliographic databases for the location of studies of test accuracy, review 
repositories represent an efficient resource for researchers and decision makers. 
The ARIF database remains the most up-to-date of the four remaining review repositories 
included in this investigation and it is now publicly available 
(http://www.arif.bham.ac.uk/databases.shtml).  
The DARE and HTA databases continue to offer relatively sophisticated search and retrieval 
features but this is offset by the fact that test accuracy reviews are not tagged for public use 
as they are in the ARIF database. DARE is the only database to contain abstracts of reviews 
that have been quality-assessed, containing a summary of the review together with a critical 
commentary about its overall quality and as a result of this is a selective rather than a 
comprehensive resource. However quality assurance is likely to be an important feature for 
those undertaking methodological research. Medion is the longest established specialist 
database devoted solely to test accuracy reviews and has separate smaller databases 
devoted solely to reviews of genetic tests and methodology. However as at October 2011 no 
additions had been made to the Medion database since 2010. The IFCC’s C- EBLM 
database with its emphasis on laboratory based tests and contribution of a large number of 
unique references is no longer available.  
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Notes to Fig.3.6: The CEBLM database is no longer publically available therefore the estimate of test 
accuracy reviews has been left unchanged from 2007. Estimated number of test accuracy reviews at 
both time points is based on the performance of our pragmatic search filter in the HTA database and 
searches undertaken by hosts of the ARIF and DARE databases. All records contained in the 
MEDION database are claimed to be test accuracy reviews. In 2007 7% of records retrieved from the 
HTA database, 3% of references provided by the ARIF host and 1% of MEDION records were not 
reviews of test accuracy. 
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3.6 Strengths and Limitations: Epidemiological mapping of test 
accuracy review characteristics 
 
The use of pragmatic filters may have missed relevant citations in databases where the 
content was not solely concerned with testing, particularly for the DARE and HTA databases 
where reviews are not tagged according to type of review question. The impact of any 
omissions would be to underestimate the contribution of these databases in terms of yield in 
the analysis, although the possibility that a basic search would skew results towards 
identifying references with particular epidemiological characteristics cannot be ruled out. The 
pragmatic filter appears to have performed well in the HTA database although further 
research would be needed to verify its performance compared to other search strategies. 
The pragmatic filter did not perform so well in the DARE database and until access to tagged 
test evaluation reviews is made possible on the public interface of DARE, a more 
sophisticated search strategy than the one adopted here should probably be advocated. 
For pragmatic reasons epidemiological characteristics of reviews were coded based only on 
review title and where available review abstract. As a result errors in classification may have 
occurred and in particular reviews that were coded as having an unclear setting or review 
purpose may have altered the pattern of review characteristics described here. Further, the 
pattern of review characteristics may have changed in the intervening 4 year period since 
conducting the original searches. However in the absence of initiatives to selectively 
encourage test evaluation in relatively neglected topic areas this is not considered likely. 
The purpose of this research was to identify reviews concerned in whole or in part with test 
accuracy. It is likely that reviews concerned with any type of test evaluation would include the 
terms sensitivity, specificity or screening 82-84. However the search strategy may have missed 
reviews where the focus was on test costs, test effectiveness and test cost-effectiveness.   
The analysis did not include the NHS EED database or the CDSR database. CDSR does not 
claim to include systematic reviews of test accuracy studies although our search filter 
identified 16 hits from CDSR between 1996 and 2006 concerned with various aspects of 
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screening; it is likely that these reviews are primarily concerned with effectiveness and are 
unlikely to include a review devoted to accuracy alone.  Using our filter in NHS EED 
(http://nhscrd.york.ac.uk/; accessed 30-11-11) between 1996 and 2006 identified in excess of 
800 hits. Without further research it is not possible to comment on the relevance of the NHS 
EED citations or their content. However, as for CDSR, it is likely that the primary objective of 
the NHS EED citations will be assessment of costs and cost-effectiveness rather than a 
review devoted solely to test accuracy evaluation.  
 
3.7 Conclusions: Epidemiological mapping of test evaluation reviews  
Recent initiatives encouraging a more critical adoption of new tests and scrutiny of existing 
tests and testing pathways 95,96 suggest that test evaluation reviews represent a crucial 
contribution to the evidence base. There are an increasing number of test evaluation reviews 
and this research suggests that the majority of these are evaluations of test accuracy. Given 
the widely held concern that applying methodological search filters to capture test accuracy 
research does not provide adequate sensitivity for systematic review purposes, specialist 
review databases are an important resource for identifying relevant research. In addition 
review databases represent an efficient resource to support methodological research, 
although the unique characteristics of individual review databases and the fact that each 
database contributed unique references to the repository should be considered when making 
a choice about which resource or resources to use.  
Issues pertaining to the identification of primary test accuracy research 82,83,84 appear to be 
pertinent to identification of test accuracy reviews in general review repositories and the 
considerable ambiguity conveyed by review titles in this investigation also has implications 
for searching. Important characteristics across all review repositories include a 
predominance of evaluations of single tests rather than test comparisons and a 
predominance of reviews concerned with application of tests in secondary care or for 
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screening.  The paucity of research concerned with the application of tests in primary care 
and in community settings has recently been demonstrated to remain current 97. This 
imbalance needs to be considered, mindful of the fact that the majority of testing occurs in 
primary care and the consequences of test errors on the number of tests performed 
subsequently is likely to be greater in the early stages of the diagnostic workup. 
Resources such as bibliographic databases can change rapidly and so a watching brief is 
recommended.  At the time of conducting this research the first Cochrane Diagnostic Test 
Accuracy Review (DTAR) 98  was not published. In the intervening years, five full DTARs and 
33 protocols have been published in the Cochrane Database of Systematic Reviews (CDSR) 
(as at 30-09-11). However currently there is no method for ascertaining a full list of Cochrane 
DTARs from the Cochrane library website although a visual ‘diagnostic’ flag appears next to 
DTARs identified as a result of an author, title, abstract, text or keyword search. The 
existence of a Cochrane handbook for systematic reviews of diagnostic test accuracy 96 and 
training of Cochrane review groups by the Cochrane Diagnostic Test Working Group 
(http://srdta.cochrane.org/welcome; accessed 30-09-11) will encourage improved review 
methodology although the visibility of the group and its resources in the Cochrane Library 
(http://www.thecochranelibrary.com/view/0/index.html; accessed 03-10-11) is currently poor.  
Despite increasing numbers, systematic reviews of test evaluations currently represent a 
small proportion of all types of systematic review 39. This favours the timing of an initiative to 
develop an overarching repository of systematic reviews of test accuracy. Such a resource 
would be invaluable in a research field still relatively in its infancy.  An alternative, more 
pragmatic approach would be to encourage existing primary study and reviews database 
producers and publishers to tag studies concerned with the evaluation of tests. Indeed such 
an initiative led by the members of an expert group advising on the development of the 
Cochrane Diagnostic Test Accuracy register of primary studies has recently successfully 
submitted a proposal for a specific indexing term “diagnostic test accuracy study” to Elsevier, 
as publishers of EMBASE. The indexing term was prospectively introduced in December 
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2010 99 and the same advisory group are drafting a formal submission to the National Library 
of Medicine, as publishers of MEDLINE (personal communication).  
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Chapter 4: Methodological Review: An investigation of the extent to 
which clinical context shapes the conduct and reporting of 
systematic reviews of test accuracy 
4.1 Abstract 
Background 
Statistical and methodological issues have, until relatively recently, dominated the test 
accuracy research landscape. Consideration of clinical context, (the intended setting 
application and role of tests, the downstream consequences of test results and the use of 
test accuracy measures to convey contextual information) has only relatively recently 
received attention. Systematic reviews and meta-analyses of test accuracy are increasing in 
number and prominence as a resource for diagnostic decision making and offer the 
opportunity to mitigate some of the current limitations of primary studies. In particular, by 
considered framing of research questions and by enabling a comparative approach to test 
evaluation they offer the opportunity to improve the contextual fit of evidence. Consideration 
of test accuracy in the absence of contextual information may mislead when making 
recommendations about test use.  
Objectives 
To investigate the extent to which a representative sample of systematic reviews of test 
accuracy represent the clinical context in which index tests are to be used when formulating 
a review question, deciding on synthesis methods, reporting results and making 
recommendations. On the basis of results to provide recommendations for how the reporting 
of contextual aspects of systematic reviews of test accuracy could be improved. 
Methods 
Published and unpublished reviews were sought by interrogation of the DARE database, the 
Cochrane Database of Systematic Reviews, the database of systematic reviews hosted by 
the Aggressive Research Intelligence Facility, University of Birmingham, the UK NHS 
National Research Register and contact with the Cochrane Diagnostic Test Accuracy 
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Working group. A final random sample of 100 reviews was included from 271 reviews eligible 
on the basis of title and abstract.  
Results 
100 reviews representing 17 disease topic areas and including between 1 and 50 index tests 
were included. Scrutiny of included reviews reveals ill-defined objectives which are reflected 
in question formulation, review synthesis (including investigation of heterogeneity) and 
reporting of findings. The place of index tests within a testing pathway is mostly not 
articulated by consideration of test role, (add, replace, triage), healthcare setting, patient 
presentation, prior tests or current testing practice: Seventy six percent of reviews did not 
state the setting in which index test were to be used and only 24% of reviews detailed all of 
index test application, role and prior tests as part of question formulation. Reporting of study 
characteristics was poor: setting, participant presentation and age were documented by just 
over 50% of reviews whilst chronicity and severity of the target disorder were documented by 
less than 1/3 of reviews. Poor reporting of primary studies was cited as a reason for this poor 
reporting by between 1% and 8% of reviews (depending on characteristic). 
Conclusions 
The findings of this review have implications for the development of standards for reporting of 
test accuracy reviews. There appears to be no relationship between review quality and 
review reporting, consideration of applicability of included studies, or completeness of review 
question formulation. Assessment of the internal validity of systematic reviews according to 
existing guidance does not appear to be a good reflection of the degree to which review 
authors have considered the external validity of their findings. There is a need for the 
development of reporting guidelines specific to systematic reviews of test accuracy; this 
might be achieved by an annex to the existing PRISMA reporting guidelines. 
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4.2 Background 
Systematic reviews have the potential to offer efficient access to medical knowledge for 
practising clinicians and policy makers.  Although systematic reviews of test evaluations 
represent a small proportion of reviews overall (approximately 8%) 39, their number has 
increased substantially over the last decade 40-42. Systematic reviews of test accuracy are 
responsible for the majority of this increase and are likely to become an increasingly 
important source of test accuracy evidence (see chapter 3). 
 
4.2.1 Clinical context and test accuracy 
 
4.2.1.1 Heterogeneity  
 
A particular challenge associated with systematic reviews of test accuracy is a consequence 
of the fact that test accuracy is not a fixed property and is specific to the circumstances under 
which a test is being applied. Contextual variation is proposed to play a greater role in the 
estimation of test accuracy compared to the estimation of effectiveness. Contextual variables 
that are potential modifiers of test accuracy encompass: 
 Features of the population to be tested (population spectrum: for example age, sex, 
presence or absence of symptoms, disease severity, disease chronicity, prior tests). 
 Features of tests being evaluated: for example technical variation of the test itself, 
operating threshold,  the skill and experience of those operating and interpreting the 
test and the operating environment, for example laboratory or bedside.  
Variation in prevalence of the target disorder in study populations is often a proxy for 
variation in population spectrum as are variations in the intended test application (screening, 
diagnosis, prognosis, monitoring). In addition proposed test role (add to existing tests, 
replace existing tests or triage for further testing) will determine population spectrum, as test 
role determines at what point in a care pathway a test is being evaluated (prior tests that will 
have been performed) as well as identifying comparator tests that should be considered. The 
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use of healthcare setting as a measure of clinical context is likely to be fairly congruent with 
characteristics of index tests being evaluated but a crude measure of variation introduced as 
a result of population spectrum.  
 
4.2.1.2 The downstream consequences of test results 
 
 The application and role of tests is also an important determinant of the relative value placed 
on the two dimensions of test accuracy – the degree to which a positive test result increases 
the probability of the target disorder and the degree to which a negative test result decreases 
the probability of the target disorder 28. The absolute and relative value placed on erroneous 
test results (false negatives and false positives) will be contextually dependent. For example 
the ability of a test to decrease the probability of disease is usually relatively more important 
when tests are applied for screening purposes where test positives receive further testing 
providing the opportunity for false positives to be identified but test negatives receive no 
further testing. Similarly the ability of a test to decrease the probability of disease is usually 
relatively more important early on in the diagnostic work-up. It has been suggested that 
sensitivity and negative likelihood ratios (LR-) may be the more important dimension of test 
accuracy in generalist, primary care settings. General Practitioners, in their role as ‘gate-
keepers’ to secondary care, use tests to rule out serious disease, provide reassurance or 
adopt a safe watchful waiting approach rather than pursuing a precise positive diagnosis for 
conditions that have a high probability of being self-limiting 48,100. Conversely the importance 
of specificity and the positive likelihood ratio (LR+) increases when there are severe 
consequences attached to false positive test results, typically at later stages in the diagnostic 
process where the consequences of a positive test result may be stigmatising, (for example 
the diagnosis of sexually transmitted diseases) and may result in initiation of treatments that 
may be lifelong and/or toxic.  Added complexity is introduced as the two dimensions of test 
accuracy are affected to differing and largely unpredictable degrees by clinical context 101. 
The relationship between healthcare setting, pre-test probability and the utility of test 
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accuracy measures has also been highlighted 102; negative predictive values (NPVs) of 
comparable magnitude are likely to be of more use in generalist, lower pre-test probability 
settings compared to specialist, higher prevalence settings. Similarly positive predictive 
values (PPVs) of comparable magnitude will be of more use in specialist, higher pre test 
probability settings compared to generalist, lower pre-test probability settings. 
 
4.2.1.3 Translating test accuracy to test effectiveness 
 
Comparable estimates of test accuracy may have different policy implications in different 
clinical contexts according to those factors that are associated with the translation from test 
accuracy to test effectiveness (the impact of testing on patient outcomes): ease of access to 
tests, acceptability of tests to professionals and patients, training implications of introducing a 
new test, the availability of effective treatments, cost and the clinical and economic burden of 
the condition for which the test is to be used. Comparable or superior test accuracy does not 
equate with comparable or superior test effectiveness 91.  
 
4.2.1.4 Incorporating context in evaluations of test accuracy 
 
It is argued that the nature of contextual modification of test accuracy and the implications of 
this for the application of test accuracy estimates has to date been overlooked relative to 
addressing the complex statistical issues associated with meta-analysis of test accuracy 2. 
Indeed the challenges of identifying and synthesising test accuracy literature have dominated 
guidelines for systematic reviews and meta-analysis of test accuracy 5,36,40,103,104 until 
relatively recently 34,101. Research has demonstrated that lack of contextual information 
relevant to decision making represents an important barrier to use of evidence 30 and there 
has been a call for greater clarity about the intended application of tests for those attempting 
to use evidence about test accuracy and in particular when considering the potential impact 
of testing on patient management 105.  
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The potential to use particular properties of different test accuracy metrics to reinforce 
contextual considerations has also not received attention to date. Although the indiscriminate 
use of test accuracy metrics is suggested as a potential source of confusion 6,43, there has 
been no attempt to delineate single or combinations of metrics that might be more useful to 
convey information in specific testing contexts. For example a feature of the majority of 
existing summary measures of test accuracy such as sensitivity, specificity, predictive values 
(PVs), and the area under the curve (AUC), is that these metrics are explicit with respect to 
correct disease classification whilst test errors are communicated implicitly. The common 
practice of communicating test accuracy probabilistically may also mislead with respect to 
the consequences of test errors in different testing contexts: a test with a specificity of 90% 
and a false positive rate of 10% will result in ten times the number of false positives when 
pre-test probability is 1% compared to when pre-test probability is 10%. 
  
4.2.2 The potential contribution of systematic reviews for improving the 
contextual fit of test accuracy evidence 
  
 Although dependent on the quality of the primary evidence base, systematic reviews offer 
the opportunity to improve the contextual fit of test accuracy evidence by synthesising 
evidence according to the intended application and role of the test under evaluation, by 
investigation of contextually dependent modifiers of test accuracy and by highlighting 
deficiencies in the evidence base.  Question formulation is crucial to this process and 
dependent on consideration of the place of the index test in the testing pathway for the target 
disorder.  
 
4.2.3 Existing research 
A recent review of epidemiological characteristics of systematic reviews concluded that 
reporting of systematic reviews generally was inconsistent 39. Only a minority of the reviews 
were concerned with diagnosis or prognosis (23/300 (8%)) and findings were not presented 
 145 
 
separately for this subset. Although the poor reporting, quality and contextual fit of primary 
test accuracy studies have been well documented 2,3,34-38, the extent to which this is true of 
systematic reviews of test accuracy is unclear.  
Recent empirical research on the reporting of systematic reviews of test accuracy confined to 
the cancer literature 106 did conclude that reporting of reviews of test accuracy in the cancer 
literature was poor and in particular the clinical setting of studies was reported in only 17% of 
reviews and details of included patients in only 45% of reviews. Information on disease 
severity was reported in a minority of studies. However in addition to being limited by topic, 
this research did not attempt to address the extent to which contextual factors influenced 
review question formulation, analysis and interpretation or the degree to which inadequacies 
in primary test accuracy studies contribute to inadequacies in the conduct and reporting of 
systematic reviews of test accuracy. 
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4.3 Aims and Objectives 
Aims 
The aim of this review is to investigate the degree to which clinical context shapes the 
conduct and reporting of systematic reviews of test accuracy. Clinical context encompasses 
contextual variables that are potential modifiers of test accuracy, prevalence of the target 
disorder in study populations and the intended role and application of the test under 
evaluation including downstream consequences of test results. 
 
Objectives 
 Identify a sample of systematic reviews of the accuracy of tests applicable to the 
primary healthcare setting, representative in terms of quality and target disorder. 
 Assess the extent to which reviewer authors have considered clinical context at each 
stage of the review process: 
- formulation of review question (background, inclusion and exclusion) 
-synthesis, including investigation of heterogeneity (methods; results) 
-summarising and discussing results (results; discussion) 
-making recommendations (discussion; recommendations) 
 Assess the extent to which the quality and reporting of primary studies of test 
accuracy impact on the contextual fit of systematic reviews of test accuracy. 
 
4.4 Methods 
4.4.1 Search strategy 
Published reviews were sought by interrogation of the DARE (Database of Abstracts of 
Reviews of Effectiveness, Centre for Reviews and Dissemination, University of York) 107 
database, the Cochrane database of systematic reviews via the Cochrane library 2006   
Issue 3 108 and the database of systematic reviews hosted by the Aggressive Research 
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Intelligence Facility (‘ARIF’) at the University of Birmingham (West Midlands Commissioning 
Support Unit 2011 109. Searches were carried out in January 2007 and limited to the period 
1996-2006. Given the number of references likely to be retrieved and the difficulties caused 
by poor indexing of systematic reviews of tests already described, searches of DARE and the 
Cochrane database of systematic reviews were limited to MeSH index terms to make them 
as specific as possible. The text word ‘mass screening’ was added to the MeSH term 
‘Sensitivity and Specificity’ (exp) 93 in order to capture a variety of testing applications. The 
MeSH term ‘Diagnosis’ (exp) or text word ‘diagnostic’ greatly reduced the specificity of the 
searches and so these terms were not used. The ARIF database has been running since 
1996 and relies mainly on the weekly alerting services of ZETOC (British Library), Science 
Direct and PUBCrawler (PubMed). The ARIF database does not have a controlled 
vocabulary and was searched on the subset diagnosis (keyword) as well as the text word 
screening. (See chapter 3 and appendix 3.1 for further details of the search strategy). 
The rationale for the selection of these 3 databases followed an interrogation of 5 specialist 
review databases (see chapter 3) and is as follows: 
 Searching these specialist databases was an efficient way to achieve a 
representative sample of reviews of test accuracy. The search strategy was not 
designed to be comprehensive of all reviews of test accuracy. 
 DARE has a comprehensive strategy for identifying reviews. However inclusion in the 
database is dependent on reviews meeting 3 of a possible 4 criteria encompassing 
inclusion of primary studies following the PICO framework, an adequate search 
strategy, consideration of study quality and presentation of sufficient detail about 
included studies 107. The ARIF database has a less comprehensive capture strategy 
but does not restrict the type of reviews it contains, therefore ensuring a broader 
representation of reviews.  
 The Cochrane Database of systematic reviews was interrogated as although this is 
primarily a database of effectiveness reviews, a small number of reviews primarily 
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concerned with screening are contained in the database that might not be captured 
by searches of the other databases interrogated for this review. 
The Cochrane methods database was not considered an important source of test 
accuracy reviews at the time of searching. 
Unpublished reviews were sought by interrogating the National Research Register 
http://www.nrr.nhs.uk/search.htm  2006 issue 3 and by contacting the Cochrane 
Collaboration Diagnostic Test Accuracy Working Group. 
All searches stopped September 2006. 
 
4.4.2 Inclusion / Exclusion: 
To be included reviews had to be concerned in whole or in part with estimation of test 
accuracy. It was recognised that this strategy might miss reviews primarily concerned with 
the impact of tests on treatment effectiveness and cost-effectiveness.  
As methodological quality was not the focus of this review, reviews not adhering fully to 
accepted systematic review methods were not excluded but documentation of key aspects of 
methodological quality were noted. Nine items taken from those used in the AMSTAR 
checklist 110 and the original QUOROM checklist 111 (current at the time of undertaking this 
review), were used to score included reviews as it was hypothesised that quality may have 
an impact on review conduct. Reviews not using a recognised reference standard were not 
excluded; use of a recognised reference standard is not always possible or appropriate 
under certain clinical circumstances and is not a pre-requisite for consideration of the clinical 
context in which a test is to be used. 
Generalist settings represent an important part of the diagnostic work up process where the 
cumulative volume of test errors and in particular their contribution to further testing will be 
substantial. A mapping exercise of the epidemiology of existing systematic reviews of test 
accuracy suggested a paucity of test evaluations in the primary care setting, (Chp. 3) 112. The 
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practicalities of recruiting sufficient numbers of eligible participants from a broad spectrum of 
patients 113,114, access to reference standard tests and the necessity for multiple reference 
standards are possible explanations for this under-representation. In addition patients 
presenting in primary care are at the beginning of a diagnostic work-up with a greater range 
of differential diagnoses and testing is often symptom rather than target disease based. By 
contrast, testing in secondary care is characterised by a narrower disease spectrum following 
a referral process and the emphasis is on deriving a definitive diagnosis, often relying on a 
smaller repertoire of tests. In order to capture as diverse a spectrum of disease and test type 
as possible and to ensure that specific challenges associated with evaluation of tests in 
generalist settings were represented, reviews were only included if they were concerned with 
the evaluation of tests that were considered accessible (directly, without the need for 
consultation with a specialist) to primary care professionals. Few (if any) tests that can be 
accessed by primary care professionals are not also available in secondary care settings.   
Papers were initially screened on the basis of title alone to determine whether they included 
a review of test accuracy. Potentially relevant reviews were categorised, on the basis of the 
clinical experience of the author, according to whether the test under evaluation could be 
applied: 
 in the primary care setting or available to the primary care physician via 
referral but where the primary care physician would normally be responsible 
for any changes in patient management following a test result (included) 
 in the secondary care setting only (excluded) 
 for screening as part of national screening programmes. It was considered 
that the contextual considerations associated with tests at this stage of 
evaluation would have been well rehearsed as part of the criteria for 
evaluating screening programmes (National Screening Committee 2009)115 
(excluded) 
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 in non medical settings such as dentistry (excluded) 
 for screening in the primary care setting outside of a UK national screening 
programme (for example alcohol abuse) (included) 
In some instances it was not clear where the main responsibility for performing and 
interpreting a test lay. In such instances a decision to include was based on the probability 
that primary care professionals were likely to take responsibility in some testing situations. 
Whilst recognising that this categorisation would exclude some tests where primary care 
physicians may be requested by patients to perform and / or interpret test results the process 
was pragmatic and designed to provide an unambiguous and representative rather than 
comprehensive sample of reviews of test accuracy relevant to the primary care setting. 
Reviews were further categorised according to the target disorder being tested for. Appendix 
4.1 illustrates the pro-forma used to ensure consistency of inclusion decisions. 
A random 150 reviews were initially sampled from the 271 included on the basis of title and 
abstract, with the aim of achieving a final sample of 100 reviews. Depending on the number 
of exclusions at full text stage further random samples were to be taken until a minimum 100 
reviews had been included.  
After obtaining full copies, reviews not concerned in whole or part with estimation of test 
accuracy or with tests that directly accessible to primary care professionals were excluded. 
Exclusion decisions at full copy stage were performed in duplicate. 
 
4.4.3 Data extraction 
Data extraction was undertaken using a pre-piloted electronic ACCESS data extraction form 
by a single reviewer.  Information was collected on the index test(s), reference standard(s) 
used, number of included studies, search strategy, and whether testing context was 
considered at each point in the review methods (question formulation; inclusion and 
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exclusion process; data synthesis including investigation of heterogeneity; presentation of 
results; discussion and recommendations).  
If publications referred to additional electronic files or previous publications these were 
consulted for information on review conduct. However, with the exception of determining 
whether a clinician was included on a review team, contact with authors was not considered 
appropriate as this could have introduced bias given the subjective nature of much of the 
data being extracted.  
 
4.4.4 Synthesis 
Synthesis was narrative. Findings were discussed under the following headings: 
demographic details of included reviews; question formulation; reporting of study 
characteristics; outcome reporting; contextualisation of review findings (including 
investigation of heterogeneity). 
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4.5 Results  
Fig 4.1: Study Flow 
 
 
* Notes to fig 4.1: This includes modelling studies where systematic searches performed to populate 
the model identified a systematic review which was used to estimate test accuracy; modelling studies 
where a single study was chosen to populate the model on the basis of quality or relevance; modelling 
studies where searches used to populate the model were not systematic. 
 
Hits: 1215 
Duplicates: n=303 
Reviews not concerned with 
testing: n=119 
Test reviews not concerned with 
test accuracy: n=63 
Reviews not concerned with 
testing applicable to the 1y 
care setting: n=448 Methodological reviews: n=7 
Included test accuracy reviews after 
consideration abstract: n=271 
Reviews not concerned with 
1y care after obtaining full 
copy: n=1 
Systematic reviews not 
concerned with test accuracy 
after obtaining full copy n=16 
Included primary care diagnostic reviews 
after consideration full text: n=100 
 
Not systematic reviews: n=4 
Not systematic reviews after 
obtaining full copy: n=13* 
Author conflict of interest: n=1 
Abstract only: n=1 Required translation: n=2 
Random selection of reviews n=150 
121+16: n=137 
reviews eligible on 
abstract, full copy 
not considered  
Full text not 
considered: 
n=16 
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4.5.1 Study Flow 
Figure 4.1 documents the volume of literature encountered at successive stages of the 
inclusion process. No relevant research was identified from the National Research Register 
and the Cochrane Collaboration Diagnostic Test Methods group did not provide any 
unpublished accuracy reviews for consideration. A total of 18 potentially relevant reviews 
were identified in the Cochrane database of Systematic Reviews, 522 from the DARE 
database and 675 from the ARIF database. 
 
4.5.2 Characteristics of included reviews   
For characteristics of included studies tabulated by review see appendix 4.2. 
 
4.5.2.1 Authorship, date, type and place of publication of included reviews 
 
The date of publication of the 100 reviews spanned 1990 to 2006; 23% of reviews before 
2000 and 73% on or after 2000. Eleven reviews were undertaken as part of a health 
technology assessment. The majority of reviews (43/100) were conducted in the USA, 23 in 
the UK, 12 in the Netherlands and eight in the rest of Europe, six in Australia, four in Canada, 
two in Peru and one each in Columbia and China. A clinician was not represented in the 
author contact details of one included review and in a further seven reviews it was unclear 
whether a clinician contributed. In all remaining reviews (94/100) there was representation 
from at least one clinician. 
 
4.5.2.2 Disease topic areas covered by included reviews 
 
A total of 16 disease topic areas were represented (see figure 4.2). The distribution of 
disease topic areas differs from that observed in a concurrent sample of reviews compiled 
without the ‘accessible to primary care professionals’ restriction applied to selection (3.5.4.1). 
The greatest difference observed in this selected sample of reviews is the markedly fewer 
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number of reviews concerned with obstetrics and gynaecology; a finding that might be 
expected. In addition relatively fewer reviews in the sample selected for this methodological 
review were concerned with infectious disease and a relatively greater proportion with 
musculoskeletal disorders.  
 
 
 
 
4.5.2.3 Healthcare setting represented by included reviews 
 
Despite an attempt to include reviews of tests directly accessible to primary care, only a 
minority of reviews (20/100) were explicitly concerned in whole or part with evaluation of the 
clinical history and examination (TAR2; TAR5; TAR9; TAR11-TAR13; TAR16; TAR25; TAR29; TAR38; TAR47; TAR49; TAR50; 
TAR55; TAR61; TAR75; TAR77; TAR79; TAR85; TAR89; TAR93). In addition only five reviews were conducted from 
the perspective of evaluating the utility of symptoms and signs for a variety of target 
disorders (TAR5; TAR38; TAR47; TAR55; TAR93). Two reviews successfully approached this task by 
restricting consideration of target disorders to those representing important rule out 
diagnoses for low back pain in generalist settings (vertebral cancer, spinal infections, 
inflammatory spondyloarthropathies, compression fractures, herniated discs and spinal 
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stenosis (TAR38; TAR93) and restricting inclusion to primary studies concerned with only one of 
these target disorders. However three reviews were compromised by inclusion of primary 
studies that failed to follow up negative test results or where positive test results were not 
confirmed by a reference standard due to the possibility of multiple target disorders (TAR5; 
TAR47; TAR55). These three reviews reported the (true positive (TP) + false positive (FP)) / all 
tested (termed diagnostic yield or detection rate) as an outcome when it was not possible to 
derive test accuracy. Two further reviews using this outcome measure (TAR24; TAR34) did so 
alongside test accuracy in the context of discussing the consequences of positive test results 
(see also 4.5.5.3).  
 
4.5.2.4 Index tests and number of included primary studies 
 
 Between one and 50 index tests were evaluated by a single review (median 3) (see figure 
4.3). In five reviews the number of included studies was not stated and the number of studies 
included was unclear in a further two reviews. In 22 reviews the number of participants was 
not stated. The number of included studies reported by 93 reviews ranged from 0 to 213 
(median 24; inter-quartile range 13-47) (see figure 4.4) and the total number of included 
participants reported by 78 reviews ranged from 0 to 211369 (median 5620; inter-quartile 
range 2328-15020).   
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4.5.2.5 Quality of included reviews 
 
Quality of included reviews was assessed using nine criteria taken from QUOROM 111  and 
AMSTAR 110 checklists (see figure 4.5 below) which were current at the time the research 
was conducted. The quality score assigned to the reviews ranged from the 0-9/9 (median 
4.6; inter-quartile range 3 to 6). 
 
Fig 4.5 Quality of included reviews 
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4.5.3 Quality of Question Formulation  
For quality of question formulation tabulated by included review see appendix 4.3  
In the majority of reviews judgements about the clarity of question formulation were based on 
information from both background and methods sections. Figure 4.6 summarises the level of 
detail included in included reviews as part of question formulation. 
 
 
 
 
4.5.3.1 Test application 
 
A total of 86 reviews included detail about index test application. Fifty nine of 100 reviews 
stated they were evaluating tests to be used in the diagnosis of a target disorder or 
disorders, 16 for screening and one for prognosis. In eight reviews more than one application 
was stated and it was mostly unclear whether this represented lack of clarity about the 
intended application of the test or inconsistent use of terminology. For example the concepts 
of diagnosis and prognosis overlap, particularly when reference standards are applied distant 
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to index test diagnosis as part of clinical follow up. In six reviews the intended application of 
the test was not specified. 
 
4.5.3.2 Test role 
 
Assessment of test role was mostly based on implicit information provided in the review and 
was not explicitly addressed by review authors. Fifty seven of 100 reviews included detail 
about index test role; 26 reviews were concerned with evaluating a test as a replacement, 21 
evaluating a test as an addition, eight evaluating a test for triage and in two reviews multiple 
included index tests had different roles.  
In 35/100 reviews the intended role of the test was unclear and in 8/100 reviews was not 
specified. In over half of reviews where test role was not clearly detailed, information about 
tests usually performed prior to the index test was also unclear or not specified (25/43). 
Although lack of clarity of test role may be part of a review question, this was not clearly 
articulated for any of the included reviews at question formulation stage.  
 
4.5.3.3 Prior tests 
 
In 39 reviews prior tests were clearly detailed as part of question formulation. Twenty four of 
100 included reviews did not specify tests usually performed prior to the index test and in 
37/100 reviews other tests used in the diagnostic work up of a condition were mentioned but 
the testing pathway was unclear. 
  
4.5.3.4 Setting 
 
The proposed setting in which an index test is to be used is a crucial and basic element of 
question formulation as even within healthcare settings other patient and test characteristics 
can vary considerably. Setting was the least well articulated component of review questions. 
Of the 24 reviews specifying settings 10 were to be used in primary care, two in secondary 
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care, three in the community and in nine reviews more than one setting was specified. 
Twenty nine of 100 reviews did not specify a setting and in 47/100 reviews the proposed 
setting was unclear.  
 
4.5.3.5 Spectrum 
 
As healthcare setting can conceal important variation in spectrum, review inclusion criteria 
were also interrogated for specification of more detailed spectrum characteristics. Twenty 
five of 100 reviews specified chronicity as part of inclusion criteria, 49/100 the presence or 
absence of symptoms, 48/100 age, 19/100 target disorder severity and 25/100 presence or 
absence of co-morbidity. No reviews specified a prevalence range as part of inclusion criteria 
which may reflect lack of clarity concerning setting, an appreciation of the range of 
prevalence rates typically encountered in primary test accuracy studies, or the limitations of 
prevalence as a measure of spectrum (see 4.5.4 below). 
 
4.5.3.6 Inclusion of key components of question formulation: test application; test 
role and prior tests 
 
In summary only 24/100 reviews clearly specified all of test application, test role and prior 
tests as part of question formulation; 26% of the 73 reviews published on or after 2000 (TAR2; 
TAR3; TAR9-TAR11; TAR15; TAR21; TAR23-TAR25; TAR32; TAR33; TAR52; TAR56; TAR60-TAR62; TAR65; TAR78) and 22% of the 
23 reviews published before 2000 (TAR5; TAR26; TAR35; TAR77; TAR93). 
 
4.5.4 Reporting of primary study characteristics  
For reporting of primary study characteristics tabulated by included review see appendix 4.4. 
One included review (TAR75) reported finding one poor quality relevant study for which no 
results were reported and therefore review reporting of study characteristics (4.5.4), use of 
outcome measures (4.5.5) and discussions concerning the contextualisation of review 
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synthesis and applicability of review findings (4.5.6) is based on a denominator of 99 test 
accuracy reviews. 
Figure 4.7 provides a summary of reporting of study characteristics either in tabular form or 
discussed in the text for the 99 reviews. Setting, participant presentation and age were 
documented by just over 50% of reviews. Chronicity and severity of the target disorder, 
participant co-morbidity and tests performed prior to the index test were documented by less 
than a third of reviews. Failure to document study characteristics due to limitations in 
reporting by primary studies was cited by a very small number of reviews (1-8 reviews per 
characteristic). 
 
 
 
Forty three of 99 reviews commented on the quality of reporting in primary, included studies. 
Five of 43 reviews commented that primary study reporting was moderate to good, one 
review commented that primary study reporting was variable and 37/43 reviews commented 
that primary study reporting was poor: 4/37 reviews did not give further details; 10/37 reviews 
commented on poor reporting of study methods; 22/37 commented on poor reporting of 
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aspects of spectrum; 12/37 reviews commented on poor reporting of index test details and 
5/37 reviews commented on poor reporting of reference standard details. 
Fifty four of 99 studies reported the healthcare setting of included studies and for the majority 
of these (38/54) more than one healthcare setting was included. Health care settings 
included population level application of tests, for example screening; tests administered by 
health professionals in the community (for example testing for sexually acquired infections); 
tests obtained over the counter (for example pregnancy testing); tests administered following 
contact with a primary healthcare professional and tests administered in secondary care 
settings. Figure 4.8 illustrates a breakdown of settings represented in these 54 reviews. 
Tests restricted to use in the community, primary care and ‘over the counter’ were 
represented by only 5/54 reviews and tests restricted to use at population level by 1/54 
reviews. Forty eight of 54 reviews reporting setting included secondary care populations. 
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Setting 
combination 
Example Study  
Populn and 2y Abdominal 
symptoms and 
gallstones 
(screening and 
diagnosis) 
Berger 
2000 
Comm and 1y Screening for type 
II diabetes 
Harris 
2003 
Comm and 2y Whispered voice 
test in the detection 
of  hearing 
impairment 
Pirozzo 
2003 
1y and 2y Assessment of 
shoulder pain 
Dinnes 
2003 
Comm and 1y 
and 2y 
Detection of 
domestic violence 
Ramsay 
2002 
Populn and 
comm and 2y 
Detection of 
dementia 
Peterson 
2001 
 
Fig 4.8: Settings Included in Test Accuracy Reviews 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to Fig 4.8: Populn: population; Comm: community; 1y: primary care; 2y: secondary care.  
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Prevalence of the target disorder varied widely across included studies, including the minority 
of reviews (6/55) including only one healthcare setting. The six reviews reporting prevalence 
within a single setting were restricted to secondary care and variation in prevalence of the 
target disorder across included studies ranged from 33% to 76% (TAR2; TAR14; TAR30; TAR33; TAR79; 
TAR96). This variation of prevalence, even in reviews restricting themselves to single settings, 
highlights the importance of detailing the characteristics of participants, as opposed to 
healthcare setting only, in order to convey the spectrum variation. 
 
4.5.4.1 Summary: reporting of primary study characteristics by review authors 
 
To some extent the importance of recording of individual study characteristics for an 
assessment of applicability of review findings will vary by review topic. However presentation 
(symptomatic, asymptomatic or both), healthcare setting and tests performed prior to the 
index test in included studies could be considered key characteristics. Only 9/99 reviews 
recorded all of these details (TAR9; TAR15; TAR22; TAR33; TAR40; TAR67; TAR73; TAR78; TAR94) and a further 
three reviews explicitly stated that poor reporting in primary studies prevented them from 
doing this (TAR18; TAR50; TAR76).   
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4.5.5 Use of outcome measures  
For use of outcome measures tabulated by included review see appendix 4.5. 
One of the 100 included reviews reported finding one poor quality relevant study for which no 
results were reported (TAR75). Use of outcome measures, reporting of study characteristics and 
contextualisation of review synthesis is therefore presented for 99 reviews. The frequency of 
use of individual outcome measures by the 99 reviews is illustrated in figure 4.9. 
Notes to Fig. 4.9: PPV: positive predictive value; NPV: negative predictive value; LR: likelihood ratio; 
TN: true negative; TP: true positive; FN: false negative; FP: false positive; DOR: diagnostic odds ratio; 
ROC: receiver operator characteristic; AUC: area under the curve 
 
4.5.5.1 Synthesis and use of outcome measures 
 
Just over half of the reviews with included studies (60/99) proceeded to meta-analysis. Only 
60/99 reviews included confidence intervals for some or all outcome measures. A minority of 
reviews, (3/99) compared tests using relative pooled accuracy measures: relative Diagnostic 
Odds ratio (rDOR) (TAR33; TAR59) or difference in pooled estimates of sensitivity and specificity 
(TAR48).  
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The majority of reviews (83%) reported sensitivity and specificity, followed by likelihood ratios 
(LRs) (35%), predictive values (PVs) (26%) and the summary Receiver Operator 
Characteristic (sROC) curve (25%). Outcome measures illustrating both dimensions of test 
accuracy (sensitivity and specificity, LRs, PVs, the constituents of the 2x2 table and sROC 
curves and plots) were preferred over global measures of test accuracy (Diagnostic Odds 
Ratio (DOR), Area Under the Curve (AUC), Q) although only 41/99 reviews explicitly 
distinguished between these two dimensions of accuracy for the intended application and 
role of index tests. A minority of reviews explicitly reported test errors (15%). Only 6% of 
reviews illustrated the change in disease probability pre to post index test result. 
A single dimension of test accuracy (a measure of the degree to which a positive test result 
increases disease probability or a measure of the degree to which a negative test result 
decreases disease probability) was reported on 17 occasions by 16 reviews. In five reviews 
concerned with screening or use of an index test in a triage role the reason for reporting a 
single dimension of accuracy (PPV in the absence of NPV and sensitivity in the absence of 
specificity) was due to some or all included studies provided information only on test 
positives (TAR24; TAR32; TAR67; TAR78; TAR81). 
 
4.5.5.2 Consideration of the downstream consequences of test results 
 
Less than half of reviews made an attempt to link test accuracy to clinical decision making. 
Only 41/ 99 reviews with included studies made a clear distinction between the ability of a 
test to increase the probability (rule in) the condition being tested for and the ability of a test 
to decrease the probability (rule out) the condition being tested for. Forty four of 99 reviews 
discussed the consequences of test results, (some or all of true positives, false positives, 
true negatives, false negatives). Where the reason for not distinguishing between the two 
dimensions of accuracy was due to limitations in primary studies (5 reviews), this was either  
where  tests were being used in a screening context and index test negatives were not 
verified (TAR24), where the reference standard was invasive and test negatives were not 
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verified (TAR78) or where a test was being used to detect multiple underlying target disorders, 
requiring multiple reference standards to comprehensively verify index  test results (TAR5; TAR55; 
TAR47).   
 In three reviews authors clearly articulated a preference for one or other dimension of 
accuracy. For example LR- alone was reported by one review, (combined use of d-dimer 
testing and estimation of clinical probability in the diagnosis of deep vein thrombosis) (TAR21), 
and sensitivity alone (TAR24) or false negative (FN) rate alone (TAR4) were reported by two 
reviews concerned with screening, where the ability to rule out the target disorder was clearly 
articulated as the more important dimension of test accuracy. LR+ alone was reported by one 
review, (a meta-analysis of the performance characteristics of the free prostate-specific 
antigen test) (TAR45) where review authors commented that false positives (FP) are the more 
important test error. 
In one review, (a meta-analysis of the papanicolaou smear and wet mount for the diagnosis 
of vaginal trichomoniasis) authors illustrated variation in PPV with prevalence to discuss 
when further testing with wet mount following a positive papanicolaou smear might be 
considered appropriate (TAR99). 
In five reviews (TAR44; TAR51; TAR55; TAR58; TAR73) it was unclear why a single dimension of accuracy 
was reported when data were available to derive both dimensions 
 
4.5.5.3 Less common outcome measures used by review authors 
 
Seventeen reviews used a total of seven outcomes ‘other’ than those specified in figure 4.9 
and these are detailed in table 4.10.  
Six of the 17 reviews reporting outcome measures other than those in figure 4.9 were 
method comparison studies where both index and reference standard tests were on the 
same continuous scale (TAR3; TAR6; TAR34; TAR39; TAR53; TAR54). Three of these reviews (TAR53; TAR34; 
TAR3) reported the limits of agreement 116 in addition to correlation coefficients as provided in 
primary studies. In one review concerned with early test development, a statistical 
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comparison of mean index test scores in diseased and non-diseased individuals was 
reported in addition to correlation coefficients between index and reference tests (TAR54). Two 
reviews (TAR6; TAR39) expressed accuracy in terms of the standardised mean difference 
between index test results in diseased and non diseased individuals, also termed the 
effectiveness score 117. The effectiveness score is a simple re-expression of the DOR. 
In addition to test accuracy, two reviews provided detail on inter and intra-observer variability 
(TAR53; TAR54).  
Table 4.10: ‘Other’ outcome measures used by a total of 17 reviews 
Outcome measure Review Topic 
Correlation coefficients Ambulatory blood pressure monitoring and blood pressure self-
management in the diagnosis and management of hypertension (TAR3)  
A review of near patient testing in primary care (TAR34) 
Reliability of reporting left ventricular systolic dysfunction by 
echocardiography: a systematic review of 3 methods (TAR53) 
Application of surface electromyography in the assessment of low back 
pain (TAR54) 
Limits of agreement 
(Altman 1991)116 
Reliability of reporting left ventricular systolic dysfunction by 
echocardiography: a systematic review of 3 methods (TAR53) 
Ambulatory blood pressure monitoring and blood pressure self-
management in the diagnosis and management of hypertension (TAR3) 
A review of near patient testing in primary care (TAR34) 
Effectiveness score 
(standardised mean 
difference) (Hasselblad 
1995)117 
Diagnostic efficacy of home pregnancy test kits (TAR6)  
Methods of Screening for Dementia: A meta-analysis of studies 
comparing an informant questionnaire with a brief cognitive test (TAR39) 
Average, unweighted 
sensitivity and specificity 
Evidence for the Diagnosis and Treatment of Acute Uncomplicated 
Sinusitis in Children (TAR37)  
Meta-analysis of exercise testing to detect coronary artery disease in 
women (TAR42) 
Inter and Intra observer 
variability 
Reliability of reporting left ventricular systolic dysfunction by 
echocardiography: a systematic review of 3 methods (TAR53)  
Application of surface electromyography in the assessment of low back 
pain (TAR54) 
(TP+FP)÷ all tested 
(termed detection rate; 
yield) 
TP÷ all tested (termed test 
positive rate) 
Antenatal screening for postnatal depression: a systematic review (TAR4)  
Systematic review of the school entry medical examination (TAR5) 
WHO Systematic Review of Screening Tests for Pre-Eclampsia (TAR14) 
Exercise tolerance testing to screen for coronary heart disease (TAR24) 
A review of near patient testing in primary care (TAR34) 
Diagnosing syncope: Value of history, physical examination and 
electrocardiography (TAR47) 
A comprehensive Evidence-Based approach to fever of unknown origin 
(TAR55) 
Screening for depression in adults( TAR67) 
Should health professionals screen women for domestic violence? 
Systematic review (TAR70) 
Diagnosis, management and screening of early, localised prostate 
cancer (TAR83) 
Notes to Table 4.10: TP: true positives; FP: false positives. 
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Where tests were being used to detect multiple target disorders the outcome measure used 
was diagnostic yield which was variably defined: “true positives ÷ all tested” where 
verification of all test positives was possible or “(true positives (TP) + false positives (FP)) ÷ 
all tested” where verification of all test positives was not possible. Seven of these reviews  
were concerned with screening tests where test negatives did not receive verification (TAR4; 
TAR5; TAR14; TAR24; TAR67; TAR70; TAR83) and four were reviews concerned with tests for multiple 
underlying disorders that would require multiple reference standards in order to 
comprehensively verify test positives (TAR5; TAR34; TAR47; TAR55). 
 
4.5.5.4 Number of outcome measures used by review authors 
 
The number of outcome measures reported by the 99 reviews with included studies is 
illustrated in figure 4.11. 
 
Notes to Fig 4.11: Sensitivity and specificity reported together considered one outcome. Similarly LR+ 
and LR-; PPV and NPV; FN, FP, TN, TP. 
 
 
The majority of reviews reported between two and three outcomes although a substantial 
minority (26/99) reported four or five outcomes. Three reviews reported a total of six 
outcomes (TAR34; TAR60; TAR98) although one of these reviews was evaluating a large number of 
10
31
29
19
7
3
0
5
10
15
20
25
30
35
1 2 3 4 5 >5
Nu
m
be
r o
f r
ev
ie
w
s
Number of outcomes
Fig 4.11: Number of outcomes reported by included 
reviews
 170 
 
index tests and review authors commented on the lack of comparable outcomes across 
included studies (TAR34). 
 
4.5.6 Contextualisation of review synthesis and consideration of applicability 
of review findings  
 
 
For details of contextualisation of review synthesis and consideration of applicability of 
findings tabulated by included review see appendix 4.6 
 
4.5.6.1 Contextualisation of review synthesis 
 
Contextualisation of review findings encompasses consideration of the proposed application, 
role and intended setting in which index tests are to be used when planning the analysis 
strategy including investigation of heterogeneity. For example the proposed application of a 
test will affect which dimension of test accuracy is more important and therefore choice of 
outcome measures, the intended role of a test will determine the type of synthesis that is 
undertaken (for example whether a comparative evaluation of accuracy is required) and the 
intended setting in which a test is to be used should guide any investigation of heterogeneity.  
 
Figure 4.12 illustrates the percentage of reviews that contextualised findings by defining test 
application, defining test role, discussing the applicability of review findings and considering 
the downstream consequences of test results.  
Index test application 
 
At the point of synthesis of review findings the proposed application of the index test had 
been defined by 95/99 reviews, in two reviews the proposed test application was unclear 
(TAR85; TAR36) whilst the objectives of three reviews included determination of the optimal 
application based on index test properties (TAR45; TAR66; TAR69). 
 171 
 
Of the 95 reviews defining test application 74/95 included diagnosis, 32/95 included 
screening, 7/95 included prognosis and 3/95 included monitoring. Eighteen of 95 reviews 
stated more than one potential application and of these, 12/18 distinguished between 
different applications in the review synthesis. In seven reviews where the application of the 
test was not specified at formulation stage the application was clarified as part of the review 
synthesis (TAR39; TAR45; TAR54; TAR66; TAR69; TAR76; TAR77). 
 
 
 
 
Index test role  
In 15 reviews where the role of the test was not specified or unclear at formulation stage the 
role was clarified as part of the review synthesis (TAR18; TAR20; TAR27; TAR47; TAR58; TAR66; TAR68; TAR69; 
TAR71; TAR72; TAR79; TAR81; TAR84; TAR90; TAR94). 
Seventy two reviews had defined test role at the point of review synthesis. Twenty eight 
reviews were concerned with evaluation of tests as replacements to existing tests, 30 /99 
reviews with evaluation of index tests as a potential addition to testing practice, 9/99 reviews 
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with evaluation of index tests in a triage role and 3/99 reviews with multiple concurrent roles.  
In 3/99 reviews test role was explicitly stated as a review objective (TAR45; TAR79; TAR97) although 
this had not been clearly articulated at question formulation stage (see 4.5.3). One review 
was clearly concerned with early test evaluation (TAR54).  
In 23/99 reviews the proposed role of the index test was unclear. 
 
Test comparisons (see figure 4.13) 
A total of 64 reviews (both reviews that had defined test role and those who had not) 
undertook a comparison of tests (comparison of two index tests or replacement of current 
practice with the index test) or testing strategies (additive or triage roles). Of these 64 
reviews, 49 were restricted to indirect comparisons, 13 undertook indirect and direct 
comparisons and two were restricted to direct comparisons (see figure 4.13). It was not clear 
the extent to which the comparative approach adopted by reviews (direct or indirect) 
reflected the study design of included primary studies. Despite the absence of methods for 
pooling direct comparisons without access to individual patient data, direct comparisons are 
still considered more valid as they reduce the effects of study level confounding by 
population spectrum. 
Twenty four of 64 reviews undertaking comparisons presented confidence intervals to assist 
with interpretation, although few reviews explicitly used these when discussing results and 
6/64 reported the results of significance testing (TAR2; TAR31; TAR48; TAR52; TAR80; TAR82).  
Ten of the 30 reviews concerned with the addition of the index test to existing testing strategy 
assessed incremental accuracy. Eight of ten reviews did this by means of indirect 
comparisons of primary studies evaluating the accuracy of existing tests and primary studies 
evaluating the accuracy of the index test in addition to existing tests (TAR18; TAR25; TAR42; TAR47; 
TAR62; TAR90; TAR93; TAR98). One review assessing incremental accuracy undertook Bayesian 
updating of the accuracy of existing tests with the addition of the index test (TAR51) and one 
review used both an indirect comparative and Bayesian updating approach (TAR40).  
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Fig 4.13: Test Role: Flow of Studies  
 
 
 
 
 
 
Investigation of heterogeneity 
Sixty seven of 99 reviews with included studies considered the potential effects of 
heterogeneity on test accuracy. Studies adopted one or more of five approaches: restricting 
inclusion, sub-grouping findings, meta-regression, illustrating the effect of prevalence on 
post-test probability or discussing effects narratively with the aid of graphics such as Forest 
plots and sROC space plots. The majority of reviews investigating heterogeneity used sub-
grouping of studies (37/67) of which 31/37 stated a priori potential modifiers of heterogeneity. 
Twenty of 67 reviews used meta-regression, all of which stated a priori potential modifiers of 
heterogeneity to be investigated. Nineteen of 67 reviews illustrated the effects of variation of 
prevalence on post-test probability, 14/67 reviews restricted themselves to a narrative 
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discussion of studies grouped according to characteristics and 5/67 reviews restricted 
inclusion criteria as a means of achieving a homogeneous sample. 
All reviews undertaking an investigation of heterogeneity (67/99) investigated the effects of 
spectrum variables or prevalence, 48% investigated the effects of index test variation 
(including threshold) and 38% study quality. In only two reviews the quality or reporting of 
primary studies was stated as a limitation to the accommodation of spectrum or prevalence 
as part of the review synthesis (TAR12; TAR16).  
 
4.5.6.2 Assessment of applicability of review findings 
 
Sixty nine of the 99 reviews with included studies considered whether characteristics of 
included studies were applicable to a specified testing context. Fifty six of the 69 reviews 
considered the applicability of the spectrum of the tested population whilst applicability of 
threshold and / or technical aspects of the operation and interpretation of index tests was 
considered by 35/69. The applicability of the prevalence of the target disorder in included 
studies was considered by 17/69 reviews and the applicability of the healthcare system in 
included studies by 4/69 reviews. 
 
4.6 Strengths and limitations: Methodological review 
Much of the assessment of included reviews relied on subjective interpretation and the 
clinical and methodological experience of the person extracting data may have resulted in an 
overoptimistic representation. For example it was common for information to be available in 
reviews to form a judgement in the absence of explicit discussion by review authors. In 
addition a broad framework for assessing the degree to which review authors had considered 
contextual factors when conducting and reporting reviews was generous and may not be 
optimal for the topic of any single review. 
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A potential limitation of this review is that it may not be a current reflection of the conduct and 
reporting of systematic reviews of test accuracy; searches for the review stopped in 
September 2006. However guidance pertinent to the contextualisation of test accuracy 
review questions has been limited to date and largely limited to recent initiatives within the 
Cochrane Collaboration including the publication of the Cochrane Handbook for Diagnostic 
Test Accuracy Reviews 96. The Cochrane handbook remains incomplete as at 2011. 
Chapters pertinent to question formulation and contextualisation of review findings include 
Chapter 4: Guide to the content of a Cochrane review and protocol for diagnostic test 
accuracy: published 2009; Chapter 6: Developing criteria for including studies: published 
2008; Chapter 8: Selecting studies and collecting data: not published at the time of writing; 
Chapter 11: Interpretation of results: not published at the time of writing. 
http://srdta.cochrane.org/handbook-dta-reviews. Personal experience of training within the 
Collaboration suggests that review authors, including clinicians, find question formulation in 
this area difficult. 
Other guidance that may have impacted on those aspects of test accuracy review conduct 
relating to contextualisation between 2006 and the time of writing include the development of 
the first version of the QUADAS instrument for the quality assessment of primary studies to 
be included in reviews and the STARD initiative concerned with reporting of primary studies 
of test accuracy. The original QUADAS item was developed in 2003 118 and the impact of this 
tool might be only partially captured by the reviews included in this investigation (see 4.7.1.2 
below). However the first version of QUADAS is primarily concerned with assessment of 
internal validity and a criticism of the original instrument is that it does not make a clear 
distinction between internal validity and external validity. It is therefore unlikely that QUADAS 
will have encouraged review authors to consider the applicability of the test accuracy 
evidence available to them. The STARD initiative, culminating in a checklist for the reporting 
of primary studies of test accuracy 38 aims to improve accuracy and completeness of 
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reporting of internal and external validity. The checklist includes items concerned with 
population spectrum (setting, presenting symptoms, target condition severity, co-morbidity, 
prior tests received) and technical specification of test execution (including threshold and 
expertise of the test operator). The STARD checklist may have influenced whether and how 
review authors considered applicability, both indirectly as a result of improvements in 
reporting of primary studies and directly by raising awareness of the components of an 
assessment of external validity for test accuracy research in the research community.  
However an evaluation of the impact of STARD on reporting of diagnostic accuracy studies 
up to 2005 reported no observable difference at that  time 119 In addition a recent 
methodological review 97 observed a demonstrable uptake of the QUADAS instrument only 
three years after its publication in 2003. It is therefore unlikely that the initiatives outlined 
above will have had a significant impact on the conduct and reporting of test accuracy 
reviews after completion of searches (2006). Indeed marked variation in uptake of 
methodological developments for conducting test accuracy reviews of between three and 10 
years has been observed 97. This variation is suggested to be due to variation in the level of 
complexity and technical barriers to uptake of developments; thus it might be expected that 
three years is an ambitious lag time for appropriate contextualisation of review questions, 
review methods and reporting of outcomes, particularly in the light of the personal experience 
of the author in training authors of test accuracy reviews.  
 
4.7 Discussion 
4.7.1 Applicability of findings to reviews of test accuracy 
 
4.7.1.1 Setting 
 
This review sampled three databases including one with no restriction on inclusion (the ARIF 
database) in an attempt to compile a representative sample of test accuracy reviews. In 
addition the selective inclusion of tests that could be applied in the primary care setting was 
 177 
 
an attempt to mitigate against the preponderance of test accuracy reviews concerned with 
the secondary care setting 97,112. 
Setting was only reported by 54% of reviews and it is therefore difficult to ascertain whether 
the review sampling strategy was successful. However tests restricted to use in the 
community, primary care and ‘over the counter’ were represented by only a minority of 
reviews, (5/54 reviews reporting setting), whilst 48/54 reviews included secondary care 
populations. A mix of settings was reported for 38/54 reviews and it is possible that the 
sampling strategy resulted in greater heterogeneity rather than a greater number of reviews 
restricted to generalist settings.  
Potential barriers to the evaluation of tests in generalist settings include enrolment of 
sufficient participants when pre-test probability is low, the ability to access reference 
standards in the primary care setting and the position of primary care early in the diagnostic 
work up, where the value of tests lies in their ability to identify and distinguish between 
multiple potential target disorders with an emphasis on ruling out serious conditions. 
Challenges associated with the simultaneous evaluation of test accuracy for multiple target 
disorders include the necessity for multiple reference standards which magnifies the problem 
of access to reference standards in primary care and the practicality of following up index 
test negatives with potentially invasive further testing early on in the diagnostic work-up 
where pre-test probability is low. 
The ability of this methodological review to identify barriers to evaluating tests in primary care 
was limited by included reviews, of which only a minority were concerned with generalist 
settings, with the evaluation of history and examination or with the evaluation of the utility of 
tests for multiple potential target disorders. Reviews that attempted to evaluate the accuracy 
of a test for detection of multiple disorders using the traditional test accuracy evaluation 
framework were successful if they restricted inclusion of individual primary studies to those 
evaluating only one of a multiplicity of target disorders and therefore a requirement for a 
single reference standard. This restriction is likely to increase heterogeneity and atypical 
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presentations in the review sample therefore reducing applicability but without it reviews 
were limited to reporting the number of test positives generated which provides no 
information on false positives or the ability of a test to rule out potentially serious disease; the 
emphasis in primary care settings (TTA8). There is currently no guidance applicable to the 
evaluation of test accuracy for multiple target disorders simultaneously. This is likely to be a 
reflection of the nature of medical knowledge, which tends to be organised according to 
disease rather than individual signs and symptoms; a framework which may be better suited 
to specialist rather than generalist, primary care settings 49 (see 1.4) and may be an 
important factor contributing to the under-representation of test accuracy evaluations in 
primary care and of the clinical history and examination.   
 
4.7.1.2  Quality of included reviews 
 
The median quality score of included reviews was 4.6/9 with 46% of reviews scoring less 
than 4/9 and 21% of reviews scoring greater than 6/9. A review of 189 diagnostic test 
accuracy reviews in the Database of Abstracts of Reviews of Effectiveness (DARE) database 
up to 2002 by Dinnes 7 demonstrated that 48% of included reviews searched more than one 
database (MEDLINE) and  69% undertook quality assessment. In this review 43% of reviews 
searched more than one database and 78% undertook quality assessment. The DARE 
database only contains reviews meeting a minimum quality standard 107 and the expectation 
would therefore be that the Dinnes’ 2002 review would contain a larger proportion of higher 
quality reviews. The greater number of reviews undertaking quality assessment in this review 
is likely to be a reflection of the publication of the QUADAS quality assessment tool in 2003, 
after completion of searches in the Dinnes’ review. This is supported by the findings of a 
recent methodological review that demonstrated widespread uptake of the QUADAS tool 
approximately 3 years after its publication 97. 
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4.7.2 Adequacy of question formulation 
The clarity of question formulation was generally poor. Only 24% of included reviews detailed 
all of index test application, role and prior tests as part of question formulation. In addition 
51% of reviews did not distinguish symptomatic from asymptomatic presentation, 75% 
reviews did not specify details about each of chronicity or severity of the target disorder and 
co-morbidities. Reviews evaluated between one and 50 index tests (median 3) and 76% of 
reviews did not state the setting in which index tests were to be used. The inclusion of 
multiple settings and multiple tests in test accuracy reviews has been noted in other work 97. 
Possible explanations for the observed inadequacy in question formulation are the limitations 
imposed on review reporting by publication in journals. However this hypothesis was not 
supported by improvements in clarity as reviews progressed and only a minority of reviews 
explicitly acknowledged that lack of clarity was to be addressed as a review objective. 
Clarity of review question formulation did not appear to change over the time period covered 
by this review.   
 
4.7.3 Contextualisation of review findings  
Reporting of study characteristics was poor in this sample of reviews with no study 
characteristic being clearly reported by more than 54/99 reviews. Reporting of primary study 
characteristics is particularly important to assist decision makers with the applicability of 
review findings given the considerable potential for heterogeneity in evaluations of test 
accuracy. In addition inadequacies at question formulation stage that result in broad inclusion 
criteria are magnified if details of primary studies are not reported. Even when question 
formulation is adequate there are circumstances when inclusion criteria need to be modified 
in the light of literature searches. For example in this sample of reviews only 9 reviews 
specified more than one testing setting at question formulation stage and at least 38 included 
more than one setting. Failure to document study characteristics due to limitations in 
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reporting by primary studies was cited by a very small number of reviews (one to eight 
reviews per characteristic). Given the poor quality of review question formulation it appears 
that inadequacies in reporting review findings may be as much a reflection of poor review 
methodology as limitations in primary study quality and reporting.  
 
4.7.3.1 Index test role and application 
 
Although the majority of reviews articulated the proposed application of index tests, in one 
quarter of included reviews the proposed role of the index test was unclear. Accommodation 
of test role at synthesis stage was variable with limited use of basic statistical techniques (for 
example use of confidence intervals) to assess the uncertainty associated with any observed 
difference for test comparisons (30 of 64 reviews undertaking comparisons). Further only one 
third of reviews evaluating tests in an additive role attempted to quantify incremental 
accuracy. This is additional evidence to suggest that the observed inadequacies in question 
formulation and reporting of study characteristics reflect a deficiency in methodological 
approach rather than poor reporting of methods (see 4.7.2; 4.7.3).  
 
4.7.3.2 Spectrum  
 
Only 9/99 reviews reporting all of population presentation, healthcare setting and tests 
performed prior to the index test.  
Between one half and two thirds of reviews did not report each of setting, details of patient 
spectrum and prevalence. Only 22% of reviews commented that spectrum was poorly 
reported by primary studies and less than 10% stated that poor reporting in primary studies 
was a review limitation. This finding suggests any inadequacies in primary studies may be 
exacerbated by a lack of appreciation of spectrum effects by review authors. Similarly one 
third of included reviews did not consider whether the characteristics of included studies 
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were applicable to a target testing context. This again suggests inadequacies in question 
formulation rather than poor reporting of methods.  
 
4.7.3.3 Investigation of heterogeneity 
 
The potential to investigate and accommodate heterogeneity has existed for some time and 
certainly over the time period represented by this review. The definition of investigation of 
heterogeneity adopted by this review was broad and extended to sub-grouping graphically or 
narratively in the absence of statistical tests. Using this broad definition only 68% of reviews 
explored one or more of the potential modifying effects of spectrum, index test variation and 
methodological quality of included studies. By contrast, using a stricter definition of 
exploration of heterogeneity, an earlier methodological review sampling the quality assured 
DARE database demonstrated that 83% of reviews explored heterogeneity potentially 
introduced by clinical, test or study quality variables 7. The discrepancy between the two 
reviews may be a reflection of differences in the quality of included reviews, although this is 
not obviously apparent from the limited information available for comparison (see 4.7.1.2 
above).  
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4.7.3.4 Use of outcome measures 
 
The results of two reviews conducted in the DARE database in 2000 (Honest 2002 6)  and 
2002 (Dinnes 2005 7) are compared to the findings of this review in table 4.14: 
Table 4.14: Comparison of outcome measures used in systematic reviews of test 
accuracy, 2000 (Honest 20026); 2002 (Dinnes 20057); 2006. 
Outcome 
measure 
DARE 2000  
(Honest 20026) (N=90) 
DARE 2002 
(Dinnes 20057)  
(N=189) 
This Review 2006 
  
(N=189) 
 Meta-
Analysis 
60 (67%) 
Narrative 
 
30 (33%) 
Meta-
Analysis 
133 (70%) 
Narrative 
56 (30%) 
Meta-
Analysis 
60 (61%) 
Narrative 
 
39 (39%) 
ROC curve 44% NR 64 (48%) NR 24(40%) 5 (13%) 
Sensitivity and 
specificity 
58% NR 117 (88%) NR 33 (55%) 28 (72%) 
Predictive values 18% NR 11 (8%) NR 9** (15%) 14 (36%) 
Likelihood ratios 22% NR 26 (20%) NR 20 (33%) 11 (28%) 
DOR 8% NR 14 (11%) NR 13 (22%) 0 (0%) 
Effectiveness 
score  
NR NR 8 (6%) NR 2 (3%) 0 (0%) 
‘Q’ NR NR 18 (14%) NR 4 (7%) 0 (0%) 
Test accuracy NR NR 5 (4%) NR 0% 3 (8%) 
AUC NR NR 13 (10%) NR 11 (18%) 1 (3%) 
Pre-post-test 
probability 
NR NR NR NR 5 (8%) 0% 
Comparative 
measures 
(Relative or 
absolute) 
NR NR NR NR 3 (5%) 0% 
Test errors NR NR NR NR 2† (3%) 14 (36%) 
TP, TN, FP, FN NR NR NR NR 0% 10 (26%) 
Notes to table 4.14: 
TP: true positives; TN: true negatives; FP: false positives; FN: false negatives; ROC: Receiver 
Operator Characteristic; DOR: Diagnostic Odds Ratio; AUC: Area Under the Curve. 
* One included review did not report outcomes 
**One review derived PVs from sROC average sensitivity and specificity 
† Both reviews derived test errors from ‘Q’ 
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The proportion of reviews proceeding to meta-analysis is greater in earlier reviews (67% and 
70%) compared to this review (61%). This discrepancy may have been expected if the 
sampling strategy of this review (to include tests that were available to generalists) had the 
effect of increasing the mix of settings of included studies and therefore heterogeneity in 
included reviews. However investigation of heterogeneity in this review was also less than 
earlier reviews (see section 4.7.3.3 above).  
Sensitivity and specificity remain the most commonly used outcome measures although the 
frequency of their use in meta-analyses is variable. Use of ROC curves in meta-analyses 
appears comparable across the time period covered by the three reviews whilst the use of 
LRs, AUC and the DOR in meta-analysis has increased. However the increase in the use of 
the DOR is less marked if considered in combination with the effectiveness score, which is a 
simple re-expression of this metric. The use of Q has decreased between 2002 and 2006. 
Predictive values are suggested to be the most intuitive summary measure of test accuracy 
(see Chapter 2). The use of PVs in meta-analysis is markedly less than sensitivity and 
specificity, less than the use of LRs and between 2002 and 2006 less than the DOR. The 
variation of PVs with prevalence, and the impact this has on heterogeneity, may be deterring 
review authors, particularly if combined with a lack of appreciation that prevalence to some 
extent is a proxy for spectrum and therefore affects all test accuracy measures (see chapter 
2). Derivation of PVs from average sensitivity and specificity was used by two reviews in this 
review. The validity of direct derivation of pooled PVs has only recently been explored 86 and 
has the potential to impact on the use of this metric in the future.  
It is interesting to note that the use of test errors in narrative reviews is comparable to PVs 
and LRs although the extent to which this is driven by primary study reporting is unclear. 
 
More than half of reviews reported more than three outcomes. Although there may be a need 
to use and report complimentary outcome measures, (for example global measures may be 
used to compare tests and pre to post test probability to illustrate the potential diagnostic 
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impact of testing),  this was rarely explicitly articulated by review authors and mostly the 
rationale for choice of outcome measures was unclear. There is currently no guidance that 
attempts to link the setting, test application and test role with synthesis approach and choice 
of outcome measures. Such guidance would encourage reporting of outcomes that highlight 
unique contextual considerations pertinent to individual test evaluations and would therefore 
ensure a better contextual fit of the test accuracy evidence base. 
 
4.7.3.5 The downstream consequences of test results 
 
The use of outcome measures should be linked to decision making. Although summary 
measures distinguishing between the two dimensions of accuracy were more frequently used 
than global measures, less than half of included reviews made an attempt to link test 
accuracy to decision making by differentiating between the two dimensions. In addition less 
than half of reviews explicitly acknowledged the downstream consequences of test results as 
a means to discuss the implications of false positives and false negatives.  
In the existing research environment, which is characterised by a paucity of RCTs of test and 
treat combinations 90 it becomes all the more important to consider the downstream 
consequences of test results on patient outcomes when reporting test accuracy evaluations. 
 
4.7.4 Implications for the conduct and reporting of test accuracy reviews 
Systematic reviews offer the opportunity to formulate a focused question, identify primary 
studies of relevance to that question and synthesise a volume of evidence according to the 
intended application and role of the test under evaluation. This is particularly important where 
primary research is characterised by ill defined objectives in relation to the application and 
role of an index test or tests and without consideration of the potential variation in spectrum 
in the population to be tested. Indeed it is claimed that the potential contribution of systematic 
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reviews to the test accuracy evidence base is compromised by the quality and reporting of 
primary studies (see section 1.3). 
A recent review of meta-analyses of diagnostic or predictive tests by the Agency for Health 
Care Research and Quality 120 suggested that over the period 1996 and 2009 substantial 
improvements in literature review methods, quality assessment and statistical analysis 
methods employed have taken place. The authors note that improvements in quality 
assessment are associated with the use of quality item checklists which concurs with the 
findings of this methodological review (4.7.1.2). 
However this review suggests that currently, systematic reviews and meta-analyses of test 
accuracy are characterised by ill defined objectives which is reflected in review synthesis and 
reporting of review findings. Key pieces of information that may help determine the relevance 
of the review to readers are absent or not highlighted sufficiently in the review abstract or 
review objectives.  
Inadequate question formulation underpinned by a lack of appreciation of spectrum effects 
on estimates of test accuracy appears the most probable explanation for this finding which 
will exacerbate any inadequacies in primary studies. Inadequacies in question formulation 
raise the issue as to the degree to which synthesis is data led rather than addressing 
questions of most clinical importance. Lack of clarity at the question formulation stage 
precludes judgement about the rationale for the review, the proposed role of the index test in 
a care pathway and therefore the utility of the information provided by the review findings.  
It has been suggested that failure to investigate heterogeneity and wide variation in methods 
used 7 may be a reflection of the complexity and continuing development of methods for 
undertaking meta-analyses of diagnostic tests. However a lack of recognition of the degree 
to which test performance varies with clinical context and inadequacies in question 
formulation may be additional explanations. Question formulation and structuring the review 
process, including a priori statement of variables to be investigated as potential sources of 
heterogeneity should be complementary processes. Against a complex and developing 
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methodological framework, refining a review question as far as possible to ensure the 
provision of clinically relevant and focused information becomes increasingly important.  
It is proposed that engaging stakeholders, including the end users of the findings from test 
accuracy evaluations, will help to ensure appropriate and focused test accuracy review 
objectives 120. However between 94% and 99% of included reviews included a clinician as 
co-author. A possible explanation for this observation may be the use of clinical 
methodologists rather than clinical topic experts on review teams. However the personal 
experience of those undertaking training for Cochrane review groups and authors suggests 
that even clinical topic experts have difficulty formulating test accuracy review questions, 
particularly contextualising the role of index tests in testing pathways.   
Figures 4.15 to 4.17 (see also appendix 4.7), illustrate the relationship between the quality of 
included reviews, as measured by nine quality items taken from the original QUORUM 111 
and AMSTAR 110 checklists and each of completeness of review question formulation (as 
evidenced by explicit mention of one or more of the index test application, index test role and 
any tests performed prior to the index test), completeness of review reporting of study 
characteristics (as evidenced by reporting of one or more of tests received prior to the index 
test, patient presentation (symptomatic or asymptomatic), prevalence of the target disorder 
and quality of included studies) and consideration of applicability of review findings (as 
evidenced by discussion of one or more of spectrum, prevalence and index test 
characteristics of the included studies). These measures were chosen from the more 
comprehensive assessment used in this review as measures that might be considered key to 
test accuracy reviews, regardless of review topic (see 4.5.3; 4.5.4; 4.5.6). There appears to 
be no relationship between the quality of included reviews and review reporting, 
consideration of applicability of included studies, or completeness of review question 
formulation. Assessment of the internal validity of systematic reviews according to existing 
guidance does not appear to be a good reflection of the degree to which review authors have 
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considered the external validity of their findings. It is therefore likely that inadequacies in test 
accuracy question formulation at the current time are due to the developmental stage of test 
accuracy evaluation methodology, limited dissemination of methods to review authors and a 
lack of reporting guidelines specific to systematic reviews of test accuracy. 
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Figs 4.15-4.17 
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Chapter 5: Survey of understanding and application of test 
accuracy measures  
5.1 Abstract 
Background 
 Increase in test use over recent decades has occurred despite disappointing results from 
test accuracy evaluations. Difficulties with understanding and application of test accuracy 
information are purported to be important contributors to this observed evidence ‘gap’. 
Empirical research to date is based on the premise that formal probability revision is a 
necessary pre-requisite for informed diagnostic decision making and is characterised by self 
selected samples with recent experience or expertise in test evaluation. The survey aimed to 
describe how clinicians apply existing test accuracy metrics for diagnostic decision making. 
Methods 
An incentivised, electronic survey was used. Informed application of test accuracy 
information was evaluated by asking respondents to indicate their management decision 
following presentation of nine different representations of the same test accuracy information 
to a common hypothetical scenario. Quantitative and qualitative synthesis was employed 
based on closed an open responses to management decisions. 
Results 
204 General Practitioners (response rate 95%) did not appear to be self selected on the 
basis of academic position, involvement in policy or experience in test evaluation. 
Sensitivity and specificity, the annotated 2x2 diagnostic table and predictive values were 
reported to be familiar metrics by the most respondents. Likelihood ratios the DOR and AUC 
were familiar to less than 1/3 of respondents. Application of test accuracy metrics resulted in 
marked variation in responses to both positive and negative test results although greater 
inconsistency and management uncertainty was observed following presentation of a 
negative test result in comparison to a positive test result. Formal probability revision was not 
 190 
 
a feature of the diagnostic decision making process. Test errors (false negatives and false 
positives) were prominent as part of the translational pathway from quantitative summary 
estimates of test accuracy to management decisions. Summary measures that separate the 
two dimensions of test accuracy in the absence of prevalence information (for example 
sensitivity and specificity) appeared to result in a misplaced emphasis in one or other of false 
positive or false negative test errors. Presenting test accuracy data using the 2x2 diagnostic 
table or a pictograph attenuated this effect. 
Conclusion 
Choice of test accuracy metric appears to have a profound effect on diagnostic decision 
making. Understanding, contextual factors and motivational biases are likely to be 
contributing factors to the observed variability. It is unclear to what extent any advantage of 
test accuracy metric for informed decision making is based on familiarity as opposed to their 
intuitive nature. Simultaneous illustration of both dimensions of test accuracy in order to 
facilitate informed diagnostic decision making requires further exploration.  
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5.2 Survey rational and aims  
The rationale for undertaking primary research was to begin to address gaps in the existing 
literature about how clinicians use test accuracy information and to refine emerging 
hypotheses about characteristics of test accuracy metrics that facilitate their application. The 
target audience, content and distribution methods of the final survey reflect the findings from 
the literature reviews (chapter 2), mapping the epidemiological characteristics of existing test 
accuracy reviews (chapter 3) and a pilot electronic survey, distributed using NHS e-mail 
accounts, to general practitioners in the Birmingham and Black Country (BBC) region of the 
UK in 2009.  The pilot survey was assessed by the National Research Ethics Service as a 
service evaluation and therefore did not require NHS ethical review. The survey did receive 
Research & Development approval from each of the seven Primary Care Trusts (PCTs) 
initially sampled.  
 
5.3 Survey Aims and Objectives 
 
Aims 
The aims of the survey were to describe how a representative sample of primary care 
clinicians use sources of test accuracy information and to evaluate whether and how existing 
test accuracy metrics are understood and applied. 
Objectives 
 To identify which sources of test accuracy information are used by primary care 
clinicians and facilitators and barriers to their use 
 To evaluate the utility of existing test accuracy metrics as measured by self-reported 
familiarity with terminology, perceived ability to define or explain metrics and self-
reported use of metrics in clinical practice 
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 To investigate how a range of existing test accuracy metrics are applied to a 
hypothetical testing scenario and in particular whether there is consistency in the 
application of different metrics. 
 To evaluate the within-person relationship between perceived understanding of test 
accuracy metrics and their application in a hypothetical testing scenario. 
 
5.4 Survey Methods 
5.4.1 Sampling and questionnaire distribution 
The lack of familiarity of clinicians with the subject area was considered a major disincentive 
relative to other aspects of questionnaire design that influence response rate and are 
amenable to change. Most studies identified during the review of empirical test accuracy 
literature (see chapter 2) were undertaken on motivated, educated participants, often during 
educational events. A major aim of this survey was therefore to capture a representative 
sample of practicing clinicians. In addition, due to under-representation of primary care in the 
existing literature (see chapters 2, 3 and 4) and because involvement in the earlier stages of 
the diagnostic work up is likely to result in a more diverse experience of testing, a general 
practitioner (GP) sample was chosen in preference to a secondary care sample. 
As part of the initial BBC pilot survey, face to face methods of distribution were explored and 
abandoned on the basis that only educational events and GP tutor and trainers’ forums were 
identified. However subsequent electronic distribution of this initial pilot survey to 1600 GPs 
via NHS e-mail accounts resulted in <3% response rate, of which 49% of respondents had 
received training in relation to testing in the preceding three years. Reliance on PCT 
communication teams for distribution and competing demands on NHS e-mail accounts were 
identified as major problems with this dissemination method. For the final survey, an 
incentivised, electronic survey hosted by doctors.net.org; a professional network of ~200,000 
General Medical Council registered doctors with access to approximately 27 000 of 41 000 
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GPs across the UK  was chosen as the distribution method most likely to achieve a large and 
as representative a sample as possible. Doctors.net.org offer ‘electronic Surfing Rewards’ as 
an incentive to participate in research which can be exchanged for products and high street 
vouchers.  
 
5.4.2 Questionnaire content 
5.4.2.1 Questionnaire structure and presentation 
 
The risk communication literature suggested the lack of an observed association between 
preference and comprehension of risk measures was a result of heuristics applied to familiar 
presentation formats.  In the final questionnaire assessment of perceived understanding 
(familiarity with test accuracy terminology and confidence in defining or explaining test 
accuracy metrics and graphics) was therefore examined separately to an assessment of 
understanding as measured by application of test accuracy information to a hypothetical 
scenario. In order to minimize invalid responses and to mitigate against a poor response 
rate, skip logic was employed such that if a respondent indicated that they were not familiar 
with a test accuracy metric or graphic they were not required to answer questions concerning 
self-reported confidence in defining or explaining the metric or graphic, or self-reported use 
of the metric or graphic in practice. However respondents’ understanding as measured by 
application of test accuracy information provided to them in hypothetical scenarios was 
examined regardless of their stated familiarity with that metric or graphic. The rational for this 
approach was to allow investigation of whether the method of presentation of test accuracy 
information modifies management decisions following a test result, regardless of familiarity. 
Open comments were invited for all questions but in contrast to closed questions were not a 
requirement to proceed through the questionnaire.  
In order to investigate the degree to which use of test accuracy information by respondents 
was informed the questionnaire presented a hypothetical, unnamed, new triage test for 
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referral of women for investigation of ovarian cancer. The design of the scenarios was 
informed by the BBC pilot. An unnamed test was used following the observation in the pilot 
that use of a named test (CA125 as a triage test for referral for specialist investigation for 
ovarian cancer) resulted in respondents drawing on published commentaries and evidence 
summaries about the CA125 test for their management decisions, rather than the test 
accuracy information provided to them. 
In order to reduce context-specific ‘noise’ and potential framing effects other than those that 
might be associated with test accuracy presentation itself (for example framing effects may 
be introduced by presentation of test errors as opposed to correct test results) a neutrally 
framed scenario identical with the exception of the method of presentation of test accuracy, 
was used.  
 
5.4.2.2 Self-reported use of test accuracy information 
 
The extent to which clinicians seek and use quantitative estimates of test accuracy and pre-
test probability does not appear to have been addressed by existing literature (see chapter 
2). Open responses from the BBC pilot indicated that clinicians relied heavily on colleagues 
when making decisions about test use. The final questionnaire therefore included questions 
concerning frequency of use of a range of test accuracy information sources common to 
primary and secondary test accuracy research and potential barriers to their use.  
 
5.4.2.3 Assessment of familiarity and perceived understanding of test accuracy 
metrics and graphics 
 
The emphasis in the literature reviewed in chapter 2 was the ability of healthcare 
professionals to manipulate a limited range of test accuracy summary metrics for the purpose 
of probability revision. Test accuracy metrics more common to systematic reviews were 
neglected. This survey investigated the familiarity of respondents with test accuracy metrics 
common to primary test accuracy evaluations (sensitivity, specificity, predictive values (PVs), 
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likelihood ratios (LRs)) as well as those more common to systematic reviews (the Receiver 
Operator Characteristic (ROC) curve, the Area Under the Curve (AUC) and the Diagnostic 
Odds Ratio (DOR). 
 
5.4.2.4 Informed application of test accuracy information 
 
The majority of empirical research attempting to evaluate clinician understanding and 
application of test accuracy metrics (as distinct from familiarity with metrics) is characterised 
by a requirement for respondents to undertake formal probabilistic reasoning. This is unlikely 
to be representative of how test accuracy information is used in practice and may not be a 
necessary pre-requisite for the appropriate use of test accuracy information for decision 
making. Consistency of respondents’ management decisions following provision of test 
accuracy information and a test result (positive or negative), in combination with 
respondents’ open comments, were therefore used as a proxy for informed application of test 
accuracy metrics in this survey (see 5.5.5 below). Open responses from the initial pilot 
survey indicated that respondents were distinguishing between the ability of a test in two 
dimensions: detecting disease and ruling out disease. The final questionnaire was therefore 
designed to allow responses separately for each dimension of accuracy: ‘If the test came 
back positive would you refer for further investigation?’; ‘If the test came back negative would 
you be confident not to investigate further at this time?’  
Separation of test accuracy dimensions also allowed an assessment of any distinction made 
between false positive and false negative test errors and relative ease of application of 
negative and positive test results; the latter being an issue raised by the literature reviews 
(2.5.3.3; 2.9.3.3).  
Self reported variation in tolerance of test errors was evident in the BBC pilot, (tolerance of 
false negatives was reported to be markedly less in screening compared to diagnostic 
applications of tests and tolerance of test errors was less for tests used to diagnose more 
serious disease compared to less serious disease). In order to investigate the extent of 
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variation in test-treat thresholds across the sample elicitation of respondents’ tolerance of 
test errors for the testing context used in the scenarios was elicited after they had submitted 
responses to the hypothetical scenarios (see section 5.4.6 below). 
 
Test accuracy presentation formats evaluated in hypothetical scenarios  
The literature reviews presented in chapter 2 include few examples of direct comparisons of 
informed application of commonly used summary test accuracy metrics. The few existing 
direct comparisons have advantaged LRs over other metrics by the use of plain language 
explanations and there has been minimal evaluation of understanding of PVs despite them 
being promoted as more intuitive test accuracy metrics. The priority for this survey was 
therefore a comparison of the informed application of summary test accuracy metrics likely to 
be more familiar to practising healthcare professionals: sensitivity, specificity, LRs and PVs. 
In addition, an annotated 2x2 diagnostic contingency table was included as a natural 
frequency presentation format and sensitivity and specificity and PVs were presented using a 
normalized frequency presentation format in addition to their more conventional percentage 
probabilistic representation. The inclusion of frequentist representations of probabilistic 
information was included in recognition of the considerable body of evidence suggesting that 
these may be more accessible for probability revision (2.5.3.2). An additional consideration is 
that frequentist representations communicate test errors more explicitly than conventional 
test accuracy summary measures and use of test errors appeared a prominent aspect of 
diagnostic decision making in the BBC pilot survey. Finally, in response to the suggestion 
from the review of the risk communication literature that use of multiple presentation formats 
are preferred over the use of any single format alone, an annotated pictographic (numeric, 
verbal and graphic) representation of test accuracy was included.  
The target sample for this survey comprised practising healthcare professionals and the 
hypothetical scenarios required the application of test accuracy information for diagnostic 
decision making at the bedside. The expectation was that test accuracy metrics not 
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distinguishing between the two dimensions of test accuracy would not be helpful for decision 
making in this context. However the DOR was included in order to gain insight into 
respondents’ understanding of the properties of global test accuracy measures distinct from 
those metrics that allow estimation of  disease probability following a test result (positive or 
negative). 
A paper based version of the complete survey can be found in appendix 5.1 
 
5.4.3 Synthesis 
Survey results were collated in Microsoft Office Excel 2007. Synthesis was mostly 
descriptive. Chi squared tests for paired data were undertaken in STATA IC11.  
 
5.5 Results 
5.5.1 Description of survey participants 
A total of 222 UK GPs accessed the incentivised survey link via Doctors net. The survey 
distribution was designed to ensure responses were geographically representative. Seven 
respondents accessing the link met eligibility criteria but were excluded as they came from 
regions with sufficient representation; 11 respondents met eligibility criteria but of these three 
declined to participate once the survey topic area (test accuracy measures and their use in 
practice was revealed (see appendix 5.1) and eight respondents agreed to participate but did 
not complete the survey. Two hundred and four of 215 eligible participants (95%) completed 
the survey in full and the analysis is based on these 204 complete responses.  
Sixty four percent of respondents were male; 75% of respondents were in full time 
employment and the number of years since qualification in the specialty ranged from 0-41 
(median 14 years) see figure 5.1.  
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The distribution of work responsibilities across respondents is detailed in figure 5.2: 
 
 
 
Although respondents who are GP trainers, who hold academic positions or who are involved 
in policy development may have a greater familiarity with evaluation of test accuracy and test 
accuracy metrics, few respondents (11%) were in any of these positions. In addition only 
13% of respondents had undertaken training that included test accuracy interpretation in the 
last three years. 
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Figure 5.3 illustrates the geographical distribution of respondents. Stratified sampling was 
used by the survey host in order to reflect the geographical distribution of GPs across the 
UK. 
  
 200 
 
 
 
 
0
2
4
6
8
10
12
North East 
SHA
North West 
SHA
Yorkshire 
and 
Humber 
SHA
West 
Midlands 
SHA
East 
Midlands 
SHA
East of  
England 
SHA
South 
West SHA
South 
Central SH
South East 
Coast SH
London 
SHA
Scotland Wales Northern 
Ireland
%
 o
f r
es
po
nd
en
ts
 
Region
Fig 5.3: Region of work of Survey Respondents 
 201 
 
Some demographics of respondents to this survey can be compared with workforce surveys 
of UK GPs 121,122. Respondents to this survey were more likely to be male compared to the 
GP workforce (64% compared to 57% respectively). However there are fewer full time female 
GPs 121 and this may at least in part account for the lower percentage of female practitioners 
responding to the survey. Respondents to this survey appear to be younger compared to the 
UK GP workforce. Twenty two percent of GPs in the UK are older than 55 years in age 
compared to an estimated 12% of this survey sample 121 (see figure 5.4). However this 
comparison is limited by the fact that years spent practising in general practice and not age 
in years was recorded for survey respondents (see foot notes to figure 5.4). Using years 
spent in medical practice is likely to underestimate age in years of survey respondents as 
career breaks or variable periods of time spent practicing prior to gaining specialist 
certification in general practice will not have been accounted for. The discrepancy in age 
between survey respondents and the UK GP workforce is therefore likely to be less than that 
suggested by figure 5.4. 
 
Notes to Fig: 5.4: *Age of survey respondents was estimated from reported years specialising in 
General Practice: (years in general practice <5=<30 yrs; years in general practice 5-9 =30-34 years; 
years in general practice 10-14=35-39 yrs; years in general practice 15-19=40-44 yrs; years in general 
practice 20-24=45-49 yrs; years in general practice 25-29 =50-54 yrs; years in general practice 30-
34=55-59 yrs; years in general practice >35 = > 60 years)   
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5.5.2 Test accuracy information sources used by respondents 
 
 
 
Figure 5.5 illustrates how respondents stated they used different sources for information 
about test accuracy. Clinical experience was used as a source of test accuracy information 
by most respondents, (99 (49%)). Ninety three respondents (46%) considered that the 
laboratory normal range conveyed information about the accuracy of a test; this was 
elaborated on in free text responses:  
“Textbooks/research papers/guidelines are usually unhelpful as the ranges used in them are 
not always relevant to the tests performed at the local hospital lab. and (they) may even use 
different units esp(ecially) if (the)research or textbook (is) from (a) different country.” 
 
 “Usually not appropriate to look through textbooks or published articles for results - we have 
good relationship with our labs and departments and use their data for test accuracy 
information.” 
 
Clinical guidelines and colleagues were also frequently used as sources of test accuracy 
information whilst research papers were used least. One hundred and eighty eight of 204 
respondents, (92%) stated that they used other information sources, the majority of these, 
(76/188), used web-based resources. Specific sites mentioned by respondents were 
www.gpnotebook.co.uk ,  www.patient.co.uk,  Egton Medical Information Systems Ltd (EMIS) 
Mentor (www.emis-online.com/mentor-www.doctors.net.uk , the British Medical Journal, the 
British National Formulary (BNF), the Royal College of General Practitioners, BMJ clinical 
evidence, www.clinicalevidencebmj.com and NHS clinical knowledge summaries, 
www.cks.nhs.uk, (see appendix 5.2). On the basis of brief internet browsing of these online 
resources the diagnostic information provided is in the form of guidelines for assessing 
presenting complaints and managing healthcare conditions or in the form of evidence based 
summaries with an emphasis on the effectiveness of interventions in the absence of 
numerical test accuracy information. Some of these online resources do provide evidence 
“Please estimate how often you use the following test accuracy 
information sources as part of your clinical work” 
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based medicine training related to test evaluation, for example BMJ clinical evidence:  
http://clinicalevidence.bmj.com/ceweb/resources/EBMtraining.jsp   
Other information sources included direct contact to discuss results with the local laboratory 
(n=2), patient generated information (n=1), direct contact with specialists in secondary care 
(n=2), local protocols (n=1), the ‘general press’ (n=1), ‘GP magazines’ (n=1) and continuing 
professional development (n=3). 
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5.5.3 Barriers to use of information sources 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6 illustrates the perceived barriers to use of test accuracy information sources. 
 
 
 
 
 
Guidelines were perceived to present the least barriers to use with 164 (80%) of respondents 
suggesting there were no barriers to their use. Research papers were perceived to present 
the most barriers to their use. The most commonly suggested barrier to use of all resources 
was timeliness of access (53% to 66% of all barriers per source) followed by relevance of 
information (23% to 29% of all barriers per source). Ability to understand terminology used 
was suggested to account for 7% to 18% of all barriers per source with research papers 
prominent in this respect.  
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“Please indicate which statements apply to the following test accuracy information 
sources: Text books; Research papers; Guidelines; Manufacturers’ information: 
• I don’t know how to access the source 
• I can’t access the source at the time I need information 
• The source uses terminology I don’t understand 
• The source does not contain information relevant to my practice 
• None of the statements apply” 
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Free text responses revealed a mistrust of industry generated information: 
“Manufacturers information is sometimes hard to trust.” 
 
“Of manufacturers information: (it is) often skewed to make the drug look good.” 
 
“Accuracy is often dependant on the source and funding of the source.” 
 
The internet and guidelines were viewed positively with respect to timeliness and currency of 
information and textbooks negatively: 
“Time is often the greatest factor.” 
 
“No problem following guidelines/reading textbooks. Main problem is finding relevant 
guidelines when needed.” 
 
“Difficult to access original research in a timely manner.” 
 
“(I) use the internet the most as (it is) quick.” 
 
“Guidelines most easy to access.” 
 
“Text books - OK if I have a problem that I can look up in library/at home, not so good 
generally if I'm in surgery.” 
 
“Sometimes difficult to do a relevant search of research papers and would tend to look for 
'summary' of evidence.” 
 
“With guidelines I accept that they have clarified the test accuracy information source and 
rely on them - the same with text books.” 
 
“It is usually easier to access information via internet than rely on printed material which may 
not be up to date.” 
 
“Text books are becoming less useful as out of date quickly and can gain information via 
internet.” 
 
“Textbooks - often out of date.” 
 
 
Explanations as to why terminology was not understood included difficulty with the statistical 
aspects of test accuracy information: 
 “(Research papers) - I don't know if my knowledge of stats is good enough to use this 
source appropriately.” 
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5.5.4 Utility of test accuracy metrics for clinical decision making 
5.5.4.1 Familiarity with test accuracy metrics and graphics 
 
 
 
Figure 5.7 demonstrates the familiarity of survey respondents with test accuracy metrics and 
graphics. 
 
Notes to Fig 5.7: illustrative diagrams of the annotated 2x2 diagnostic contingency table and an 
example of a pictograph were provided for respondents 
 
Sensitivity and specificity, the annotated 2x2 diagnostic table and PVs were reported to be 
familiar metrics by the most respondents. Sixty nine percent of respondents had seen an 
annotated pictograph which does not reflect the use of this graphic to communicate test 
accuracy information in the research literature. It is likely that familiarity with the pictograph is 
associated with its use in the risk communication literature (5.5.4.4) and this is supported by 
open responses (see below). Only 26% of respondents indicated that they had heard of LRs.     
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Test accuracy metrics more commonly used in systematic reviews of test accuracy (DOR, 
AUC and ROC curves) were familiar to 32% of respondents or less; the relatively greater 
reported familiarity of the DOR is likely to represent confusion with the odds ratio (OR). 
  
5.5.4.2 Perceived ability to define or explain test accuracy metrics  
 
 
 
 
 
 
Figure 5.8 demonstrated the self-reported confidence of respondents in defining or 
explaining test accuracy metrics and graphics. 
 
 
 
Respondents’ reported confidence in defining metrics followed a similar pattern to reported 
familiarity. Of those respondents that had heard of a metric or graphic, sensitivity, specificity, 
the pictograph and the annotated 2x2 diagnostic table were those that respondents reported 
having most confidence in defining, followed by PVs (see table 5.9). There was little 
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discrepancy between respondents’ reported confidence in defining those metrics 
representing one or other of the two dimensions of test accuracy with slightly more (2%) of 
respondents who had heard of sensitivity and specificity reporting being very or moderately 
confident in defining specificity compared to sensitivity, (1%) more of respondents who had 
heard of the positive predictive value (PPV) and the negative predictive value (NPV) 
reporting being very or moderately confident in defining PPV compared to NPV and (2%) 
more of respondents who had heard of the positive likelihood ratio (LR+) and the negative 
likelihood ratio (LR-) reporting being very or moderately confident in defining LR+ compared 
to LR-. 
Table 5.9: Percentage of respondents who had heard of a test accuracy metric who 
reported being able to define that metric 
Metric / Graphic Number of 
respondents 
heard of 
metric  
% of respondents 
heard of metric 
reporting very or 
moderate confidence 
in defining 
Sensitivity 203 85% 
Specificity 200 87% 
Pictograph 141 79% 
 2X2 diagnostic table 156 78% 
Positive Predictive Value (PPV) 181 60% 
Negative Predictive Value (NPV) 181 59% 
Area Under the Curve (AUC) 18 44% 
Positive Likelihood Ratio (LR+) 50 38% 
Negative Likelihood Ratio (LR-) 50 36% 
Receiver Operator Characteristic Curve (ROC) 12 33% 
Diagnostic Odds Ratio (DOR) 65 29% 
 
Less than 50% of respondents who had heard of the AUC, LRs, the ROC and the DOR 
responded that they would be very or moderately confident in defining them. 
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5.5.4.3 Use of test accuracy metrics in practice 
 
 
 
 
 
 
Figure 5.10 illustrates which metrics and graphics respondents reported using in practice. 
 
 
 
As expected, reported use of metrics and graphics follows a similar pattern to respondents’ 
confidence in defining them, with the exception that PVs were reported to be used more than 
the diagnostic 2x2 table, despite a relatively greater proportion of respondents stating that 
they could explain the 2x2 table. A pattern across all metrics and graphics is that their 
reported use in practice is much less (approximately 1/3) the number of respondents’ stating 
they would be very or moderately confident in defining them. This observation may be a 
result of reporting patterns of metrics and graphics in the test accuracy literature or 
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• “Do you use sensitivity and specificity in clinical practice? (Yes / No)” 
• “Please comment on how you use the measure sensitivity in practice” 
• “Please comment on how you use the measure specificity in practice” 
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alternatively a reflection of differences in the utility of metrics and graphics specifically for 
diagnostic decision making. Problems with timely access to test accuracy information may 
also explain the observed discrepancy between familiarity and use across all metrics. 
 
5.5.4.4 Open responses concerning use of test accuracy metrics / graphics in 
practice 
 
 
Open responses concerning use of test accuracy metrics and graphics were received from 
between one (<1%) and 102 (50%) of respondents. 
 
Sensitivity and specificity (N=102 (50%)) 
Several respondents related their use of sensitivity and specificity to specific tests and this 
was mostly in the context of ruling out disease which is probably a reflection of the primary 
care sample (TTA8). 
Sensitivity/rule out: 
“The d-dimer test, high sensitivity so if negative I am happy the patient does not have a DVT 
(deep vein thrombosis).” 
 
“D-dimer sensitive but not very specific.”  
 
“In discussion with patients how reassuring a negative result - eg PSA (prostate specific 
antigen) will mean that the (patient) should not have a particular condition - eg prostate 
cancer.” 
 
“In explaining the usefulness of some screening tests to patients.” 
 
“We use it to explain test results to pts e.g. when explaining rheumatoid factor results.” 
 
“Eg when we use inflammatory markers, they are sensitive for inflammation but not specific.” 
 
 (Sensitivity)...“I think about it when ordering a test and when assessing the result eg PSA is 
a very sensitive test but it still misses some patients with prostate cancer and one has to 
remember that when deciding what to do with a particular patient...(Specificity) It is especially 
important that a test for a serious illness is very specific as otherwise you may treat someone 
with a potentially toxic agent unnecessarily. PSA test eg is not specific to prostate cancer 
and is raised in BPH (benign prostatic hypertrophy) and uti (urinary tract infection).”    
   
(Sensitivity)...“Urine dipstix etc”  
 
(Sensitivity)...”D-Dimer.”  
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(Sensitivity and Specificity)...“I don’t measure (them), but place more emphasis on more 
sensitive tests.” 
 
“I prefer tests to be sensitive in order to reduce false negatives and pick up the disease that I 
am looking for - sensitive tests give me peace of mind. I also prefer specific tests ie few false 
positives but I can live with them and work round them.” 
 
Specificity/rule in: 
 
“Explaining the pitfalls of a screening test eg PSA (prostate specific antigen) which may not 
be specific to prostate cancer.” 
 
“When want to diagnose specific medical condition like sle (systemic lupus erythematosus) 
etc.” 
 
 (Specificity)... “Screening eg faecal occult blood.” 
 
(Specificity)... “Troponin.” 
 
Several respondents used the open response option to define sensitivity and specificity 
without any indication of how the metrics were used in practice:  
“(Sensitivity)...The percentage of sick people who are correctly identified as having the 
condition...(Specificity)...The percentage of healthy people who are correctly identified as not 
having the condition.” 
 
“(Sensitivity)...The proportion of actual positives which are correctly identified...(Specificity)... 
The proportion of negatives which are correctly identified.” 
 
“(Sensitivity)...Reflects a tests being positive in the presence of disease true positive divided 
by true positive plus false negative...(Specificity)... Reflects the test being negative in 
absence of disease false negative divided by false negative plus true positive.” 
 
(Sensitivity)... “Tp/Tp+FN”...(Specificity) “TN/TN+FP” 
 
Some definitions of sensitivity and specificity offered by respondents were more closely 
linked to how the respondents applied them in practice: 
(Specificity)... “Deciding whether test will point towards one likely disease, or many possible 
diseases.” 
 
(Sensitivity)... “How accurate a test comes out positive when the patient is positive”... 
(Specificity)...”How accurate a test comes out negative when the patient is negative.” 
 
(Sensitivity)... “The likelihood of detecting the disease”...(Specificity)... “The likelihood of 
detecting other conditions.” 
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Several responses indicted that sensitivity and specificity were used when communicating 
with patients about tests: 
 “Sometimes use the term when discussing value of test with patient.” 
 
“Explaining to patients the limitations of a test. Deciding if and when to use a test.” 
 
“I explain the concepts to patients in order for them to understand that a test is rarely 
definitive.” 
 
Positive and negative predictive values PVs (N=36/204 (18%)) 
As with sensitivity and specificity, several respondents related their use of PVs to specific 
tests although the emphasis on ruling out disease was not evident: 
(PPV)... “Talk about things like rheumatoid factor”...(NPV)... “When explaining e.g. d-dimer.” 
 
(PPV)... “eg consolidation on X ray when pneumonia is suspected...(NPV)...  “eg normal 
chest X ray when TB is suspected.” 
 
(PPV)... “When thinking of elements of a history that would lead to a diagnosis”... (NPV)... 
“When thinking of tests to exclude certain conditions eg celiac.” 
 
(PPV)... “Cardiac enzymes”...(NPV)... “d-dimer” 
 
As for sensitivity and specificity several respondents illustrated their use of PVs by defining 
the metrics: 
(PPV)... “Number of people who have a screening test that test(s) positive that have the 
disease”.... (NPV)... “Number of people who have a screening test (that tests negative) 
correctly identified as being free from disease.” 
 
(PPV)... “Proportion of subjects with positive test results who are correctly diagnosed”... 
(NPV)... “Proportion of subjects with a negative test result who are correctly diagnosed.” 
 
(PPV)... “People with positive result who have disease...(NPV)...People with negative test 
who do not have disease.” 
 
(PPV)... “Looking at a test, I say 'If the test says YES, how likely is it that that is a TRUE 
YES?”... (NPV)... “Looking at a test, I say 'If the test says NO, how likely is it that that is a 
TRUE NO?'” 
 
(PPV)... “TP/TP+FP”...(NPV)... “TN/TN+FN.” 
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Positive and negative likelihood ratios (LR+ and LR-) (N=4/204(2%)) 
The low number of open responses for use of LRs reflects the low number of respondents 
across the whole sample indicating that they use these metrics in practice (see figure 5.10).  
Two of the four responses concerning LRs were definitions of these metrics with no 
indication of how they were used: 
(LR+)... “the probability of a person who has the disease testing positive divided by the 
probability of a person who does not have the disease testing positive”...(LR-)... “the 
probability of a person who has the disease testing negative divided by the probability of a 
person who does not have the disease testing negative.” 
 
“LR+ = Sensitivity / False positive rate ...LR- = False negative rate / Specificity.” 
 
 
One respondent related the use of LRs to the value of the clinical history: 
 
 
 “When taking a history to ascertain likelihood of diagnosis.”  
 
 
This may be a reflection of the promotion of LRs in general practice settings to evaluate the 
utility of multiple components of the clinical history and examination (2.4.1.6). 
 
One open response relating to use of LRs in practice referred to guidelines for interpretation 
but it was unclear whether the reference was to a generic guideline to assist with 
interpretation (for example Fagan’s nomogram 63 or a rule for interpreting the magnitude of 
likelihood ratios 62, or whether the reference was specific to a disease or laboratory: 
“We refer to the guideline for positive likelihood ratio / negative likelihood ratio or phone the 
lab for advice.”  
 
2x2 Diagnostic table (N=24/204 (12%)) 
The predominant response was use of the 2x2 table as a method for explaining test accuracy 
metrics and test results to colleagues, patients and students: 
“When discussing screening e.g. prostate screening with colleagues or patients.” 
 
“Teaching trainees.” 
 
“Teaching medical students.” 
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“eg PSA testing, to explain possible outcomes to patient asking for the test.” 
 
“Explaining the importance of a screening test to a patient.”  
 
“Patient education when (usually) trying to reassure them after a bad result.”  
 
“Sometimes draw table in explaining to patients.” 
 
Whilst several respondents indicated that they used the 2x2 table as the basis for deriving 
and interpreting test accuracy metrics: 
“That is in my head.” 
“Calculate sensitivity.” 
 
Receiver Operator Characteristic (ROC) Curve (N=1/204(0.4%)), Area Under the Curve 
(AUC) (N=2/204 (0.9%)), Diagnostic Odds Ratio DOR) (N=3/204(1%)) 
 
All responses concerning the ROC curve, AUC and DOR were general, non specific 
statements or responses demonstrating limited understanding of these metrics: 
(DOR) “To explain mammograms.” 
(ROC) “Interpreting clinical / experimental studies.” 
 (AUC) “Bells curve.” 
 
 
As for LRs, the low number of open responses for the ROC curve, AUC and DOR reflects the 
low number of respondents across the whole sample reporting that they use these metrics in 
practice, (see figure 5.10).  
 
Annotated pictogram (N=45/204 (22%)) 
Annotated pictograms were the second most commonly used metric / graphic across the 
whole sample after sensitivity and specificity (see figure 5.10) and invited the second highest 
volume of open responses regarding use in practice. The majority of open responses 
referred to the use of pictograms in communicating risk more generally as opposed to the 
uncertainty conveyed by test accuracy, reflecting the findings of the literature reviews (2.5): 
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“Predicting the cardiovascular risk and risk reduction which is achieved.” 
 
“To explain Framingham scores.” 
 
“10 year heart disease prediction.” 
 
“…on our computer system (eg cardiovascular risk) - discussing potential treatment with 
patients.” 
 
“Explain extra risk of breast cancer in HRT (hormone replacement therapy).” 
 
“Warfarin counselling in AF (atrial fibrillation).” 
 
“Smoker at risk of cancer.” 
“Pill and breast cancer.” 
 
The use of pictograms for explaining difficult concepts to patients, such as the number 
needed to treat (NNT) was also prominent: 
“Explaining difficult nnt etc concepts to patients.” 
 “Statins NNT.” 
 
A minority of open responses concerning the pictogram referred to its application to testing in 
practice: 
“PSA (prostate specific antigen) testing and breast screening.” 
 
“In PSA (prostate specific antigen) and Ca 125.” 
 
“Smiley face chart for PSA (prostate specific antigen) screening.” 
 
“Very useful to explain value of test results to patients, or value of screening, etc.” 
 
 
In summary, the frequency of open responses to the use of test accuracy metrics in practice 
mirrors the relative use of metrics across the whole sample which suggests open responses 
were not unduly influenced by respondent fatigue, even though questions were not 
randomised. In addition, reference to specific tests when illustrating how the most frequently 
used metrics were used (sensitivity, specificity, PPV, NPV, and the pictogram) is evidence of 
the construct validity of open responses. Although the low response rate for open comments 
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(median of 7% across eight metrics) would suggest that they represent those more 
knowledgeable in the area of test accuracy, open responses including respondents’ own 
definitions of test accuracy metrics are useful examples of language that might be accessible 
to clinicians more generally.  
Many respondents used the open responses to illustrate their ability to define test accuracy 
metrics and illustrated this with practical examples including clear differentiation between the 
two dimensions of test accuracy. There was limited evidence of confusion about definitions of 
metrics and graphics although the voluntary nature of the open responses is likely to have 
deterred those with less confidence.  The exceptions were metrics more commonly 
associated with systematic reviews of test accuracy (DOR, AUC and the ROC curve) and 
this could be seen as evidence that few if any respondents understand these metrics.  
The 2x2 diagnostic contingency table and annotated pictogram were prominent as graphics 
used in practice to explain difficult concepts to patients, students and colleagues. Although 
the majority of practical examples for the pictogram concerned communication of risk more 
generally, there were examples where practitioners had used this graphic to communicate 
test accuracy.  
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5.5.5 Comparison of application of nine different test accuracy presentation 
formats to a common testing scenario  
 
Table 5.11 and figure 5.12 illustrate the responses of the 204 GPs to a series of nine 
scenarios concerning a hypothetical new biological marker for ovarian cancer available to 
primary care physicians: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Each scenario was identical with the exception of the test accuracy metric used to convey a 
constant estimate of test accuracy. 
The test accuracy information provided across all scenarios was that a positive test result 
would increase the probability of having ovarian cancer (as indicated by sensitivity, LR+, PPV 
and the number of false positive test results) to a greater extent than a negative test result 
would decrease the probability of having ovarian cancer (as indicated by specificity, LR- , 
NPV and the number of false negative test results). It was anticipated that the management 
decision indicated by respondents for each scenario would be modified by variation in the 
test-treat (or for this hypothetical scenario test-refer) threshold across the sample. Therefore 
test-refer thresholds were elicited from respondents at the end of the survey in order not to 
influence responses to the hypothetical scenarios. 
 
 
“The questions that follow will ask you to apply test accuracy information to clinical 
scenarios. Each scenario reflects a primary care setting where the prevalence of 
ovarian cancer in asymptomatic, post-menopausal women is ~3%. 
 
A new biological marker for ovarian cancer has been identified and is available as a 
blood test for use in primary care. A 57 year old asymptomatic woman presents to 
you concerned about her risk of ovarian cancer and you perform the blood test at 
her request.” 
TEST ACCURACY INFORMATION PRESENTED IN ONE OF NINE DIFFERENT 
FORMATS 
“If the test came back positive would you refer the woman for further investigation? 
 
If the test came back negative would you be confident not to investigate further at 
this point in time?” 
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5.5.5.1 Across sample application of nine different test accuracy presentation 
formats to a common testing scenario   
 
There was marked inconsistency in responses to both positive and negative test results 
across the sample. Respondents had particular difficulty applying LRs and the DOR with 
61% and 58% of respondents respectively indicating that they did not know what 
management decision they would take on the basis of a positive test result and 70% of 
respondents indicating that they did not know what management decision they would take on 
the basis of a negative test result for both metrics. 
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Table 5.11: Responses to hypothetical scenarios using nine different test accuracy 
presentation formats 
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“If the test came back positive would you refer the woman for further investigation?” 
Yes 93% 82% 62% 85% 36% 76% 73% 39% 75% 
No 4% 3% 8% 5% 2% 4% 7% 3% 6% 
Don’t 
know 3% 14% 30% 10% 61% 19% 20% 58% 19% 
 
“If the test came back negative would you be confident not to investigate further at this point in time?” 
Yes 31% 30% 52% 59% 11% 51% 43% 13% 46% 
No 54% 48% 18% 25% 19% 20% 28% 18% 28% 
Don’t 
know 15% 22% 30% 15% 70% 28% 28% 70% 26% 
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Fig 5.12: Responses to hypothetical scenarios using nine different test accuracy presentation formats 
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Management decisions following a positive test result 
The response to a positive test result when presented as sensitivity and specificity (%), 
sensitivity and specificity expressed as normalised frequencies and PVs expressed as 
normalised frequencies, resulted in the most consistency across the sample (> 85% 
respondents indicating they would refer on the basis of a positive test result). Presentation of 
pre to post-test probabilities derived from LRs, the annotated pictograph and the annotated 
2x2 diagnostic table resulted in 76%, 75% and 73% of respondents respectively indicating 
they would refer on the basis of a positive test result. PVs presented in percentage terms 
resulted in less consistency across the sample with 30% of respondents indicating they did 
not know whether they would refer on the basis of a positive test result.  Across all test 
accuracy presentation formats a minority of respondents indicated that they would not refer 
on the basis of a positive test result. 
 
Management decisions following a negative test result 
There is greater inconsistency in respondents’ management decisions following a negative 
compared to a positive test result.  
Sensitivity and specificity presented both in percentage terms and using normalised 
frequencies resulted in the majority of respondents indicating that they would pursue further 
testing despite a negative test result (54% and 48% respectively). The management decision 
indicated by the majority of respondents for the remainder of the test accuracy presentation 
formats (PVs (%), PVs (normalised frequency presentation), pre to post-test probability, the 
annotated 2x2 diagnostic table and the annotated pictograph), was a decision not to pursue 
further investigations following a negative test result (52%, 59%, 51%, 43% and 46% 
respectively). 
 
The literature reviews presented in chapter 2 suggested that health professionals may have 
more problems with the application of negative test results (2.5.3.3). However evaluation of 
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the application of negative test results was sparse compared to evaluation of the application 
of positive test results. Table 5.13 presents a comparison of ‘Don’t know’ management 
responses following positive and negative test results for each of the nine hypothetical 
scenarios. The table illustrates that with the exception of one scenario (PVs %), a greater 
proportion of respondents indicated they were not able to make a decision about referral, 
(responding ‘don’t know’), following a negative test result in comparison to a positive test 
result. This difference was significant at the 5% level for 5/9 scenarios. The differential 
between ability to apply positive and negative test results is least marked for a normalised 
frequency presentation of PVs and the annotated pictogram. 
 
Table 5.13: Comparison of ‘don’t know’ management responses following positive 
and negative test results for each of nine scenarios  
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5.5.5.2 Within-person application of nine different test accuracy presentation formats 
to a common testing scenario  
 
Investigating the degree of decision making consistency for individual respondents controls 
for between-person variation in test-refer thresholds and tolerance of test errors.  
Fig 5.14 and 5.15: Within Person Variation in Management Decisions Across Nine 
Scenarios Depicting a Constant Estimate of Test Accuracy  
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Fig 5.14: Decision Following Positive Test Result
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Figures 5.14 and 5.15 are concordant with the across sample distribution of management 
decisions (see table 5.11 and figure 5.12 above).  
There is greater consistency in management following a positive test result with only six 
respondents (outliers) indicating they would not refer (for between one and six of nine 
scenarios) (figure 5.14). The median number of scenarios for which respondents indicated 
they would refer following a positive test result was seven, (inter-quartile range 5-8 of nine 
scenarios) and the median number unsure of their management decision following a positive 
test result was two, (inter-quartile range 0-4 of nine scenarios). On the basis of this 
examination of within-person responses it appears that the relatively greater consistency in 
management decisions following a positive test result observed across the whole sample 
appears to reflect within-person consistency rather than an artefact caused by random 
within-person variation across scenarios. 
 
Following a negative test result the median number of scenarios for which respondents 
indicated they would refer in any case was two, (inter-quartile range 1-4 of nine scenarios) 
(figure 5.15). The median number of scenarios for which respondents indicated they would 
not refer following a negative test result was three, (inter-quartile range 1-5 of nine 
scenarios). The median number of scenarios for which respondents indicated they would be 
unsure of their management decision was three, (inter-quartile range 1-4 of nine scenarios). 
On the basis of this examination of within-person responses it appears that the inconsistent 
pattern of responses following a negative test result observed across the whole sample is 
real and reflects within-person inconsistency rather than an artefact caused by random 
within-person variation across scenarios.  
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5.5.5.3 Open responses to application of nine different test accuracy presentation 
formats to a common testing scenario  
 
Open responses concerning scenario management decisions were received from between 
6% (for the last scenario) and 28% (for the first scenario) indicating respondent fatigue.  
Figure 5.16 illustrates the relationship between a respondent’s median confidence in their 
ability to define or explain the test accuracy metrics/ graphics presented across the nine 
scenarios and the total number of open responses they provided across the nine scenarios. 
For the purposes of this analysis respondents were assigned to the ‘could not define’ 
category if they reported not having heard of a metric (see details of the skip logic application 
as part of the questionnaire design (5.4.2.1). 
 
Fig 5.16: Median self-reported confidence (ability to define metrics) and 
number of open responses 
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Fig 5.16: Median Confidence (ability to define metrics) and Number of Open Responses
Median Self-Reported Confidence Score (ability to define test accuracy metrics)
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test accuracy metrics. It does not appear that respondents more confident in their ability to 
define metrics were also those more likely to offer open responses in support of their 
scenario management decisions. 
With the exception of the LR and DOR scenarios, where the majority of open responses 
were concerned with lack of familiarity with these metrics, two themes emerged from free text 
responses to scenarios: the importance of shared decision making with patients and a 
requirement for additional diagnostic information including a feeling of obligation to pursue 
further testing even in the presence of negative test results. 
 
Shared decision making 
A common comment, particularly concerning negative test results, was the importance of 
involving patients in the decision making process: 
“Would discuss further each case with p(atien)t”...(Not to investigate following a negative test 
result)... “only after in depth discussion.” 
 
 “The NPV of 99% indicates a low risk of false negatives and I would discuss risks with 
patient and feel that further screening is not appropriate.”  
 
“If she were asymptomatic I would explain to her the short comings of the test and symptoms 
that she should report, etc.” 
 
“Again I would discuss with patient and inform them there is a 1% false negative rate and 
combined with a low prevalence it would be reasonable not to investigate further.” 
 
“Probably confident w(ith) lowering to 0.6%, but p(atient)t would need to be happy w(ith) that 
level of risk.” 
 
“Assuming patient aware of possibility of false negative test.” 
 
“I would explain that 46% with a positive result are unaffected and if there is no FH (family 
history) and she is asymptomatic, these are favourable factors but would refer for specialist 
advice and further testing/imaging.” 
 
“Patient choice as well - but if she wanted further referral I would do this.” 
 
The annotated pictogram attracted positive comments as a tool to facilitate shared decision 
making: 
 “Useful for showing patient.” 
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“I would use the diagram to show the patient and explain result.” 
 
“This I understand and explain to patient is easy.” 
 
Requirement for additional diagnostic information 
Several respondents commented that they would like additional diagnostic information to 
inform their management decision with the clinical history and examination prominent in this 
respect:   
 “Only 76% sensitive (therefore) need to assess the whole hx (history) and risk.” 
“Other clinical information will guide.” 
“Need clinical context and examination.” 
 
“It is sensitive, but not specific and no one test predicts.” 
 
“We cannot base diagnosis on a blood test alone. Ultrasound and examination would be 
useful in assessment probably prior to referral.”  
 
“As sensitivity is lower then (I) would consider referral for USS (ultrasound scan) especially if 
FH (a family history of ovarian cancer).”  
 
“A lot depends on the clinical findings at examination.” 
 
Obligation to pursue further testing 
Several respondents indicated that they would feel obliged to investigate further even in the 
event of a negative test result. This may reflect the specific clinical context depicted in the 
scenarios and the relatively greater importance placed on false negative test errors: 
 
 
“I would refer -ve result here...would be difficult to defend if subsequently turned out to have 
ovarian carcinoma.” 
 
“Small number of false positives, so +ve results indicate disease highly likely. Although much 
larger proportion of false -ves, a wrong decision would be difficult to defend, especially with 
3% prevalence of disease in this population.” 
 
“But would probably investigate (on the basis of a negative test result) but (I am) aware all 
further tests may be negative.” 
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Some respondents identified that pursuing further investigations in the presence of a 
negative test result suggests that decision making should be at the point of consideration of 
test use as distinct from decision making following test results. This was contextualised with 
respect to the test and population depicted in the scenarios: the consequences of the higher 
false negative rate (lower sensitivity) for detection of a serious disease and high absolute 
numbers of false positives in a low prevalence population:  
 
“She is asymptomatic. If you are going to Ix (investigate) asymptomatic p(a)t(ient)s with 
neg(ative) tests, there is no point using the test.” 
 
“I would try to explain the use of the test in an asymptomatic patient who I would otherwise 
not have been investigating for ovarian cancer.” 
 
 “Would have to investigate further with positive test...would have concerns over doing test in 
view of high false positive rate.” 
 
“You would have to refer a positive result wouldn't you! I think counselling before the test 
(aka PSA (prostate specific antigen)) would be the way forward as so many false positives.”  
 
“If someone tests +ve even with a poor predictive test then I feel you cannot ignore it and not 
investigate further.” 
 
“Would need referral in view of high specificity. I am not sure I would have done the test in 
the first place in view of the low sensitivity.” 
 
 “If negative, then her risk is lower than the normal population risk of 3%, and as I don't 
screen for the normal population, I wouldn't screen for her.” 
 
“Woman is asymptomatic, and after a negative test her likelihood of ovarian cancer is even 
less then general population of same age.” 
 
 “The prevalence of ovarian cancer in the symptomatic population is only 3% and the risk of 
false negative result is 10:1360 and therefore I feel it is appropriate not to investigate further.”  
 
 
Understanding of Test Accuracy Metrics 
Several respondents justified their management decisions by providing a definition of the 
metric being used. For sensitivity and specificity the majority of respondents emphasised the 
false negative rate: 
“High specificity, so +ve indicates disease present Low-ish sensitivity - cannot exclude 
disease on basis of -ve result.” 
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“Will miss about 1/4 +ve cases so would need f/u (follow up).” 
 
“Only 76% sensitivity therefore will be negative in 24% of cases (of ovarian cancer).” 
 
“The 98% specificity means that if positive it is almost certain the woman has ovarian cancer.  
The 76% sensitivity means it'll miss a quarter of cancers - to rule out the cancer, you need a 
better test. As a screening test, it is (to use the technical term) crap.” 
 
“I would not be confident not to investigate due to the sensitivity of 76%.” 
 
“24% women with ovarian cancer would test negative.” 
 
“24% false negative - too high.” 
 
 “I would worry about the potential 24% who may be missed.” 
 
“I think the test sensitivity is poor - ie there are a lot of falsely negative results - ie less useful 
in terms of reassuring asymptomatic women.” 
 
A minority of open responses to the sensitivity and specificity scenarios suggested some 
confusion over application of the SpPIN and SnNOUT rules (TTA27): 
“Test with high specificity means fewer false negatives, ie a positive result is likely to be 
true.” 
 
“High specificity so if test -ve unlikely to have the disease, quite high sensitivity so +ve test 
needs Ix (investigation).” 
 
 “Specificity 98% not adequate for "rule out" test.” 
 
When presented with predictive values a greater emphasis was placed on false positive test 
errors, in contrast to the emphasis on false negative test errors observed for sensitivity and 
specificity: 
“Sufficiently high risk to check +ve tests and sufficiently low risk 1% to monitor –ve (test 
results).” 
 
If positive there is a 54% chance of cancer so need to investigate. If asymptomatic and 
negative I would not refer.” 
  
“Some concern over low positive predictive value,” 
 
“A lot of healthy women would be investigated due to a positive result.” 
  
“Negative test reassuring. Would have concerns over doing test in view of high false positive 
rate.” 
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“If positive she needs a better test to say whether is or isn't cancer: the odds are about 50:50; 
if -ve then cancer is highly unlikely, so 'see again if symptoms persist'.” 
 
 
This change in respondent emphasis on test errors may have arisen due to the considerable 
difference in magnitude between the PPV (54% or 54/100) and NPV (99% or 99/100) when 
presented in percentage or normalised frequency format due to the low disease prevalence 
in the scenario population. By contrast the difference between sensitivity (76% or 76/100) 
and specificity (98% or 98/100) when presented as either percentage or normalised 
frequency format was less marked.  
Several respondents stated they had difficulty interpreting PVs when presented as a 
percentage: 
“Not familiar with terminology here, presume PPV and NPV correspond with sensitivity and 
specificity but I would need to check.” 
 
“Not used to working with these figures.” 
 
“Can’t understand this.” 
 
“Don’t understand the terminology.” 
 
  
In addition there was evidence of reference class confusion between sensitivity and 
specificity and PVs when these metrics were presented using percentage presentation 
formats: 
 
 (PPV and NPV %)...“This test could lead to a lot of anxiety and distress in women who test 
positive although its specificity is quite low.” 
 
(PPV and NPV %)...“Test not sensitive enough-only 1% false negative.” 
 
In common with respondents’ illustrations of their understanding of sensitivity, specificity and 
PVs, test errors were used by respondents when explaining the information contained in the 
2x2 diagnostic table.   
 “Small number of false positives, so +ve results indicate disease highly likely. Although 
much larger proportion of false -ves, a wrong decision would be difficult to defend, especially 
with 3% prevalence of disease in this population.” 
 
 232 
 
“High false negative rate.”  
 
 “I am concerned that so many cases are missed.” 
 
“1 in 4 women are incorrectly tested negative...a media pr nightmare for gps.” 
 
“The prevalence of ovarian cancer in the symptomatic population is only 3% and the risk of 
false negative result is 10:1360 and therefore I feel it is appropriate not to investigate further”.  
 
“Risk of true +ve being +ve is 26/57 = high enough to refer.”  
 
“Some concern over relative high false positives compared with true positives.” 
 
 
For some respondents the 2x2 diagnostic table was effective in conveying the implications of 
disease prevalence on the absolute numbers of test errors which in turn led to an attenuation 
of the emphasis placed on one or other of false positives or false negatives as observed with 
predictive values or sensitivity and specificity respectively: 
“1303 women had neg(ative) tests. You cannot send all of these for further Ix(investigation) - 
you would swamp the system. The 10 false -ves will just have t(o) c(ome) in if (they develop) 
symptoms.”  
 
“Too many false positives-they nearly equal the true positives. It is much better at helping 
you predict who does not have ovarian cancer but still too many false negatives.” 
 
“Test still misses 30% of cancers yet only 10 in 1293 women.” 
 
Several respondents used the 2x2 table to derive summary test accuracy metrics to inform 
their management decisions: 
“Strong negative predictive value.” 
 “I tend to convert most info(rmation) to sensitivity and specificity.” 
 
The scenario depicting pre to post test probability received few responses. Some 
respondents responded that this presentation of test accuracy information was accessible 
and might be helpful in dialogue with patients:  
“Easier to understand the terms.” 
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“Again difficult to rule out on basis of -ve test - here I would be happier to advise patient that 
probability of having disease was 0.6% if test -ve and would leave if she understood and was 
happy with explanation.” 
 
 
Some respondents did not understand the information provided by pre-post test probabilities: 
 
“I wouldn't be able to make a decision or discuss results with a patient using this data” 
 
“Not sure what these values actually mean.” 
 
 
 
The annotated pictogram also received few open responses, although all comments about 
this graphic as a diagnostic decision making tool were positive: 
“Very clear diagram.” 
“Useful for showing patient.” 
“Looks much better with this presentation!!” 
 
The metrics that appeared least well understood by respondents were the DOR and LRs; 
91% (21/23) and 77% (20/26) of comments respectively were concerned with respondents’ 
lack of familiarity with these metrics: 
“Don't understand this value - where does 190 lie on scale of 1 to infinity?” 
 
“DOR 190 - is this good or bad?” 
 
“Would need guidelines to follow here because I have no experience of the DOR.” 
 
“Can't understand this presentation of test accuracy at all.” 
 
“Would have to look further into DOR to know what this meant.” 
 
“I do not understand the LR terminology.” 
 
“Not confident with measures.”  
 
“Not sure what LR - or + means.”  
 
“Not used to these measurements.”  
 
“I have no experience of using likelihood ratios so would have to research before deciding on 
next course of action.”  
 
“I do not know what these ratios mean.” 
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One respondent, unfamiliar with the DOR, suggested that having information about the DOR 
of familiar tests would help with the interpretation of the magnitude of the DOR presented for 
the unknown test in the scenario: 
“Would like to know DOR values for other tests which have been in widespread use for some 
time.” 
 
 
A further respondent identified the limitations of the DOR in distinguishing between the 2 
dimensions of test accuracy: 
“I think other statistical ways would help to clarify whether the test is useful for a negative or 
a positive test.” 
 
 
Only one open respondent illustrated some understanding of the interpretation of likelihood 
ratios: 
“The LR+ is quite high at 38 so high possibility she has the disease. The LR- is not low 
enough for me to feel confident not to investigate.” 
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Probabilistic versus normalised frequency representation 
 
 
 
 
 
 
 
 
 
 
 
 
 
Open responses suggested that plain language, normalised frequency representations of 
sensitivity and specificity and PVs were successful in mitigating against reference class 
confusion observed with percentage representations of these metrics. Characteristics of plain 
language normalised frequency representations that facilitate informed application are likely 
to include the incorporation of information about the reference class and explicit 
quantification of test errors.  
 
Respondent preference for guidelines  
 
A small number of respondents across all scenarios stated a preference for guidelines rather 
than quantitative test accuracy information to inform their decision making:  
“This is very confusing and would need definite guidelines to tell us what to do.” 
“I would need referral guidelines.” 
“Would depend on local /national guidelines.” 
 
“Looks like the false negative rate is low - I would await guidelines.” 
 
 
• Plain language, normalised frequency representation of sensitivity and 
specificity: 
“Of every 100 women with ovarian cancer, 76 would test positive (be detected by 
the test) but 24 would test negative (be missed. 
 
Of every 100 women without ovarian cancer, 98 would test negative (receive a 
correct diagnosis) but 2 would test positive (be falsely labelled as having cancer).” 
 
• Plain language, normalised frequency representation of positive and 
negative predictive values: 
“Of every 100 women who test positive, 54 will have ovarian cancer but 46 will not.  
 
Of every 100 women who test negative with the marker 99 will not have ovarian 
cancer but 1 will have ovarian cancer and be missed.”   
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One respondent expressed the opinion that probabilistic information incited a feeling of 
gambling with patients’ lives. This suggests either ignorance of the inevitability of test errors 
or an intolerance of any level of false negatives in this testing situation: 
 
“It’s clinical medicine...not based on any form of probability. That’s Gambling with lives.” 
 
Probability revision 
One respondent demonstrating an appreciation of the importance of pre-test probability for 
the clinical application of test accuracy information and attempted to undertake probability 
revision using information presented in the PVs scenarios, both percentage and normalised 
frequency representations: 
 
 “If +ve then 54% chance of having condition, so in total population 100-54 = 46% are false 
+ve.  True +ve are 3%, 99% identified by test.  So if +ve 3/(46+3) chance of being true +ve = 
6%, so possibly worth referring.”  
 
Inter-relationship between different test accuracy metrics 
There was limited evidence from open responses that respondents had an appreciation of 
the relationship between different test accuracy metrics: 
(Open responses to normalised frequency representation of PVs)...“Poor positive predictive 
value/specificity but impossible not to recommend investigating a positive result. Good 
negative predictive value/ sensitivity at 1%.” 
 
 
Several respondents recognised the similarity of test accuracy estimates across scenarios: 
 
“Similar to previous worked example showing higher risk = referral; lower than population risk 
= wouldn't refer the negative.” 
 
“Same scenario again (very clever).” 
 
 
Whilst several respondents also recognised that different presentation formats were having 
an influence on their management decisions: 
“Is this the same data being presented with different indices? Scary how presenting the same 
data differently induces different behaviour!” 
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“It’s slightly scary how the way this is presented can change the way you feel about the 
results.” 
 
 “Interesting - when asked this question earlier I would have referred -ve result patient, but 
realising now I can confidently say she has only a 0.6% chance of having the disease I would 
explain this to her.” 
 
(Open response to sensitivity and specificity normalised frequencies)...“Too many false 
neg(ative)s for me to feel comfortable when presented in this way.” 
 
(Open response to annotated pictogram)...“Interesting change in my own responses -i would 
still refer for positive test, but more worried now if it is the right test in the first instance.”  
 
 
Summary of open responses to hypothetical scenarios 
Open responses to the hypothetical scenarios provide an insight into respondents’ 
understanding and application of different test accuracy metrics. Responses do not appear to 
be biased with respect to respondents’ perceived ability to define metrics and included 
examples of misunderstanding and inability to interpret and apply metrics. Understanding 
and ability to apply test accuracy information appeared to vary substantially amongst 
respondents. 
A common theme that emerged was a feeling of obligation to pursue testing in the face of 
uncertainty and a desire to share uncertainty with patients. This is coherent with 
commentaries suggesting that fear of litigation and a quest to reduce uncertainty are features 
of medical culture that contribute to excessive testing behaviour (1.2). 
Respondents appeared most familiar with sensitivity and specificity and could use these 
metrics to assist with decision making. This is internally consistent with responses to closed 
questions earlier in the questionnaire (5.5.4.1). The use of test errors was a prominent 
feature of the application of sensitivity and specificity for decision making. 
 In contrast PVs did not appear to be as well understood by respondents as earlier closed 
responses had indicated. An annotated pictogram and an annotated 2x2 diagnostic table 
received positive comments by the minority of respondents providing open responses, 
particularly with respect to their usefulness for shared decision making. There was also 
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evidence that respondents were able to accurately use graphics to assist with decision 
making and in order to derive summary metrics. Metrics resulting in the most decision 
making uncertainty were the DOR and LRs. The DOR is not a metric promoted for use for 
decision making in individual patients but open responses did not suggest that this sample of 
clinicians were aware of its limitations in this respect. By contrast LRs are specifically 
promoted as an aid to probability revision and decision making at the bedside. Open 
responses suggested that respondents were not familiar with guidelines for interpretation of 
LRs 62 and a plain language explanation of the change in disease probability pre and post-
test did not help respondents with their decision making. The familiarity of sensitivity and 
specificity and their associated heuristics (SpPIN and SnNOUT) (TTA27) appear dominant as 
test accuracy metrics for decision making, despite recognised limitations with their 
application (2.4.1.3; 2.4.1.4). Although the 2x2 diagnostic table prompted some respondents 
to question their management decisions made on the basis of sensitivity and specificity, 
there was no evidence that this was underpinned by recognition of the limitations of 
sensitivity and specificity as a guide to the clinical utility of a test at extremes of prevalence. 
Empirical test accuracy literature reviewed in chapter 2 (2.4.3.2) suggested that normalised 
frequencies offered little or no advantage over percentage representations for probability 
revision as neither of these representations incorporates base rate information. Open 
responses in this survey suggested that plain language normalised frequency 
representations of test accuracy are effective in removing the reference class confusion 
observed with summary test accuracy measures such as sensitivity, specificity, PPV and 
NPV. Normalised frequency representations may have the potential to facilitate the use of 
test accuracy evidence, particularly if probability revision is neither prominent or a necessary 
pre-requisite for informed diagnostic decision making. 
Open responses suggested that sensitivity and specificity representations of test accuracy 
resulted in respondents placing a greater emphasis on false negative test errors, whilst PVs 
resulted in respondents placing a greater emphasis on false positive test errors. Although the 
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impact of prevalence on post-test probability will have in part have contributed to this 
observation in the low prevalence scenarios used in this questionnaire, this is an important 
observation that requires further investigation. 
The 2x2 diagnostic table was the closest approximation to a natural frequency representation 
of test accuracy presented to respondents in this survey.  The differential emphasis placed 
on false negative and false positive test errors with sensitivity and specificity and PV 
representations of test accuracy appeared attenuated by the 2x2 table and this presentation 
also prompted comments concerning the impact of prevalence on the absolute number of 
test errors.  
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5.5.6 Tolerance of test errors (false positives and false negatives)  
 
 
 
Figure 5.17 illustrates variation in the percentage of test errors indicated as acceptable in the 
context of screening or triaging for a serious disease across the 204 respondents. With the 
exception of 13 (6%) respondents, the acceptable percentage of false negative test errors 
was less than false positive test errors which might be expected for this scenario. A minority 
of individuals (4 for false negative test errors and 15 for false positive test errors) indicated 
acceptable error rates up to 40%, suggesting this question may have been misunderstood by 
these respondents. 
 
 
  
“When tests are applied in a screening / triaging context, asymptomatic individuals 
who test positive undergo further definitive testing (for example following referral to 
secondary care). Individuals who test negative usually do not receive any further 
testing unless they re-present with new symptoms. The clinical significance of false 
positive test errors (individuals without disease who test positive) depends on the 
risks associated with further investigation. The clinical significance of false negative 
test errors (individuals with disease who test negative) depends on the risks 
associated with missed, untreated disease. If a test was being used to screen 
asymptomatic individuals for a potentially serious condition, such as cancer, please 
indicate on the scale below an acceptable level of missed disease (% false negative 
test results) and an acceptable level of healthy individuals wrongly labeled as having 
disease (% false positive test results) that you would tolerate from the test before 
you would consider it accurate enough to be used for this purpose.” 
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Fig 5.17: Acceptable % of test errors indicated by respondents when triage testing / screening for a serious disease
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Figure 5.18 illustrates the sample distribution of tolerance of test errors for triage/ screening 
for ‘serious disease’. The median tolerance of false negatives was ≤ 1%, with a relatively 
narrow inter-quartile range (4%) compared to a median tolerance of false positives of 5%, 
inter-quartile range 10%. 
Fig 5.18: Sample distribution of test errors 
 
 
 
Open responses to tolerance of test errors when screening / triage testing for a 
serious disease such as cancer 
 
Open responses concerning tolerance of test errors were provided by 23 of 204 respondents 
(11%). Respondents who offered a definitive opinion of the relative importance of false 
positive and false negative test errors mostly supported the greater importance of false 
negative test errors in the testing context presented to respondents (screening / triage for a 
serious disease): 
“false negatives more significant than false positives in this context. (I) would have checked a 
<0.1% box if there was one!” 
 
“Missing diseased individuals potentially much more serious issue than over-investigation of 
healthy individuals.” 
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“Do not want to be too falsely reassured by negative tests in asymptomatic population but 
false positive rates can be higher as presumably further investigations can be carried out if 
clinically indicated or appropriate.” 
 
“In an ideal world - the lower the numbers the better but false +ve safer than false -ve.” 
 
 
The importance of not missing disease was also suggested to be relatively more important to 
patients. Respondents indicated that it was easier to deal with the possibility of false 
positives compared to false negatives when communicating test results to patients: 
“It is not good to miss cases - patients wish (for) a very sensitive test.” 
 
“A false reassurance can be dangerous, if you KNOW that many (even most) +ves are false 
positives, then that is safer, and not difficult to explain to patients.” 
 
 
There was evidence that respondents recognised the inevitability of test errors and that 
evaluation of the performance of a new test needed to be undertaken mindful of the accuracy 
of existing practice: 
“Admittedly tests are not 100% accurate.” 
(Respondent indicating ≤1% as an acceptable number of false negative test errors)...“Or < 5 
% false neg - the test may still be better than no test for some people.”  
 
“Depends on seriousness and usual presentation of the disease in question: for ovarian 
cancer which has few symptoms, accuracy in testing is paramount.” 
 
“...but in real life I accept for example the FOB (faecal occult blood) testing for bowel ca(ncer) 
and welcome its input.” 
 
“This also depends what other clinical tests / findings may be used as often it is a mixture of 
tests / findings that is used.” 
 
“Use in conjunction with clinical hx and exam makes clinical situation more specific/sens.” 
 
However, despite the fact that the majority of respondents indicated the relative greater 
importance of false negatives in the testing context presented, there was an appreciation of 
the potential consequences of false positive test results that should be considered: 
“The acceptance of false positives depends on the available follow up, eg the more invasive 
the follow up the lower the acceptable false positive rate.” 
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“We want a test that minimises anxiety (and extra work) as much as possible.” 
 
“Acceptable level of false positives would depend on morbidity associated with further 
testing.” 
 
 
In summary the open responses supported the lower tolerance for false negatives as 
indicated by a lower acceptable proportion on a continuous scale from 0-50% and a smaller 
degree of variation in the acceptable number of false negatives across the sample. There is 
evidence that respondents recognise the inevitability of test errors and that their 
consequences are context dependent.   
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5.5.7 Relationship between tolerance of test errors and management 
decisions 
 
Figures 5.19 and 5.20 illustrate the results of an investigation of the relationship between 
respondents reported tolerance of test errors (5.5.6) and the management decision indicated 
by respondents (to refer or not to refer) for the sensitivity and specificity scenarios 
(percentage and normalised frequency presentation), the annotated pictograph scenario and 
the annotated  2x2 diagnostic table scenario. These four of the nine test accuracy metrics 
used across scenarios were selected for this investigation on the basis that they contain 
information on test accuracy with disease as reference class. Test accuracy metrics that do 
not have presence or absence of disease as reference class, (LRs, PVs, pre to post-test 
probability and the DOR) were not included in this investigation as they are not directly 
comparable with test error rates. Respondents choosing a ‘don’t know’ management 
response to sensitivity and specificity, 2x2 table and pictograph scenarios were not 
considered in this investigation. 
 
Tolerance of false negatives 
For the purposes of this analysis it is assumed that those respondents who understood 
probabilistic and normalised frequency representations of sensitivity and specificity, the 2x2 
table and an annotated pictograph and indicating a tolerance of false negative test errors 
≤25% (5.5.6) would be expected to refer in the presence of a negative test result for the test 
in the scenarios with a sensitivity of 76% (false negative rate of 24%). Similarly, it is assumed 
that those respondents indicating a tolerance of false negative test errors of >25% would be 
expected not to refer in the presence of a negative test result for the test in the scenario with 
a sensitivity of 76% (false negative rate of 24%). 
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False positive test errors 
For false positive test errors it is assumed that respondents indicating a tolerance of false 
positive test errors ≤5% (5.5.6) would be expected not to refer in the presence of a positive 
test result for the test in the scenarios with a specificity of 98% (false positive rate of 2%) 
whilst respondents indicating a tolerance of false positive test errors of >5% would be 
expected to refer in the presence of a positive test result for the test in the scenarios with a 
specificity of 98% (false positive rate of 2%). This assumption ignores motivational biases 
that may result in a feeling of pressure to refer in the presence of a positive test result as 
indicated in open responses (5.5.5.3). 
 
Within person investigation of relationship between tolerance of test errors and 
management decisions for individual test accuracy metrics 
 
Figures 5.19 and 5.20 illustrate that overall, for between 36% and 62% of respondents there 
was no concordance between stated tolerance of test errors and management decisions for 
individual test accuracy metrics. Figure 5.19 illustrates that following a negative test result, 
sensitivity and specificity appear to result in a slightly increased concordance between 
respondents’ indicated tolerance of test errors and management decisions compared to the 
2x2 table and annotated pictograph. 
Figure 5.20 illustrates that following a positive test result the distinction between the 
summary measures sensitivity and specificity and the 2x2 table and annotated pictograph 
are no longer evident.  
The slight increase in concordance for sensitivity and specificity for negative test results is 
likely to be a result of a combination of factors including familiarity with and use of these 
metrics in practice (5.5.4) and the fact that false positive and false negative test errors and 
sensitivity and specificity both encourage artificial partition of the two dimensions of test 
accuracy from each other and from the effects of disease prevalence in the tested population 
(2.4.1.3). 
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5.5.8 Relationship between reported understanding and application of test 
accuracy metrics in scenarios 
 
Figure 5.21 illustrates the relationship between respondents familiarity with test accuracy 
metrics: high confidence, (very confident could define or moderately confident could define) 
and low confidence: (not very confident could define or could not define or not heard of) and 
the indicated management decision following a positive test result (to refer, not to refer or 
don’t know whether to refer). Figure 5.22 illustrates the relationship between respondents 
stated ability to define metrics and the indicated management decision following a negative 
test result (to refer, not to refer or don’t know whether to refer).  For the small number of 
respondents where there was a discrepancy in familiarity between different dimensions of 
test accuracy (sensitivity versus specificity; PPV versus NPV; LR+ versus LR-) (see 5.5.4.2) 
the less familiar response was used for that metric. 
 
5.5.8.1 Management decision following a positive test result 
 
Figure 5.21 illustrates that for the majority of test accuracy metrics and graphics, the 
percentage of respondents indicating management uncertainty following a positive test result 
is higher for respondents with a low degree of confidence in their ability to define or explain 
that metric or graphic compared to respondents with a high degree of confidence. The 
increase in management uncertainty in low confidence respondents was largely at the 
expense of decisions to refer following a positive test result: fewer low confidence 
respondents indicated they would refer following a positive test result compared to high 
confidence respondents. The percentage of respondents deciding not to refer following a 
positive test result was relatively small and affected little by metric or degree of confidence. 
Exceptions to this pattern were observed for a normalised frequency representation of PVs 
where the impact of respondent confidence on management decisions following a positive 
test result is less marked than for other metrics. Presentation of pre to post-test probabilities 
resulted in an increase rather than a decrease in referrals in low confidence respondents. 
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However this may be explained by the fact that assessment of respondent confidence was 
based on stated confidence defining LR+ and LR- rather than pre to post-test probability 
information.   
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Fig. 5.21 Respondents’ confidence in ability to define test accuracy metric and management decision following a positive test result 
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Fig. 5.22: Respondents’ confidence in ability to define test accuracy metric and management decision following a negative test result  
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5.5.8.2 Management decision following a negative test result 
 
Figure 5.22 illustrates that management uncertainty following a negative test result is also 
higher for low confidence compared to high confidence respondents. However there was no 
consistent relationship observed between lower confidence and management decisions 
following a negative test result in contrast to the relatively consistent trade off of a decision to 
refer with management uncertainty observed following a positive test result (figure 5.21 
above),  
In summary, decreasing confidence increased management uncertainty following both 
positive and negative test results. Following a positive test result the increase in 
management uncertainty was largely at the expense of decision to refer, whilst for negative 
test results an increase in management uncertainty did not result in any consistent trade off. 
This observation may reflect the specific testing context depicted, where the consequences 
of false negative test results were viewed as relatively more important than those associated 
with false positive test results (see 5.5.6 above). Alternatively this observation may reflect a 
generic difficulty applying negative test results as suggested by the literature reviews 
(2.5.3.3): an insensitivity to negative test results, reflecting an emphasis on the presence 
rather than the absence of symptoms and disease in clinical practice.    
  
 253 
 
5.6 Strengths and Limitations: Survey of understanding and application 
of test accuracy measures in primary care 
 
A major strength of this survey, particularly in comparison with previous empirical research in 
this area, is the size and representativeness of the sample. It is unlikely that selection bias is 
entirely absent and the survey would need replicating to check the external consistency of 
findings. However respondents do not appear to be self-selected on the basis of expertise or 
experience in the topic area. In addition, although opportunities for comparison are limited, 
the survey findings do not contradict earlier empirical research.  
In the interests of achieving a reasonable and representative response rate the questionnaire 
was limited in terms of what it could cover. The findings can therefore not be generalised to 
different healthcare settings where the importance attached to test errors, the magnitude of 
test errors, pre-test probabilities and experience with any particular test will vary. The 
purposive sampling of GPs in the UK may also preclude generalisation to other health care 
settings where testing culture may differ. Findings based on hypothetical scenarios may not 
be generalisable to the actual clinical encounter. 
 
The survey findings demonstrate internal consistency and where possible within-person 
response patterns have been compared to assist with identification of real from artefactual 
associations caused by variation within the sample. However these analyses were not 
comprehensively conducted across all outcomes and were based on aggregated data 
(median confidence across metrics /sub-categories of metrics). It is therefore possible that 
additional sources of variation were missed. 
 
Respondent fatigue was evident in the open responses to scenarios and in the absence of 
randomisation of question order it is possible that the compulsory closed responses were 
also affected, resulting in less considered and repetitive answers.  
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5.7 Discussion: Survey of understanding and application of test 
accuracy measures in primary care 
 
The survey of understanding and application of test accuracy measures was primarily 
exploratory in nature with the aims of addressing gaps in the existing empirical literature and 
refining emerging hypotheses about features of test accuracy measures that facilitate their 
understanding and application. In particular the survey aimed to represent a sample of 
practicing clinicians from a generalist setting; to describe whether and how test accuracy 
information is used by clinicians in practice; to assess the perceived utility of existing test 
accuracy metrics and to assess whether there is consistency in the application of different 
test accuracy metrics across a common hypothetical scenario. 
 
5.7.1 Representation of practising clinicians in a generalist setting 
Survey respondents appear more likely to be female although the effect of confounding by 
part-time practice could not be assessed. In addition older practitioners may be 
underrepresented by the survey. The extent of any age bias may be postulated to 
overestimate the ability of UK GPs to understand and apply test accuracy measures as the 
evidence based medicine movement is only two decades old.  
Importantly only 11 of 222 GPs accessing the survey questionnaire electronically failed to 
participate once the research topic area was revealed or withdrew part way through the 
questionnaire. The survey sample appears to be representative of GPs working in the UK 
and not self selected on the basis of previous training or interest in the topic area. Similarly 
the small proportion of respondents offering open responses in the survey does not appear 
to be self selected on the basis of confidence in the topic area. 
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5.7.2 Sources of test accuracy information used by clinicians 
Personal clinical experience, colleagues, guidelines, web based resources and local 
laboratories were prominent sources of test accuracy information and the timeliness and 
currency of these information sources were cited as facilitating characteristics. 
The popularity of guidelines may stem from the fact that they translate quantitative test 
information into recommendations and as such their use may not require an understanding of 
probabilistic information or the ability to undertake probability revision. The view that 
guidelines represent an accurate and trusted source of test accuracy information was a 
theme in open responses for those respondents encountering difficulty applying quantitative 
test accuracy information. Indeed it may be unrealistic and inappropriate to expect clinicians 
to formally work with probabilities in the clinical encounter when deciding to use a test or 
when applying test results. In addition a theme in open responses to scenarios is that a test 
is rarely applied in isolation. Guidelines may therefore represent an important tool to 
encourage evidence based testing and greater consistency of test use. However informed 
assessment of guideline credibility and applicability is underpinned by an understanding of 
how recommendations have been reached. Guidelines therefore cannot be considered a 
replacement for an understanding of test properties.  
The web based resources cited in open responses were mostly condition rather than 
symptom based guidelines or were evidence based summaries concerned with clinical 
effectiveness without quantitative test accuracy information.  The prominence of local 
laboratories as a source of test accuracy information in this sample appeared, at least in part, 
underpinned by a misunderstanding that the normal range communicates the accuracy of a 
test.  However the timeliness and ease of access of these information resources make them 
a potentially powerful education and dissemination medium for test accuracy information.   
Although personal clinical experience and colleagues were the sources of test accuracy 
information reported to be most frequently used by respondents, their value needs to be 
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judged in the light of an assessment of the ability of clinicians to interpret and apply test 
accuracy information (see 5.7.4 below).  
 
5.7.3 Perceived utility of existing test accuracy metrics 
The utility of existing test accuracy metrics (sensitivity and specificity, PVs, LRs, the 2x2 
diagnostic table, the ROC curve, DOR and AUC) and an annotated pictogram more 
commonly used in the communication of risk were assessed on the basis of familiarity, 
perceived ability to define and self reported use in practice. Clinicians may have a preferred 
presentation format based on familiarity rather than understanding (2.6.1; 5.4.2.1) and 
triangulation allowed investigation of any association between these three utility measures. In 
addition the relationship between respondents’ perceived understanding of metrics and their 
actual application was examined (see 5.7.4.1). 
Sensitivity and specificity, the annotated 2x2 diagnostic table and PVs were reported to be 
familiar metrics by the most respondents. It is likely that this pattern of familiarity reflects 
exposure to these metrics, including their use in sources of test accuracy sources used by 
respondents. Certainly the familiarity of respondents with the pictograph is associated with its 
use in the risk communication literature. Importantly LRs and test accuracy metrics more 
commonly used in systematic reviews of test accuracy (DOR, AUC and the ROC Curve) 
were familiar to 32% of respondents or less.  
Perceived ability to define metrics and use of metrics in practice followed a similar pattern to 
familiarity. The exception was that despite a greater reported confidence in defining the 2x2 
diagnostic table, PVs were reported to be used more in practice. This finding is likely to be 
influenced by greater exposure to PVs in the literature. No research documenting the use of 
test accuracy metrics in primary evaluations of test accuracy has been identified in support of 
this hypothesis although sensitivity and specificity were the most common metrics used in 
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test accuracy reviews as documented by three recent methodological reviews 6,7 see 
(4.7.3.4).   
 
5.7.4 Application of nine different test accuracy presentation formats to a 
common testing scenario  
 
Application of test accuracy metrics across 9 hypothetical testing scenarios resulted in 
marked variation in responses to both positive and negative test results. Greater 
inconsistency and management uncertainty was observed following presentation of a 
negative test result in comparison to a positive test result. The greater inconsistency for 
negative test results was corroborated by a within-person analysis of responses, arguing 
against the observation being an artefact of random variation at sample level.  
Sensitivity and specificity (percentage and normalised frequency representations) resulted in 
the most consistency in management decisions across the sample for both positive and 
negative test results. Respondents had particular difficulty applying LRs and the DOR. 
 
5.7.4.1 The impact of respondents’ understanding of test accuracy metrics and 
graphics on management decisions 
 
An assessment of the degree to which the observed pattern of responses to scenarios can 
be explained by respondents’ understanding and informed application of test accuracy 
metrics as distinct from other contextual factors and motivational biases was informed by 
investigating the within-person relationship between self reported confidence in ability to 
define metrics and management decisions (5.5.8) and the within-person relationship between 
self reported tolerance of test errors and management decisions (5.5.7). 
 
Relationship between reported ability to define metrics and management decisions 
Lower median confidence in reported ability to define metrics was associated with an 
increase in uncertainty as measured by the proportion of ‘Don’t know’ management decisions 
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across scenarios for both positive and negative test results. This suggests informed 
application of test accuracy metrics was impacting on management decisions.  
 
Relationship between reported tolerance of test errors and management decisions 
Within-person association between tolerance of test errors and management decisions 
suggested no consistent relationship. However greater consistency in agreement between 
tolerance of false positive test errors and management decisions following positive test 
results was observed with combination graphics (2x2 table and pictograph) and greater 
consistency in agreement between tolerance of false negative test errors and management 
decisions following negative test results was observed with representations of sensitivity and 
specificity. This is congruent with effects observed in the open responses to scenarios 
(5.5.5.3) suggesting that different test accuracy presentations may have the effect of 
emphasising one or other of false positives and false negatives.  
 
5.7.4.2 Open responses as an insight to understanding 
 
Open responses to the hypothetical testing scenarios also offer an insight into the degree to 
which management decisions are informed by understanding and ability to apply test 
accuracy metrics. Open responses suggested that sensitivity and specificity appeared to be 
understood by most respondents and this is congruent with closed responses to scenarios 
where use of these metrics resulted in the most consistency in management decisions. PVs 
resulted in relatively more examples of misunderstanding by respondents and in particular 
normalised frequency representations of these metrics resulted in some respondents 
confusing PVs with sensitivity and specificity. One explanation for this observation may be 
reference class confusion (2.4.3.2).  Alternatively this observation may be a consequence of 
the relatively greater familiarity of respondents with sensitivity and specificity and the use of 
these as default metrics where there is uncertainty.  
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An annotated 2x2 diagnostic table and an annotated pictogram appeared to be accessible 
metrics for decision making and these graphics also attracted positive comments concerning 
their potential as aids to shared decision making with patients. As an approximation of a 
natural frequency presentation of test accuracy, the 2x2 diagnostic table also appeared to 
effectively communicate the relationship between pre test probability and test errors. Indeed 
test errors were prominent as part of the translational pathway from quantitative estimates of 
test accuracy conveyed by summary metrics and graphics to management decisions.  
There was no indication from open responses that normalised frequency representations of 
test accuracy offered any advantage over percentage representations, which is congruent 
with closed responses (see above). This concurs with the published literature (2.4.3.2) which 
suggests that the advantage of frequentist over percentage representations of uncertainty for 
probability revision depends crucially on the fact that natural frequencies do not require 
decision makers to consider base rates (prevalence or pre-test probability), in contrast to 
normalised frequency representations. 
The DOR, and LRs consistently attracted comments that conveyed lack of familiarity with 
these metrics. Whilst the DOR is not a metric aligned to decision making in the clinical 
encounter, the LR is a metric that has been promoted for use in this context since the mid 
1990s (2.4.1). 
 
5.7.4.3 The effects of context and motivational biases on the application of test 
accuracy metrics  
 
Context 
The context in which respondents were required to apply test accuracy information was fixed 
across scenarios in order to eliminate other factors that might modify decision making aside 
from the test accuracy metric presented. The specificity of the test presented in the scenarios 
was high and false positives regarded as the least important test error in the testing context 
presented (5.5.6) therefore a decision to refer in the presence of a positive test might be 
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considered a straightforward one and easy to communicate with patients. In contrast the 
sensitivity of the test presented in the scenarios was relatively low and false negatives were 
regarded as the more important test error in the testing context presented (5.5.6). The 
relatively greater importance attached to false negatives is likely to increase both the 
complexity of any dialogue with patients and decisions about referral which in turn may result 
in greater variation in referral decisions following a negative as opposed to a positive test 
result.  
 
The importance of prevalence and both dimensions of test accuracy when judging the 
clinical utility of a test 
 
Consideration of one dimension of test accuracy alone as a measure of a test’s clinical utility 
may mislead and the limitations of reliance on a test’s sensitivity or specificity alone in this 
respect are recognised (2.4.1.4). The relatively greater consistency in decision making 
observed with sensitivity and specificity in this survey (to refer even in the event of a negative 
test result) is likely in part to have been explained by consideration of sensitivity alone as a 
measure of a test’s ability to rule out disease (SnNOUT) (TTA27) in this particular testing 
context where false negative test errors were perceived as relatively more important.  
However an additional observation of this survey is the fact that the 2x2 diagnostic table and 
an annotated pictograph attenuated this pattern, with the majority of respondents deciding 
not to pursue further investigations following a negative test result. The simultaneous 
presentation of both dimensions of test accuracy, conveying the trade off between the two 
dimensions of test accuracy and incorporating information about prevalence are one of the 
main tenets underlying the utility of LRs. This survey demonstrates the importance of the 
complementary nature of this information for diagnostic decision making but suggests that 
presentation of these relationships using the 2x2 diagnostic table or an annotated graphic 
may be more effective at communicating these relationships than summary metrics.   
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Motivational biases 
The effect of context on the relative weight given to clinician utility relative to patient utility will 
shape how motivational biases affect decision making.  Motivational biases may occur if 
respondents are able to apply the information presented in the hypothetical scenarios 
presented in this survey:  
 Management decisions that are discrepant with test results (a decision not to refer in 
the presence of a positive test result or a decision to refer in the presence of a 
negative test result) may occur if respondents are able to incorporate information 
about test errors in their decision making.   
 The relative importance of false negative test errors is likely to result in greater 
weight given to management decisions associated with negative test results if 
respondents are able to incorporate information about test errors in their decision 
making. 
 Omission bias (1.5.2.2) is likely to operate preferentially for positive test results if 
respondents are able to incorporate information about the relative magnitude of test 
errors in their decision making: acting (an act of commission) on false positives will 
result in further investigation and anxiety for those tested, whereas acting on false 
negatives will result in increased detection of those who might benefit from treatment. 
 
The nature of the relationship between an understanding of test accuracy metrics, 
contextual factors and individual motivational biases on decision making is inevitably 
complex and the summation of effects of these contextual influences on the balance 
between patient and clinician utility are difficult to quantify.  
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5.7.5 Discussion summary 
In summary there is evidence from this survey of GPs that presentation of test accuracy 
using different metrics has a profound effect on diagnostic decision making. The ability to 
understand and apply test accuracy metrics, contextual factors and variation in individual 
motivational biases are all likely to be contributing factors to the observed variability. 
Sensitivity and specificity are understood by a significant proportion of respondents and 
result in application of quantitative estimates of test accuracy. However it is unclear to what 
extent any advantage of sensitivity and specificity over other test accuracy metrics is due to 
familiarity and reporting practice as opposed to their intuitive nature. The 2x2 diagnostic table 
and annotated pictograms appear to have promise as alternative representations of test 
accuracy and importantly may encourage consideration of the relationship between the two 
dimensions of accuracy and the effect of prevalence on these. PVs do not appear to be well 
understood and in this survey respondents did not appear aware of the potential of PVs to 
communicate the impact of pre test probability on test errors. Further research is needed to 
elucidate the degree to which the variation in decision making with different test accuracy 
presentation formats observed in this questionnaire are context-specific or are a function of 
characteristics of presentation format. 
LRs and metrics more common to systematic review of test accuracy were not familiar to 
most respondents in this survey. Metrics such as the DOR, the ROC curve and the AUC are 
not intended for use for diagnostic decision making at the bedside and therefore it might be 
expected that the majority of respondents were not able to apply them in the hypothetical 
testing scenarios presented in this survey. However the increase in the number of systematic 
reviews of diagnostic test accuracy (see chapter 3) will require practitioners to be familiar 
with the properties of these global metrics as a resource for evidence based diagnosis.  
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The lack of familiarity of respondents with LRs calls into question their usefulness as aids to 
diagnostic decision making and the effectiveness of educational interventions implemented 
as part of their promotion over the preceding decade.   
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Chapter 6: Discussion: Systematic reviews and meta-analyses of 
test accuracy: developing methods that meet practitioners’ 
needs 
 
6.1 Main findings: summary and implications for practice 
This thesis has contributed substantially towards redressing the imbalance in research 
concerned with systematic reviews of test accuracy. Test accuracy research to date has 
been dominated by methodological and statistical considerations at the expense of 
consideration of contextualisation of review findings and investigation of the extent to which 
the evidence base is accessible to decision makers. It has been observed that important 
barriers to the use of evidence include accessibility: timely access and possession of skills 
necessary for interpretation and application of information, as well as the acceptability and 
applicability of research evidence: the provision of information relevant to the decision 
context 30. Contextual information is important both because decision makers need to 
recognise the relevance of evidence to their needs and because the utility attached to 
outcomes consequent on decisions are contextually dependent.  
In recognition of recent attempts to shape the content of test evaluations both in terms of 
developing more rigorous testing policy 95 and encouraging a comparative approach to 
evaluation 96,123 this thesis is timely in reviewing the characteristics of the existing test 
accuracy systematic review evidence base and evaluating the features of test accuracy 
metrics that facilitate understanding, in order to inform such initiatives.  
 
6.1.1 Evaluation of the familiarity, use, understanding and application of test 
accuracy information for decision making (chapters 2 and 5) 
 
Whilst there is widespread belief that clinicians have difficulty applying test accuracy 
information, this has not been based on a systematic interrogation of the evidence base. As 
a result it has not been possible to date to quantify or characterise the extent of the problem 
in order to improve understanding and application. The literature reviews presented in 
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chapter 2 of this thesis have captured a breadth of perspectives pertinent to the 
understanding and application of test accuracy evidence and the findings provide a 
framework for further research.  
The survey of general practitioners presented in chapter 5 was primarily exploratory in nature 
with the aims of addressing gaps in the existing empirical literature and refining emerging 
hypotheses about features of test accuracy measures that facilitate their understanding and 
application. The primary care setting was chosen as a more diverse testing environment in 
comparison to secondary care and in order to address the under-representation of generalist 
settings in the test accuracy evidence base. The survey is an important addition to the 
existing evidence base in terms of its representativeness, particularly, in contrast to existing 
empirical literature the survey sample does not appear self selected on the basis of interest, 
expertise or experience in the topic area. 
 
6.1.1.1 Familiarity with test accuracy metrics 
 
The observation that familiarity and preference for a metric or presentation format is not a 
reliable measure of comprehension is suggested to be a function of decision makers having 
preferred presentation formats  that are based on familiarity, including example exposure to 
metrics in the published literature, rather than understanding. In addition familiarity is likely to 
encourage the use of heuristics which in turn introduce the potential for error, including 
cognitive biases. It might be expected that perceptual differences observed between ratio 
and absolute risk metrics observed in the literature concerned with communication of 
intervention risks (a relative magnification of perception of effect with ratio measures) will 
present themselves in the test accuracy literature as recent initiatives (see 6.2.1 below), 
methodological advances and a rise in the number of systematic reviews of test accuracy will 
present more opportunities for a comparative approach to test accuracy evaluation and use 
of comparative test accuracy metrics. 
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In common with the empirical literature reviewed, sensitivity and specificity, and PVs were 
reported to be familiar metrics by the most survey respondents (Chp 5) which mirrors their 
use in the published literature (4.7.3.4). Interestingly LRs were not familiar to survey 
respondents which may be a reflection of the fact that these metrics have not been widely 
adopted by the test accuracy research community or that they are difficult to comprehend 
and apply for diagnostic decision making. Metrics more commonly used in systematic 
reviews of test accuracy (DOR, AUC and the ROC Curve) were familiar to 32% of 
respondents or less which has implications for the accessibility of test accuracy reviews at 
the current time.  
 
6.1.1.2 Self reported use of test accuracy evidence for decision making 
 
Although the validity of self reported use of metrics is reliant on respondents’ understanding 
of metrics, one of the questions raised by the literature reviews in chapter 2 was the extent to 
which published estimates of test accuracy and pre-test probability are used for diagnostic 
decision making in practice. Although PVs were reported to be used by 80% of clinicians in 
one study, sensitivity and specificity were reported to be used by <4% clinicians and ROC 
curves and LRs by <1%. In addition there was evidence that decision makers were drawing 
on personal clinical experience rather than published estimates of test accuracy and pre-test 
probability. 
Similarly, in the general practice survey, personal clinical experience, colleagues, guidelines, 
web based resources and local laboratories were prominent sources of test accuracy 
information in the survey sample. The popularity of guidelines may originate from the fact 
that they do not require application of quantitative test accuracy information. However whilst 
the practical application of diagnostic research findings may be best served by clinical 
guidelines, this is not a replacement for making the explicit quantification of diagnostic 
probabilities a more frequent occurrence in clinical practice. The credibility of guidelines is 
underpinned in part by an understanding of how recommendations have been reached. 
 268 
 
Reliance on guidelines to promote evidence based testing should be underpinned by an 
appreciation of generic attributes of tests: the inevitability of test errors; the fact that tests 
merely adjust the probability of disease rather than eliminating uncertainty (the concepts of 
pre and post-test probability) and the fact that accuracy is not a fixed property of tests. 
Reliance on guidelines to promote evidence based testing is also dependent on the ability of 
guideline developers themselves to understand and apply test accuracy information; the 
aptitude of the policy making community in this area is unknown at the present time as the 
policy maker perspective was absent from the empirical and non empirical test accuracy 
literature and was outside the remit of the survey. In addition, if guidelines are to underpin 
the promotion of evidence based testing, challenges will include capturing the complexity of 
the diagnostic work up which is not restricted to determining the probability of any single 
disease and is symptom rather than disease based investigation. 
 
6.1.1.3 Understanding and application of test accuracy evidence 
 
Investigation of the characteristics of test accuracy information that facilitate diagnostic 
decision making has been shaped by an implicit assumption that formal probability revision is 
a necessary pre-requisite. This is despite evidence that published estimates of pre-test 
probability and test accuracy are unlikely to be used for formal probability revision in practice. 
Self reported use of Bayes’ theorem for diagnostic decision making was less than 3% in one 
study (ETA29); estimation of pre-test probability and accuracy of named tests is observed to be 
inaccurate and highly variable and provision of quantitative information about test accuracy 
does not appear to improve probability revision. 
The discipline of psychology is dominant in this area of research which consistently 
demonstrates the greater accessibility of frequency formats over probabilistic representations 
for probability revision. 
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A consequence of the emphasis on probability revision and presentation format (frequency 
versus probability) is that investigation of the utility of summary metrics more common to 
medical research for diagnostic decision making has been limited. For example the utility of 
PVs (which are a direct expression of post-test probability) and the 2x2 diagnostic table (a 
natural frequency expression of test accuracy), has not been investigation. Only two studies 
investigating the utility of summary metrics in medical settings identified in the literature 
reviews and provide no evidence to distinguish sensitivity and specificity and likelihood ratios 
for improving the accuracy of probability revision.  
The pertinence of the existing evidence base therefore depends on the extent to which 
formal probability revision is a necessary pre-requisite for informed diagnostic decision 
making; an assumption which is challenged by the findings of the general practice survey 
presented in chapter 5.  
Open responses to the general practice survey suggest that summary test accuracy metrics 
common to the medical literature can result in informed diagnostic decision making without 
recourse to formal probability revision. It is however unclear whether this is a consequence of 
familiarity rather than inherent characteristics of individual metrics that facilitate 
understanding. Importantly test accuracy metric had a profound impact on diagnostic 
decision making which has implications if the use of quantitative test accuracy estimates is to 
be encouraged in practice. Open responses suggested several factors were likely to be 
contributing to the observed variation: 
-differences in understanding and ability to apply metrics 
-methods for combining the 2 dimensions of test accuracy (encouraging comparison of the 
magnitude of test errors (false positives and false negatives); the degree to which test errors 
are made explicit  and the impact of prevalence on the absolute numbers of test errors 
-contextual factors (the downstream consequences of test results)  
This observation is consistent with those made in the non-empirical literature presented in 
chapter 2, highlighting the need to distinguish between the two dimensions of test accuracy 
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due to the contextually dependent importance of test errors whilst also recognising that 
considering any one dimension in isolation has the potential to mislead with respect to the 
utility of a test. These findings suggest that explicit quantification of test errors (not currently 
a feature of existing summary test accuracy metrics) may represent a possible mechanism 
for aligning test accuracy more closely to clinical decision making. 
 
6.1.1.4 The interplay between contextual factors and test accuracy metric on 
comprehension 
 
The nature of the relationship between comprehension of test accuracy metrics, the impact 
of presentation format and contextual factors impacting on patient and professional utility for 
decision making is inevitably complex and the summation of effects of these influences are 
difficult to quantify and predict. Further research is needed to unpick the contribution of 
motivational and contextual influences distinct from comprehension. Although requiring 
decision makers to manipulate probabilities as a measure of comprehension of test accuracy 
information has construct validity, it is unlikely to be representative of how test accuracy 
information is used in practice or a necessary pre-requisite for informed use of test accuracy 
information for decision making. In addition an awareness of the potential contextual and 
perceptual modifiers of test accuracy information is essential in order to ascertain the degree 
to which educational interventions are likely to impact on decision making, to ensure a 
productive dialogue with clinicians who are the recipients of guidelines concerning test use 
and to ensure that choice of test accuracy metrics adequately capture both dimensions of 
test accuracy. 
 
6.1.2 Contextualisation of the test accuracy evidence base (chapters 3 and 4)  
6.1.2.1 Epidemiological characteristics of existing test evaluation reviews 
 
 Systematic reviews are an important resource for summarising existing knowledge and 
underpin guideline development and needs assessment for research activity. Systematic 
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reviews and meta-analyses of test evaluations are increasing in number and prominence as 
a resource for diagnostic decision making.  
Chapter 3 demonstrates that reviews of test accuracy dominate the test evaluation 
landscape. Within this body of research, tests more commonly applied in secondary care and 
certain disease topic areas predominate and there is a lack of comparative test accuracy 
evaluation. Based on the epidemiological characteristics of test evaluations it is unlikely that 
the existing evidence base reflects the clinical need for evidence. 
 
6.1.2.2 The contextual fit of test accuracy evaluations 
 
Question formulation 
It is particularly important that test evaluation is grounded on well defined clinical questions 
as many tests are applied far removed from a final diagnosis and by a variety of 
professionals. Lack of clarity at the question formulation stage precludes judgement about 
the utility of the information provided by review findings. Detailed scrutiny of test accuracy 
reviews presented in chapter 4 reveals ill-defined objectives which are reflected in question 
formulation, review synthesis and reporting of findings. The place of index tests within a 
testing pathway is mostly not articulated by consideration of test role, (add, replace, triage), 
healthcare setting, patient presentation, prior tests or current testing practice. The 
importance of clear question formulation for planning a synthesis framework, including 
investigation of heterogeneity and the contextualisation of review findings needs promoting. 
The investigation presented in chapter 4 suggests that at the current time inadequacies in 
question formulation and the subsequent impact on contextualisation of test accuracy review 
findings may be undermining the potential for statistical and methodological advances in 
meta-analysis of test accuracy to positively impact on diagnostic decision making. 
Existing guidance pertinent to the contextualisation of test accuracy review questions is 
limited to recent initiatives of the Cochrane Collaboration and personal experience suggests 
that review authors, including clinicians, find question formulation in this area difficult. This is 
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supported by the findings presented in chapter 4. The relative lack of familiarity of the 
research community with the architecture of test accuracy evaluation and a lack of 
appreciation of spectrum effects on test accuracy are likely to be contributing to these 
observed difficulties. Difficulty with question formulation is likely also to reflect testing culture, 
which has been characterised by indiscriminate introduction of new testing technology 
without sufficient consideration of the intended role of a test in a testing pathway (see 
chapter 1). Dissemination of a framework within which to consider evaluations of test 
accuracy will therefore need to be accompanied by a more critical approach to the adoption 
of new tests. 
 
Contextualisation of review findings 
In the absence of information about clinical context, the results of test accuracy evaluations 
will mislead and encourage a lack of consideration of the importance of spectrum effects. In 
addition consideration of the downstream harms and benefits of positive and negative test 
results is necessary to link diagnostic accuracy with clinical decision making. 
Reporting of study characteristics, consideration of the applicability of review findings and 
consideration of the downstream consequences of test results was observed to be poor in 
the reviews scrutinised as part of this research, despite the fact that ninety four percent 
included a clinician as a co-author. 
Lack of contextual fit and poor reporting of included primary studies did not appear to be 
responsible for lack of contextualisation of review findings, on the basis that a minority of 
reviews reported limitations in the primary evidence base. In addition, lack of 
contextualisation of review findings is unlikely to be due to limitations in review reporting as 
lack of clarification at question formulation stage was not rectified at subsequent review 
stages. Lack of contextualisation of review findings is therefore likely to represent 
deficiencies in methodological approach rather than being entirely a function of limitations in 
the primary evidence base and restrictions on reporting imposed by publication.  
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A structured assessment of external validity according to a clearly focused review question 
should be promoted as complementary to, and as important as, an assessment of internal 
validity. In addition any guidance concerned with contextualisation will be more effective if it 
is coherent with statistical and epidemiological developments in this area.  
 
Use of outcome measures in reviews 
The majority of reviews reported between 2 and 3 outcomes although a substantial minority 
(26/99) reported four or five outcomes. Lack of consideration of context, including the 
downstream consequences of test results in the reviews scrutinised suggests that use of 
multiple metrics is not underpinned by an appreciation of the particular dimension or 
dimensions of test accuracy that each metric conveys. Without an appreciation of the 
relationship between different test accuracy metrics, review authors are likely to use metrics 
indiscriminately without conveying those aspects of a test’s performance that are most 
important in any given clinical context. Evidence reviewed in chapter 2 suggests that multiple 
numerical metrics are perceived as unhelpful. There is therefore a need for development of 
guidance to assist with the optimum use of test accuracy outcome metrics to support 
decision making.   
 
Test evaluation in generalist settings 
The traditional test accuracy evaluation framework does not fit the early stages of the testing 
pathway well and the research community needs to consider whether this is acting to 
discourage test evaluation in generalist settings, including evaluation of the clinical history 
and examination. Greater emphasis on the purpose of testing may help to identify disorders 
that are priority ‘rule outs’ in generalist settings and for which evaluation of a single 
dimension of test accuracy across these multiple priority target disorders is justifiable. A 
similar approach could be taken for priority ‘rule- ins’. 
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6.1.3 Summary:  Implications for practice 
The evidence presented here suggests that quantitative estimates of test accuracy are not a 
prominent resource for diagnostic decision making in practise. Formal probability revision is 
unlikely to be commonplace in practice or a necessary pre-requisite for informed decision 
making. However the extent to which use of test accuracy metric impacted on decision 
making in the hypothetical testing scenarios presented in chapter 5 has important 
implications for practice.  
The thesis findings raise questions about the extent to which existing use of metrics is based 
on familiarity rather than ease of application. Counter to what might be expected from the 
review of empirical and non empirical literature presented in chapter 2, sensitivity and 
specificity appeared to result in the most informed decision making in the survey presented in 
chapter 5. Sensitivity and specificity are prominent metrics in test accuracy research and 
medical education; a situation that is likely to be historical and supported by a widespread 
misperception that they represent fixed properties of tests. Further, empirical investigation of 
the accessibility of existing test accuracy metrics has been based on the premise that formal 
probability revision should be aspired to and is common place in practice. The effect of these 
perspectives is likely to have stifled meaningful empirical investigation of the utility of existing 
metrics for diagnostic decision making and the development of novel methods for 
communicating test accuracy. The findings from this thesis suggest that presentation formats 
that encompass prevalence and quantify, in frequentist terms, the number of test errors 
relative to correct test results have the potential to facilitate informed diagnostic decision 
making.  
The concept of evidence based testing is challenged by the findings of this thesis, although it 
is unclear the extent to which this is a result of problems with comprehension and lack of 
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familiarity with test accuracy evaluations and outcome measures on behalf of decision 
makers or deficiencies in the existing test accuracy evidence base. 
 
6.2 Application of research findings 
It is extremely likely that the large observed degree of variation in testing behaviour and any 
inappropriate rise in testing is in part a reflection of the lack of contextualisation of the 
evidence base and the accessibility of test accuracy metrics for decision makers.  
 
6.2.1 Existing initiatives 
Researchers have begun to draw attention to the fact that in the absence of information 
about clinical context, presentation of test accuracy evaluations may be misleading 28 and it 
is suggested that examination of the downstream harms and benefits of positive and 
negative test results is necessary to link diagnostic accuracy with clinical decision making 44. 
Researchers are being directed to consider of the role of tests in testing pathways as a 
means of encouraging a comparative approach to test accuracy evaluation 96,123. Explicit 
links between important aspects of question formulation have recently received attention 124 
and recent guidance for undertaking medical test reviews from the Agency of Healthcare 
Research and Quality 120 stress the need for a clear distinction between internal and external 
validity.  
In addition, advances in statistical techniques that allow a more sophisticated and robust 
investigation of  heterogeneity 125,126 are now more widely disseminated and have the 
potential to support reviews in addressing questions of maximal clinical relevance. 
The GRADE (Grading of Recommendations Assessment, Development and Evaluation) 
working group (http://www.gradeworkinggroup.org/) have highlighted the importance of 
explicit consideration of the role of tests being evaluated in order to place the use of 
individual tests within the diagnostic pathway for a condition. Test accuracy is considered as 
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an intermediate outcome  and the GRADE group also recommend that the impact of all 
possible tests results (true negatives, true positives, false negatives, false positives) on 
patient outcomes (tests and treatments received and ultimately morbidity and mortality) 
should be considered 127,128. However the GRADE initiative is concerned with the 
development of frameworks within which to consider evidence for guideline developers, 
rather than targeting those undertaking test accuracy reviews or using test accuracy 
information. Thus the impact of the work of GRADE to date is likely to have a limited impact 
on encouraging contextualisation of test accuracy evaluations.  
 
The QUADAS instrument for the quality assessment of primary studies to be included in 
reviews has recently been updated (QUADAS 2) 129 to include a clear differentiation between 
internal validity (risk of bias) and external validity (applicability). Although these 
developments should encourage review authors to consider the contextual fit of included 
studies, subjective judgments about external validity based on signalling questions are not a 
replacement for the provision of information to allow an independent assessment of 
applicability by readers. In the absence of reporting guidelines for systematic reviews of test 
accuracy, the potential for review authors to consider the use of QUADAS 2 a replacement 
for a more detailed consideration of clinical context should be considered. The STARD 
initiative 38 concerned with reporting of primary test accuracy research,  has been used by 
some review authors alongside the QUADAS instrument to guide an assessment of external 
validity of included studies (personal communication).  
 
Initiatives concerned with the evaluation of diagnostic technologies in the NHS have followed 
recommendations from Lord Darzi’s next stage review 95. The Centre for Evidence based 
Purchasing (CEP)  superseded the Device Evaluation Service (DES) in 2005 and provides 
information to assist with purchasing decisions in the UK National Health Service for all 
medical devices with a CE mark, including diagnostic devices. This information can now for 
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the first time include reviews of effectiveness and cost-effectiveness. In addition, the NICE 
(National Institute for Health and Clinical Excellence) Diagnostic Appraisals Programme is 
nearing the end of its first year. The programme is not restricted to evaluations of test 
accuracy but includes assessments of the impact of diagnostic technologies across care 
pathways and should encourage a more critical adoption of new tests and scrutiny of existing 
testing pathways. 
 
The Cochrane Handbook for Diagnostic Test Accuracy Reviews 96 is an important resource 
for those undertaking test accuracy reviews. However the handbook is incomplete as at 2012 
and the personal experience of those undertaking training for Cochrane review groups and 
authors suggests that some issues pertinent to the contextualisation of reviews may not be 
clearly articulated. In addition, software developed for production of Cochrane reviews of 
diagnostic test accuracy 130 has important limitations in this respect; for example it is currently 
not possible to produce a summary table of study characteristics to allow readers to assess 
the applicability of included studies or to present the results of quality assessment or study 
characteristics for studies sub-grouped according to important potential causes of 
heterogeneity.  
 
6.2.2 Contribution of the research findings 
Dissemination of these research findings are required in order to challenge beliefs prominent 
in the existing literature which rely heavily on the views of clinical academics. Examples 
include the accessibility of LRs for decision making, the intuitive nature of PVs and the 
intractable nature of misunderstanding in this area. 
Chapter eleven of the Cochrane handbook will offer guidance on the interpretation of results 
and inform the development of a summary of results table for Cochrane Diagnostic Test 
Accuracy Reviews. A steering group is to oversee the development of the chapter which will 
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draw on relevant research concerned with the comprehension, application and 
contextualisation of test accuracy evaluations. It is anticipated that the work of the steering 
group will result in guidance on applicability, presentation of test accuracy information, 
consideration of the downstream consequences of test results and the critical and 
complimentary use of test accuracy metrics as well as highlighting areas in need of further 
research. This thesis represents an invaluable resource for the development of this chapter 
and the author is a member of the steering group. 
  
Improving the clinical relevance of questions about test accuracy should have a positive 
impact on all aspects of the conduct of systematic reviews of test accuracy and will assist 
with the interpretation of results and assessment of the impact of findings. Explicit links 
between important aspects of question formulation, such as the role in which index tests are 
being evaluated, and supporting statistical techniques are stressed as part of the guidance 
for undertaking Cochrane DTA reviews and are a key aspect of training of review authors. 
The author is member of the Cochrane Diagnostic Test Accuracy Working Group and 
recently appointed member of the Diagnostic Test Accuracy Editorial Team and will therefore 
be in a position to disseminate findings of this research in order to support an improvement in 
the contextual fit of test accuracy reviews. In addition the findings of this research have been 
presented at the most recent annual Cochrane colloquium 131,132.  Dissemination to the wider 
research community (out with the Cochrane Collaboration) is likely to be slower but will be 
facilitated by publication of the findings of this research. Raising awareness about the 
importance of question formulation to ensure contextual fit and therefore clinical relevance of 
systematic reviews of test accuracy is important in order to ensure that reviews fulfil their 
potential to improve the test accuracy evidence base in parallel with the recognised 
improvements in primary test accuracy studies needed. 
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The thesis’ findings themselves may be sufficient to inform the development of a number of 
focused educational initiatives. Guidance to those conducting test accuracy reviews might 
include: 
- providing a brief definition of test accuracy metrics as part of the reporting of review findings 
- explanation of the different and complementary nature of test accuracy metrics: this might 
be supported by an annotated 2x2 diagnostic table to illustrate inter-relationships 
 -illustration of the relationship between the two dimensions of test accuracy and the effect of 
prevalence on the magnitude of test errors 
 
Such guidance should also result in a more critical and considered use of test accuracy 
metrics by researchers.  
No reporting guidance is available for systematic reviews and meta-analyses of test accuracy 
studies. The deficiencies highlighted by the review of test accuracy reviews (chapter 4) 
represents an important addition to existing knowledge concerning the impact of primary test 
accuracy study quality and reporting practice  38,41 as well as the internal validity of the 
systematic review process itself (PRISMA) 133.  
Assessment of the quality of the systematic reviews included in the methodological review 
using tools developed for the conduct of systematic reviews and meta-analysis of 
interventions (AMSTAR) 110 and (QUOROM) 111 was not associated with quality of question 
formulation or contextualisation of review findings.  On the basis of this finding it appears that 
existing guidance for assessing the quality of conduct and reporting of systematic reviews 
does not capture important design and reporting features pertinent to systematic reviews of 
test accuracy. The potential for reporting guidelines to influence the conduct of systematic 
reviews is particularly great as reporting and conduct are closely entwined.  
Although there is no generic guidance on how to develop a reporting guideline, Moher and 
colleagues 134 propose a strategy underpinned by an executive guideline group, a systematic 
review of the literature and the need for and a face to face meeting consensus meeting with 
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key stakeholders. The importance of a dissemination strategy utilising multiple and 
simultaneous publication as well as extensive post-publication activities to encourage 
guideline endorsement is emphasised. Widespread dissemination of reporting guidelines for 
RCTs (the CONSORT statement) accompanied by endorsement by journal editors appears 
to have had an impact on research conduct 135,136.  
 
6.3 Strengths and Limitations 
Strengths 
A major strength of this thesis in comparison to existing work is the representative nature of 
the systematic review (chapters 3 and 4) and survey (chapter 5) samples.  
Investigations of test accuracy review methodology to date have been conducted on review 
samples selected on the basis of topic, (for example Mallet 2006) 106 or convenience samples 
drawn from single, quality assured review databases 6,7.The review findings presented in 
Chapters 3 and 4 represent a comprehensive review of five diverse systematic review 
databases in order to gauge the volume and type of test evaluations and their 
epidemiological characteristics. This comprehensive repository of reviews allowed the 
selection of a smaller sample of reviews for detailed scrutiny representing a range of tests, a 
range of healthcare settings and conducted to variable quality standards.  
A major strength of the survey presented in chapter 5 compared with previous empirical 
research in this area, is the size and representativeness of the sample. Respondents do not 
appear to be self-selected on the basis of expertise or experience in the topic area.   
 
In addition this thesis includes the first systematic enquiry of the published literature 
concerning the understanding and application of test accuracy information undertaken to 
date. The breadth of the bibliographic search strategy used to inform chapter 2, as well as a 
check of face and content validity at an international test evaluation symposium is likely to 
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have captured key issues that have been considered by empirical and non empirical 
researchers regarding the accessibility of existing test accuracy metrics for decision making 
to date. Adopting a qualitative approach to the investigation of understanding and application 
of test accuracy metrics presented in the published literature has offered a unique insight into 
presentation formats that may act as facilitators or barriers to their use.  
The internal validity of the thesis’ findings is supported by internal consistency observed 
across its individual elements. Opportunities for comparison concerning understanding and 
application of test accuracy information between the published literature (chapter 2) and the 
survey in primary care (chapter 5) are limited by disparities in sample composition and 
investigative approach. However themes observed in both investigations include a feeling of 
obligation to pursue further testing to reduce uncertainty (5.5.5.3; 2.4.2), problems with 
probability revision (2.5.3; 5.5.5.3), confusion of reference class (2.5.3.2; 5.5.5.3), preference 
for graphical and mixed numerical and verbal presentations of probability (2.6.1.2; 5.5.5.3), 
and unfamiliarity with and use of LRs and summary metrics more common to systematic 
reviews (2.5.1.1; 5.5.4.2; 5.5.4.3). 
 
Limitations 
The review of non empirical and empirical test accuracy literature represents the 
perspectives of experts rather than practising clinicians and it is probable that 
comprehension, accuracy of perception and ability to manipulate risks has been 
overestimated with less clear impact on preference for metric and presentation format. In 
addition, the lack of representation of the perspective of generalist settings in the published 
literature (chapter 2) is mirrored by a paucity of test accuracy evaluations in primary care 
(chapters 3 and 4). The importance of multidisciplinary perspectives and difficulties 
associated with searching for literature concerned with test accuracy present challenges to 
any attempt to comprehensively capture literature relevant to consideration of the 
accessibility of existing test accuracy metrics and graphics for decision making. However the 
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exclusive use of published literature will have resulted in under-representation of practising 
clinicians for the non-empirical evidence base reviewed. Indeed 25 of 30 non empirical 
papers were authored by clinicians, of which 16/25 were affiliated with an academic 
institution (2.4).  
The results of an assessment of the contextualisation of test accuracy reviews presented in 
chapter 4 is likely to have presented an overoptimistic picture as a result of the subjective 
nature of data extraction, the clinical and methodological expertise of the author and the 
broad assessment framework used which may not be optimal for the topic of any single 
review. It is therefore likely that the assessment of the extent to which test accuracy reviews 
addressed testing context is overoptimistic and recommended remedial action more 
pertinent. 
 
The depth afforded to the analysis in the survey was at the expense of a relative lack of 
representation of the policy maker perspective in the published literature as well as 
comprehensive consideration of different testing contexts.  The findings of the survey are 
therefore not generalisable to policy making environments. The extent to which they are 
reflective of the secondary care setting is less clear.  
 
 
6.4 Research recommendations 
6.4.1 Evaluation of the understanding and application of test accuracy 
information for decision making 
 
The results of this thesis leave considerable uncertainty regarding the most accessible 
method for integrating test accuracy evidence into decision making. This uncertainty is 
present at two levels; the first the degree to which decision makers seek and use research 
based estimates of test accuracy and the second, the presentation format or combination of 
presentation formats that is optimal for the promotion of informed diagnostic decision making. 
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The contribution of this thesis has been to characterise the existing evidence base, highlight 
deficiencies and to challenge the prevailing view that ability to undertake probability revision 
is a necessary pre-requisite for informed diagnostic decision making.  
Although the survey conducted in primary care represents an important addition to the 
evidence base it was primarily exploratory in nature and its major strength lies in its ability to 
inform future research. The scope of the primary research possible in the time available was 
limited and test accuracy metrics, testing context and the decision maker sample were 
selected to best address limitations of the existing published literature whilst supporting the 
evolution of the evidence base. In particular the content of the survey has been driven by an 
assessment of the utility of existing metrics, presentation formats and sources of test 
accuracy information and not by an evaluation of the needs of decision makers. Based on 
the contribution of the open responses to the interpretation of the findings of this 
questionnaire qualitative research should play a key role in further research aiming to 
elucidate sources of variation in understanding and application of test accuracy metrics.  
Specific research questions arising from the survey include: 
 The extent to which sources of test accuracy evidence and estimates of pre-test 
probability are sought in practice, their perceived usefulness and facilitators and 
barriers to their use.  
 The consistency of the findings of this thesis concerning the use, understanding and 
application of test accuracy information in representative clinical samples across 
different clinical disciplines in order to distinguish the effect of contextual factors and 
motivational biases on decision making distinct from methods of presenting test 
accuracy information. For example contextual variables may be specific to 
professional groups, reflecting their position in the referral pathway or particular 
challenges associated with a patient group.  
  The effect of contextual modifiers on test and test-treat thresholds in order to inform 
assessment of the potential impact of a test’s accuracy in specific clinical testing 
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contexts. Quantification of test and test-treat/test-refer thresholds in specific clinical 
contexts may also assist with prioritisation of test accuracy evaluations.  
 Understanding and application of test accuracy presentation formats that include: 
- explicit provision of information about test errors as a possible mechanism 
for aligning estimates of test accuracy more closely to clinical decision 
making. 
- the 2x2 diagnostic table as a natural frequency expression of test accuracy 
and in particular investigation of whether natural frequency expressions offer 
any advantage over PVs which provide a direct estimate of setting-specific 
post-test probability 
- graphical displays of test accuracy information  
- mixed (combinations of verbal, graphical and numerical) presentation 
formats 
 
 The importance of the ability of clinicians to undertake formal probability revision as a 
facilitator of effective diagnostic decision making at the bedside. Research efforts 
should be directed at developing and assessing the utility of test accuracy information 
that incorporates context specific information about prevalence in order to negate the 
need for probability revision in clinical practice.  
 Clarification of the complex relationship between spectrum, prevalence and test 
accuracy in order to determine whether disease reference class measures (for 
example sensitivity, specificity) and metrics derived from these measures (LRs) offer 
any advantage over PVs in this respect. Indeed recent research suggests that directly 
deriving PVs from meta-analysis produces similar estimates to PVs derived indirectly 
from summary estimates of sensitivity and specificity 86. Clarification of the nature of 
the relationship between spectrum, prevalence and test accuracy metric would also 
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inform spectrum and prevalence standardised test accuracy estimates as one method 
for promoting the contextual fit of the evidence base.  
 The degree to which the policy maker community comprehend and can apply test 
accuracy metrics. Indeed such an investigation would be timely with the introduction 
of new initiatives such as the NICE Diagnostic Appraisal Programme and the 
development of the Cochrane Database of Diagnostic Test Accuracy Reviews. 
Preliminary research in this area suggests that lack of familiarity with the architecture 
of test accuracy research may contribute to problems with the comprehension of test 
accuracy metrics in test accuracy systematic reviews 137. 
 The extent to which variation in tolerance of test errors contributes to variation in 
diagnostic decision making. Exploration should include testing scenarios that capture 
variation in the risk associated with the testing process itself and variation in the 
consequences of test errors as a result of the seriousness of the target condition and 
the risks associated with further testing or treatment. 
 
 
 
6.4.2 Contextual fit of test accuracy evidence 
The methodological review presented in chapter 4 aimed to capture how testing context was 
being incorporated into systematic review methods and represented in the reporting of 
review findings. The research strongly suggests that deficiencies in the methodological 
approach to question formulation underpin deficiencies in the contextual fit of existing test 
accuracy reviews, magnifying the complexity associated with synthesis of primary test 
accuracy studies. The process of identifying a representative sample of test accuracy 
reviews allowed investigation of the epidemiological characteristics of the existing test 
accuracy evidence base. The pattern of research activity is unlikely to be addressing clinical 
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need with under-representation of tests applicable to generalist settings and no clear 
explanation for activity concentrated in certain disease topic areas. Initiatives that are 
supported by the findings from this thesis include: 
 The development of links between identified priorities for test accuracy evaluation and 
research activity. The recently introduced NICE diagnostic appraisals programme 
should improve the clinical relevance of test accuracy evaluation.  In addition 
prioritisation of test accuracy research could be informed by expansion of initiatives 
such as the James Lind Alliance Priority Setting Partnership 
(http://www.lindalliance.org/Introduction.asp)  that aims to prioritise research on the 
basis of uncertainties shared by clinicians, patients and carers and The Database of 
Uncertainties about the Effects of Treatments (DUETS)  which has been established 
to identify and publish patients' and clinicians' questions about effectiveness that are 
not answered by existing systematic reviews, (www.library.nhs.uk/DUET ).   
 Dissemination of the epidemiological characteristics of existing review databases as 
part of resources for test accuracy review authors. These databases represent a 
resource for primary studies of test accuracy 138. The field is a dynamic one and 
revisiting the databases originally considered for chapters 3 and 4 of this thesis 
revealed considerable changes over a 4 year period.  
 The development of test accuracy review reporting guidelines (considered above 
6.2.2). Guideline development should reflect the findings of any further research 
concerned with improving the accessibility of test accuracy metrics. In addition 
educational initiatives designed to promote an understanding of the inter-relationship 
between existing test accuracy metrics and a more critical and considered use of test 
accuracy metrics (6.2.2) have the potential to encourage more imaginative 
presentation formats and may provide data on which to refine reporting guidelines, 
particularly reporting of meta-analyses of test accuracy. The success of reporting 
guidelines for test accuracy reviews should be evaluated by a re examination of the 
 287 
 
conduct and reporting of systematic reviews of test accuracy, although a minimum 
delay of 5 years between dissemination and evaluation is likely to be required 97. 
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6.5 End piece 
This thesis represents an important contribution to knowledge in the area of test accuracy 
evaluation. Existing empirical research concerning the understanding and application of test 
accuracy information is not driven by the needs of decision makers and is based on an 
unproven assumption that probability revision is a necessary pre-requisite for informed 
diagnostic decision making. Original primary research has demonstrated that quantitative 
estimates of test accuracy are unlikely to be used by clinicians at the current time. Initiatives 
to encourage evidence based testing need to be developed mindful of the fact that choice of 
test accuracy metric appears to have a profound influence on decision making. 
Comprehension of test accuracy metrics, the use of interpretation heuristics promoted in 
support of evidence based testing and characteristics of metrics themselves - particularly 
those concerned with conveying the relationship between the two dimensions of test 
accuracy and pre-test probability, are likely to be important modifiers of decision making 
behaviour.  
The existing test accuracy evidence base does not appear to reflect the clinical need for 
information. A historical pattern of research activity, a lack of comparative test accuracy 
evaluations and deficiencies in question formulation are undermining the potential 
contribution of systematic reviews of test accuracy to promote evidence based testing. 
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